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ABSTRACT 
BACKGROUND 
Joint Hypermobility Syndrome (JHS) is a heritable disorder associated with laxity and pain in 
multiple joints. Physiotherapy is the mainstay of treatment but there is little research 
investigating its effectiveness.  
 
OBJECTIVES 
To develop a comprehensive physiotherapy intervention for adults with JHS; pilot the 
intervention; and conduct a pilot randomised controlled trial (RCT) to determine the 
feasibility of conducting a future definitive RCT. 
 
DESIGN 
Patients’ and healthcare professionals’ perspectives on physiotherapy for JHS were explored 
in focus groups (Stage 1). A working group of patient research partners, clinicians and 
researchers used this information to develop the physiotherapy intervention. This was piloted 
and refined on the basis of patient and physiotherapist feedback (Stage 2). A parallel two-arm 
pilot RCT compared Advice against Advice & Physiotherapy (Stage 3). 
 
SETTING 
Stage 1: Focus groups were conducted in four UK locations. Stage 2 & 3: Piloting of the 
intervention and the pilot RCT were conducted in two UK secondary care NHS Trusts .  
 
PARTICIPANTS 
Stage 1: Patient focus group participants (n=25, 3 men) were over 18 years, had a JHS 
diagnosis and had received physiotherapy within the preceding 12 months. Health 
professional focus group participants (n=16, 3 men; 14 physiotherapists, 2 podiatrists) had 
experience of managing JHS. Stage 2: Patient participants (n=8) were over 18 years, had a 
JHS diagnosis and no other musculoskeletal conditions causing pain. Stage 3: Patient 
participants for the pilot RCT (n=29) were as for Stage 2 but the lower age limit was 16 
years. 
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INTERVENTION 
For the pilot RCT (Stage 3) the Advice intervention was a one-off session, supplemented by 
advice booklets. All patients could ask questions specific to their circumstances and receive 
tailored advice. Participants were randomly allocated to ‘Advice’ (no further advice or 
physiotherapy) or ‘Advice & Physiotherapy’ (an additional six 30 minute sessions over 4 
months). The Physiotherapy intervention was supported by a patient handbook and delivered 
on a one-to-one patient-therapist basis. It aimed to increase patients’ physical activity through 
developing knowledge, understanding and skills to better manage their condition. 
 
MAIN OUTCOME MEASURES 
Data from patient and health professional focus groups formed the main outcome from Stage 
1. Patient and physiotherapist interviews formed a major component of Stages 2 and 3. The 
primary outcome in Stage 3 related to the feasibility of a future definitive RCT. Secondary 
outcomes included clinical measures (physical function, pain, global status, self-reported 
joint count, quality of life, exercise self-efficacy and adverse events); resource use (to 
estimate cost-effectiveness); and an estimate of the value of information from a future RCT. 
Outcomes were recorded at baseline, 4 months and 7 months. 
 
RESULTS 
Stage 1: JHS is complex and unpredictable. Physiotherapists should take a long term holistic 
approach rather than treating acutely painful joints in isolation. Stage 2: A user-informed 
physiotherapy intervention was developed and evaluated positively. Stage 3: Recruitment to 
the pilot RCT was challenging, primarily due to a perceived lack of equipoise between 
Advice and Physiotherapy. The qualitative evaluation provided very clear guidance to inform 
a future RCT, including enhancement of the Advice intervention. Some patients reported that 
the Advice intervention was useful and the Physiotherapy intervention was again evaluated 
very positively. The rate of return of questionnaires was low within the advice group but 
reasonable in the physiotherapy group. The Physiotherapy intervention showed evidence of 
promise in terms of primary and secondary clinical outcomes. The Advice arm experienced 
more adverse events. There is potential for high value from a future RCT.  
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CONCLUSION 
A future definitive RCT of physiotherapy for JHS seems feasible, although the Advice 
intervention should be made more robust to address perceived equipoise and subsequent 
attrition. 
 
FUNDING 
This project was funded by the National Institute for Health Research, Health Technology 
Assessment Programme (10/98/05).    
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PLAIN ENGLISH SUMMARY 
 
We did an initial study to see if it is worth doing a much larger study of physiotherapy for 
people with Joint Hypermobility Syndrome (JHS). People with JHS are often called ‘double-
jointed’ but the condition is far from trivial, causing joint pain and problems with physical 
and mental wellbeing. Physiotherapy might help but there is no research evidence to show 
whether or not it works. 
 
We spoke to groups of patients to understand how they live with JHS. They told us it takes a 
long time to get diagnosed, JHS is unpredictable and it has a huge impact on their lives. 
Physiotherapy was best when their therapist understood JHS and treated their whole body, 
rather than concentrating on just one painful joint. We also spoke to health professionals who 
have an interest in JHS and they told us that patients need to be supported to better self-
manage their condition. 
 
Our patient research partners helped us to develop a physiotherapy intervention which 
involves attending for six 30 minute sessions over a four month period. It aims to help 
patients to better understand JHS, to manage their condition better, and to become more 
physically active. We compared people who got the new intervention against people who had 
a single advice session. People told us that they were generally enthusiastic about the advice 
session and the new physiotherapy intervention and we learned a lot about doing a study in 
this area. It seems that a much larger study is worth doing in the future to find out whether 
physiotherapy really provides worthwhile benefits.   
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SCIENTIFIC SUMMARY 
 
BACKGROUND 
Joint Hypermobility Syndrome (JHS) is a heritable connective tissue condition characterised 
by increased range of motion and pain at multiple joints. JHS is associated with significant 
impairment in physical function, psychological function and quality of life. However there is 
currently a lack of information about the experiences of living with and managing JHS. 
Physiotherapy, particularly exercise, is the mainstay of treatment but there is also little 
existing robust research evidence regarding its effectiveness. This research programme 
therefore aimed to understand patient and health professional perspectives on the 
physiotherapy management of JHS; to use this information to develop and then evaluate a 
comprehensive physiotherapy intervention package; and to determine the feasibility of 
conducting a randomised controlled trial (RCT) in this area. 
 
OBJECTIVES 
The specific objectives of the research programme were to: 
1. Develop a comprehensive physiotherapy intervention for adults with JHS informed by 
patient and health professional focus groups (Stage 1). 
2. Pilot implementation of the intervention in practice in two NHS Trusts (Stage 2). 
3. Conduct a pilot randomised controlled study of the intervention (Stage 3) to 
determine:  
(a) The number of potentially eligible patients with JHS. 
(b) The feasibility of recruitment and retention. 
(c) Acceptability of the research design and physiotherapy intervention to patients in 
terms of quality of life. 
(d) Acceptability and feasibility of the physiotherapy intervention to physiotherapists in 
terms of training and implementation. 
(e) An estimate of the value of information (VOI) from a subsequent RCT. 
 
Secondary outcomes from the pilot RCT (Stage 3) were to pilot outcome measures planned 
for a definitive RCT. These included: 
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• Physical function, pain, global status, fatigue, and self-reported joint count 
(Multidimensional Health Assessment Questionnaire - MDHAQ). 
• Pain at rest and on movement (Visual Analogue Scales - VAS). 
• A new condition-specific physical function questionnaire developed by the research 
team (the Bristol Impact of Hypermobility questionnaire - BIoH). 
• Health-related quality of life preference score (EuroQol-5 Dimensions-5 Levels - EQ-
5D-5L) 
• Exercise self-efficacy (Exercise Self-Efficacy scale - ESE) 
• Resource use questionnaires 
• Adverse events  
 
METHODS 
During Stage 1 focus groups were conducted across the UK with people with JHS and health 
professionals. The focus groups aimed to explore perspectives on physiotherapy for the 
management of JHS but also collected information on patients’ lived experiences. Also 
explored were thoughts about the design of a physiotherapy intervention and the design of a 
pilot RCT. This information was used by a working group of health professionals, researchers 
and patient research partners to design a comprehensive physiotherapy intervention package 
within a set of guiding principles which were agreed in advance. These guiding principles 
included the number of sessions (six), length of sessions (30 minutes) and duration of 
treatment (four months); that treatment should be on a one-to-one patient-therapist basis; and 
that the package should be easily implemented across the UK (i.e. avoiding complex or 
resource-intensive interventions such as hydrotherapy). These principles aimed to maximise 
the likelihood of widespread adoption by reflecting current clinical delivery patterns and 
minimising resource requirements. The physiotherapy intervention was adapted from a pre-
existing osteoarthritis programme with proven clinical and cost-effectiveness. It aimed to 
enhance patients’ ability to be more physically active through helping them to better 
understand and manage their condition. 
 
Stage 2 of the research involved a pilot of the physiotherapy intervention in practice within 
the two NHS Trusts taking part in the research. Four physiotherapists (two at each site) were 
trained in the delivery of the intervention. Patient participants were over 18 years of age who 
16 
 
met the Brighton diagnostic criteria for JHS and had no other musculoskeletal conditions 
causing pain. Consenting patients then received the physiotherapy intervention package. 
Patients and therapists were interviewed to explore their perspectives on the intervention, 
including the training received by the physiotherapists. This information was used to refine 
the intervention and training packages. 
 
Stage 3 was a pilot RCT of the intervention compared to an advice control. Patient 
participants were over 16 years of age (the minimum age was reduced slightly from Stage 2) 
who met the Brighton diagnostic criteria for JHS and had no other musculoskeletal conditions 
causing pain. All participants received a one-off advice intervention, supplemented by 
information booklets from the Hypermobility Syndromes Association and Arthritis Research 
UK. All participants had the opportunity to ask questions specific to their personal 
circumstances and to receive tailored advice from the physiotherapist. Following the advice 
intervention all participants were randomly allocated to either receive physiotherapy (six 30 
minute sessions over 4 months) [‘Advice & Physiotherapy’ arm] or to usual care (no 
additional physiotherapy or advice) [‘Advice’ arm]. Clinical outcome measures were taken at 
baseline and at 4 and 7 months and included the MDHAQ; Pain VASs; BIoH questionnaire; 
EQ-5D-5L; ESE scale; resource use (only at 4 and 7 months); and adverse events (only at 4 
and 7 months). Questionnaires were administered by post. Descriptive statistics were used to 
report recruitment and retention numbers and outcome measure data. Health economic data 
was also reported using descriptive statistics and the value of information (VOI) of a future 
RCT was estimated. Patients and physiotherapists were interviewed to determine their 
perspectives on the advice and physiotherapy interventions, outcome measures and trial 
procedures. 
 
RESULTS 
Stage 1 recruited 25 people with JHS (three men) and 16 health professionals (14 
physiotherapists and two podiatrists; three men). Patients typically described living with a 
complex and unpredictable condition which impacted significantly on their wellbeing. It was 
common for diagnosis to be much delayed but once JHS was recognised it often led to 
appropriate onwards referral. There were a lot of commonalities between the perspectives of 
patients and health professionals with regards physiotherapy for the management of JHS. The 
need to treat the condition holistically, rather than treating single acutely painful joints in 
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isolation was highlighted. The importance of education for health professionals, patients and 
more widely in society was emphasised. The findings were used to design a physiotherapy 
intervention and supporting patient handbook with a flexible delivery model that could be 
tailored to individuals’ needs. It focused on improving self-efficacy for exercise, physical 
activity and self-management; incorporating education on a number of key themes, and tools 
to support reflection and planning. Patient choice of general physical activity was 
encouraged, as opposed to therapist prescription; along with a ‘menu’ of joint-specific 
exercises which could be selected in partnership with patients. 
 
Stage 2 recruited four physiotherapists (two at each of two clinical sites) who were trained to 
deliver the physiotherapy intervention. Eight people with JHS (all women) were recruited to 
receive the intervention. Interviews were conducted will all four physiotherapists and six of 
the patients to explore their experiences of the intervention, outcome measures and, for 
physiotherapists, the training received. The intervention package was generally very well 
received by patients and physiotherapists and only minor changes were subsequently made to 
the patient handbook and the training package. Some patients and physiotherapists thought 
that the Advice intervention would not be seen as comparable to the Physiotherapy 
intervention and that this would adversely affect recruitment to the pilot RCT. Others 
understood why an Advice control was being advocated. Information was gained on the rate 
of referrals and recruitment and this was used to refine the eligibility criteria and to develop 
strategies to enhance referrals. 
 
During Stage 3 there were a total of 121 patient referrals received over the 8 month 
recruitment period. 92 were excluded (35 not eligible, 25 no response, 23 declined, nine did 
not attend). A total of 29 participants consented to take part in the pilot RCT (14 were 
randomised to Advice and 15 to Advice & Physiotherapy). Three participants withdrew from 
the study (two from the Advice arm and one from the Advice & Physiotherapy arm). 
Questionnaire return rates were 83%, 65% and 74% at baseline, four month and seven month 
follow up respectively. Return rates were higher for the Advice & Physiotherapy arm at all 
time points. When compared with the Advice control, the Advice & Physiotherapy arm 
showed evidence of promise; whilst confidence intervals were inevitably wide the direction 
of differences between the groups was in favour of Advice & Physiotherapy for both primary 
and many secondary clinical outcomes.  There was a higher incidence of adverse events 
(including withdrawal from the study) in the Advice control, although we do not know the 
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baseline adverse event rate in this population. The economic analysis estimated that the 
Advice control was the most cost-effective intervention, however uncertainty in the results 
meant that it was plausible that the Advice & Physiotherapy was the most cost effective. The 
VOI analysis indicated the potential of high value of new research if uncertainty were 
eliminated from the model. In summary, the exploratory results of this pilot trial seem to 
support a full evaluation of the Physiotherapy intervention in a definitive trial. 
 
Interviews were conducted with 18 patients and seven physiotherapists. In addition six 
patients who declined to take part in the study were interviewed. The Advice and 
Physiotherapy interventions were both generally received well. However a perceived lack of 
equipoise between the Advice intervention and Physiotherapy intervention seemed to be 
prevalent amongst patients and physiotherapists and it is likely that this impacted upon 
recruitment rates. There were some specific suggestions to improve the Advice intervention.  
The training for physiotherapists was viewed positively, although it was suggested that 
training related to the trial procedures could be more explicitly separated from training 
related to delivery of the intervention. 
 
CONCLUSIONS 
This research is the first to describe in detail the lived experience of people with JHS. It is 
important that JHS is recognised as a complex and unpredictable long term condition. 
Patients and health professionals agreed that physiotherapy for JHS should take a holistic, 
multi-joint, long term condition management approach rather than treating individual acutely 
painful joints. Education for patients, health professionals and society more generally is 
required.  
 
A comprehensive physiotherapy intervention package was developed which was generally 
very well received by both patients and physiotherapists and shows evidence of promise in 
improving the impact of JHS. The perceived lack of equipoise between the physiotherapy 
intervention and the advice control was highlighted as the most significant challenge to 
conducting the pilot RCT.  
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IMPLICATIONS FOR PRACTICE AND RESEARCH 
• A user-informed Physiotherapy intervention for the management of JHS has been 
developed and evaluated positively by patients and physiotherapists. 
• Although many patients valued the Advice intervention, there was a perceived lack of 
equipoise between the Physiotherapy and Advice interventions in the pilot RCT. A future 
definitive RCT should use a more robust Advice intervention as a comparator (to include 
telephone advice and face-to-face follow-up). Close attention should also be paid to 
training and monitoring of study personnel to ensure the use of consistent and effective 
messages regarding equipoise. 
• A future RCT should be designed as multicentre trial to ensure adequate recruitment. 
• Study questionnaires should be completed face-to-face or over the telephone to improve 
data completeness. 
• Adverse events should be recorded at baseline to more adequately determine changes in 
adverse event rates over time and between study arms. 
• With attrition rates and variability as observed here, a future RCT would require 122 
patients per arm to detect a difference of 3.6 points on the RAPID3 subscale; and 152 
patients per arm to detect a 30 point change on the BIoH questionnaire (two-sided 5% 
alpha, 90% power, 35% attrition for both RAPID3 and BIoH).  
• Based on the results of this research, a definitive RCT of physiotherapy for JHS seems 
feasible. 
 
TRIAL REGISTRATION  
This study is registered as ISRCTN29874209. 
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CHAPTER 1  INTRODUCTION 
 
1.1 JOINT HYPERMOBILITY SYNDROME 
Musculoskeletal problems represent some of the most common reasons for seeking primary 
health care.1 Joint hypermobility syndrome (JHS) is a heritable connective tissue disorder, 
characterised by excessive joint range of motion and symptoms of pain, fatigue, 
proprioception difficulties, soft tissue injury and joint instability.2 Many experts now consider 
JHS to be indistinguishable from Ehlers Danlos Syndrome - Hypermobility Type (EDS-HT),3 
although this report uses the term JHS. Asymptomatic generalised joint laxity (often 
described as being ‘double jointed’) is very common and generally asymptomatic, occurring 
in 10-20% of Western populations, with higher prevalence in Indian, Chinese, Middle 
Eastern and African populations.4-6 However symptomatic JHS is reported to be under-
recognised, poorly understood and poorly managed in clinical practice.7-9 Symptomatic joint 
hypermobility has been reported to affect approximately 5% of women and 0.6% of men.10 It 
should be acknowledged, however, that there is currently a lack of good-quality 
epidemiological evidence for the true prevalence of JHS in the general population.  
 
The revised Brighton 1998 criteria (see Table 1) are now recommended for the diagnosis of 
JHS,11 although a range of other diagnostic criteria have been used historically. A key 
component of the Brighton criteria is the Beighton score, a nine-point score of joint mobility 
which has been in clinical usage for many years.5 One point is awarded for being able to 
place the hands flat on the floor while keeping the knees straight. One point is also awarded 
for each hypermobile peripheral joint as follows: 10° knee hyperextension; 10° elbow 
hyperextension; 90° extension of the fifth finger metacarpophalangeal joint; and opposition 
of the thumb to touch the forearm (points are awarded for the left and right limbs as 
appropriate). The Brighton criteria incorporate a number of other clinical features to confirm 
a diagnosis of JHS and exclude other differential diagnoses. Diagnosing JHS is often 
challenging, as symptoms may easily be attributed to other causes. Patients report a wide 
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range of fluctuating symptoms in addition to pain, and it has been suggested that many 
patients presenting in primary care with everyday musculoskeletal conditions may have 
unrecognised JHS.12 Indeed use of the Brighton criteria has revealed a very high prevalence 
of JHS in musculoskeletal clinics, with rates of 46% of women and 31% of men referred to 
one rheumatology service;13 30% of those referred to a Musculoskeletal Triage Clinic in the 
UK;14 and 55% of women referred to physiotherapy services in Oman.15 Diagnosis of 
generalised joint laxity and JHS is contentious however. Clinch et al16 for example suggested 
that a traditional cut-off value of 4/9 on the Beighton Score was unlikely to be clinically 
meaningful, with 19.2% of 6,022 fourteen year old children meeting that criterion. A more 
stringent cut-off value of 6/9 reduced prevalence to 4.2% which seemed more discriminative. 
Remvig et al17 also found little agreement between clinicians on the criteria that should be 
used to diagnose JHS. Indeed the median importance ratings were zero for Marfanoid 
habitus; skin signs; eye signs; and varicose veins, hernias, rectal/uterine prolapse (minor 
criteria 5-8 in Table 1), suggesting that these are often not considered. This lack of consensus 
on diagnosis perhaps explains why JHS is often under-recognised in clinical practice.7-9 
 
Table 1. The Brighton criteria for JHS.11 
Major Criteria 
1. A Beighton score of 4/9 or greater (either 
currently or historically) 
2. Arthralgia for longer than 3 months in 4 or 
more joints 
Minor Criteria:  
1. A Beighton score of 1, 2 or 3/9  
2. Arthralgia (> 3 months) in one to three 
joints or back pain (> 3 months), spondylosis, 
spondylolysis/spondylolisthesis 
3. Dislocation/subluxation in more than one 
joint, or in one joint on more than one 
occasion 
4. Soft tissue rheumatism. > 3 lesions (e.g. 
epicondylitis, tenosynovitis, bursitis) 
5. Marfanoid habitus (tall, slim, span/height 
ratio >1.03, upper: lower segment ratio less 
than 0.89, arachnodactyly [positive 
Steinberg/wrist signs] 
6. Abnormal skin: striae, hyperextensibility, 
thin skin, papyraceous scarring 
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7. Eye signs: drooping eyelids or myopia or 
antimongoloid slant 
8. Varicose veins or hernia or uterine/rectal 
prolapse. 
Notes 
JHS is diagnosed in the presence two major criteria, or one major and two minor criteria, or 
four minor criteria. Two minor criteria will suffice where there is an unequivocally affected 
first-degree relative.  
JHS is excluded by presence of Marfan or Ehlers-Danlos syndromes (other than the EDS 
Hypermobility type (formerly EDS III) as defined by the Ghent (De Paepe 1996) and the 
Villefranche (Beighton et al 1998) criteria respectively).  
Criteria Major 1 and Minor 1 are mutually exclusive as are Major 2 and Minor 2. 
 
When compared with healthy controls, JHS has been shown to have a significant impact on a 
wide range of outcomes such as exercise endurance, gait, pain, proprioception, strength, 
function and quality of life both in children18-21 and adults.22-25 A recent systematic review 
and meta-analysis has also confirmed the impact of JHS on a range of psychological variables 
such as fear, agoraphobia, anxiety, depression and panic disorders.26 
 
Physiotherapy, particularly exercise, is generally considered the mainstay of treatment2,8-
9,15,27-29 and professionals within a number of centres in the United Kingdom (UK) have 
developed a specialist interest in treating people with JHS. It should be recognised that 
‘physiotherapy’ is not an intervention in itself but describes professional practice in which a 
range of interventions are often employed in complex treatment ‘packages’.30 Exercise 
therapy seems to be ‘core’ to physiotherapy practice30 but professional autonomy in the UK 
allows individual physiotherapists to assess, diagnose and treat using the best available 
evidence and their own professional judgement. Keer and Simmonds29 reported that pain 
relief and preventing the recurrence of joint pain are the main aims of treatment for JHS, with 
exercise key to achieving these aims. They reported research evidence supporting the 
importance of interventions targeting posture, proprioception, strength and motor control, in 
conjunction with education, physical activity and fitness. However, there is little empirical 
evidence supporting the efficacy of exercise or physiotherapy. Two recent systematic reviews 
included only a handful of eligible trials of physiotherapy and occupational therapy 
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interventions for JHS and found limited evidence for their clinical and cost-effectiveness.31,32 
Although there is some evidence that people with JHS who receive exercise interventions 
improve over time, there is little convincing evidence for the effectiveness of different forms 
of exercise or for exercise being more effective than a control condition.31 The current lack of 
evidence on the most effective management options for JHS may contribute to anecdotally 
reported negative experiences of management.7,33 Higher quality multi-centre trials are 
clearly required to investigate the clinical and cost effectiveness of physiotherapy for JHS. 
The following section will consider the existing research evidence in more detail. 
 
1.2 EVIDENCE FOR THE EFFECTIVENESS OF PHYSIOTHERAPY 
Although physiotherapy is considered the mainstay of treatment for JHS, there is currently 
little evidence related to its effectiveness. The research evidence is at a very early stage of 
development, with a recent systematic literature review conducted by this research team31 
identifying only three exercise studies in adults which met the inclusion criteria.24,33-34 One 
further study was conducted in children.35 
 
Barton and Bird34 conducted a cohort study to investigate the effects of exercise in 25 
hypermobile adults. They implemented a 6-week exercise intervention which included warm 
up exercises, specific joint exercises and proprioception exercises (the selection of exercises 
and number of repetitions were tailored to each individual). Patients were asked to perform 
the exercises 3 times per week. Outcome measures included a questionnaire developed for the 
project, the Beighton score and the range of movement of major joints. The results showed 
that the maximum distance walked and pain on movement improved significantly (both from 
the questionnaire). Range of motion in the knee joints also improved significantly but there 
were no significant changes in any other outcome measure. 
 
Ferrell et al33 also conducted a cohort study with 20 adults with joint hypermobility (18 
completed the study and were analysed). Their intervention and outcome measures focused 
specifically on the knee joints, although they did also include the Short-Form 36 (SF-36) 
questionnaire to assess general health perceptions. The exercise intervention included a range 
of closed kinetic chain exercises and a static hamstring strengthening exercise. Exercises 
were performed on 4 out of 7 days of the week for 8 weeks. A clear progression of the type of 
exercises and number of repetitions was described, although this did not seem to have been 
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individualised. Also included as outcome measures were knee joint proprioception, balance, 
knee flexor and extensor muscle strength and knee joint pain. The results showed significant 
improvements over time in proprioception, balance, muscle strength, physical functioning 
and mental health. 
 
Sahin et al24 conducted an RCT in 40 adults diagnosed with JHS. It seems that 15 patients 
were randomly selected to receive proprioception exercises for eight weeks and 25 received 
no exercise intervention, although there is some uncertainty about patient numbers. For 
example, within the text the control arm is said to have comprised 3 men and 17 women 
(n=20 rather than 25) and one of the tables reported n=15 in each of the exercise and control 
arms. Exercise was performed 3 times per week for 8 weeks, supervised by a doctor in clinic. 
Unfortunately the method of randomisation is not reported, nor are any details of assessor 
blinding. Proprioceptive acuity, pain and the occupational activity subscale of the AIMS-2 
questionnaire all significantly improved over time in the arm who received proprioception 
exercises. No other subscale of the AIMS-2 improved (physical status, emotional status, 
symptoms or social activity). No outcome changed over time in the control arm. 
Unfortunately, no direct statistical comparison of trial arm data after treatment is reported so 
the significance of differences between arms cannot be determined.  
 
The only other randomised trial of exercise in joint hypermobility included in the review by 
Palmer et al31 was conducted in children35. This study did not include a ‘no or minimal 
intervention’ arm but instead compared the effects of targeted (n=30) versus a more 
generalised exercise approach (n=27). Treatment was received for half an hour per week for 6 
weeks and exercises were progressed on an individual basis. Home exercises were also given, 
to be performed daily. Outcomes included pain (both child and parent reports), global 
evaluation of the impact of hypermobility (parent report), functional impairment (child 
Health Assessment Questionnaire - HAQ) and a six-minute shuttle test. When both arms were 
combined, there were significant improvements in pain (both child and parent report) and the 
child HAQ. Parental global assessment and the shuttle test did not improve significantly. 
There were no differences between arms except for parental global assessment (in favour of 
the targeted intervention). 
 
Subsequent to the census date used in the review by Palmer et al,31 a further randomised trial 
of exercise was conducted in children with knee pain and JHS.36 It also compared two 
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different types of exercise – one using exercise to neutral knee extension (n=14) and one 
using exercise into the full hypermobile range (n=12). Exercises were performed for 8 weeks. 
The primary outcome measure was knee pain, with secondary outcome measures of muscle 
strength, function and parent-reported quality of life. When the arms were combined, there 
was a significant improvement in knee pain, patient global impression of change, strength 
and parent-reported quality of life (in both physical and psychosocial health components).  
There was a difference between arms only in parent-reported quality of life; in favour of the 
neutral exercise arm for physical health, and in favour of the exercising into the hypermobile 
range for psychosocial health. No other differences were observed and there were no adverse 
events. 
 
These studies seem to suggest that patients with JHS might improve over time with exercise 
but it is important to note that only Sahin et al24 included an appropriate no treatment control 
arm. The other papers were either uncontrolled cohort studies or comparative trials of 
different forms of exercise. Unfortunately Sahin et al24 failed to report any direct head-to-
head statistical analysis of between arm differences and fundamental methodological details 
are unclear. Another systematic review of occupational therapy and physiotherapy 
interventions for JHS32 independently identified a high risk of bias in the study by Sahin et 
al24 and did not identify any additional RCTs of physiotherapy in this area. Also of note is 
that three of the five studies24,33,36 focused on the knee joint in what is a multiple joint 
condition and all assessed a relatively brief intervention of 8 weeks or less. So, the true 
effectiveness of physiotherapy (including exercise) in JHS remains unknown. Observed 
improvements over time could be explained by natural history of the condition, positive 
interactions with therapists, or other unknown factors. Therefore an appropriately controlled 
study is urgently required. 
 
1.3 THE COMMISSIONED RESEARCH 
The research commissioned by the National Institute for Health Research (NIHR) Health 
Technology Assessment (HTA) programme called for proposals to answer the following 
question: “Does physiotherapy improve outcomes in adults with musculoskeletal pain 
associated with Hypermobility Syndrome (HMS)?” It specifically asked for assessment of a 
‘whole body’ physiotherapy intervention, with examples of proprioception, muscle 
strengthening, pain management strategies, and hydrotherapy. The commissioning brief 
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requested a feasibility study in preparation for a possible RCT in outpatients or other 
specialist care settings. The comparator requested was no active physiotherapy, with 
clarification that advice on joint care could be given. Important outcomes of the feasibility 
study were specified as follows: the number of potential eligible patients with Hypermobility 
Syndrome; feasibility of recruitment; development and piloting of the intervention; and 
acceptability to patients in terms of quality of life. An estimate of the value of information 
(VOI) from a subsequent RCT was also specified. Outcomes requested for a later trial were 
function, musculoskeletal pain, quality of life, adverse events (for example dislocations and 
susceptibility to injury), range of movement, strength, proprioception and psychological well-
being. 
 
The study team carefully considered the commissioning brief when developing the research 
project which is described in the following section. 
 
1.4 THE RESEARCH PROJECT 
The study team designed a study that aimed to develop and evaluate a complex physiotherapy 
intervention. The lack of research in this area meant that it was difficult to provide firm 
recommendations for what the physiotherapy intervention should look like. Therefore 
preliminary work was planned to determine patient and health professional perspectives on 
physiotherapy and to use this information to help design the intervention package. A number 
of broad guiding principles were agreed in advance. It was agreed that the intervention should 
include one-to-one patient-therapist interaction due to the complexity of individual patient 
needs. It was also agreed that the devised physiotherapy intervention should be easily 
implementable across the National Health Service (NHS), meaning that very specialist 
interventions or those requiring specialist facilities (such as hydrotherapy) would be 
excluded. The team was also mindful of trying to ensure that the frequency and duration of 
sessions and overall duration of treatment was broadly in line with usual care at the two NHS 
Trusts taking part in the research (approximately six 30 minute sessions over four months). A 
subsequent UK-wide survey conducted by the research team has revealed that this pattern of 
care fits very well with what is delivered by physiotherapists nationally.37 By agreeing such 
broad guiding principles the research team wanted to ensure that the physiotherapy 
intervention package developed stood the best chance of being adopted in practice, should it 
ultimately prove to be beneficial. 
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As part of the commissioning process there was discussion with the funding committee about 
the identity of the comparator arm, with the study team initially preferring a delayed 
intervention arm. This preference was due to concerns about the ethics of delivering an 
advice-only control which was less than ‘usual care’ at the two centres involved and the 
potential negative impact this would have on study recruitment. The funding committee 
asserted that a delayed intervention arm would cause problems for long-term follow-up in 
any future trial (as all patients would have received treatment) and that genuine equipoise was 
present due to the lack of robust evidence for the effects of physiotherapy. The study team 
therefore agreed to deliver an advice-only control intervention. 
 
The commissioned study was therefore designed in 3 stages (see Figure 1). Stage 1 aimed to 
understand the physiotherapy management of JHS, from patient and health professional 
perspectives. This information was used by a working group of researchers, health 
professionals and patient research partners to develop the physiotherapy intervention 
package. Stage 2 aimed to pilot the intervention in practice so that it could be adapted and 
refined as necessary before moving on to Stage 3 which was a pilot RCT of the intervention, 
with a comparison against an advice only control arm. Full details of each stage of the 
research are contained in subsequent chapters. 
 
Figure 1. Flow diagram illustrating the overall study design. 
 
  
Stage 1: Focus groups with patients & health professionals to inform development of a 
comprehensive physiotherapy intervention 
Guiding design principles: One-to-one; six 30 minute sessions over four months; easy to 
implement. 
Stage 2: Pilot implementation of the intervention in practice 
Two NHS Trusts. Qualitative interviews with patients and physiotherapists. 
Stage 3: Randomised controlled pilot study of the intervention 
Two NHS Trusts. Qualitative interviews with patients and physiotherapists. 
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CHAPTER 2  STAGE 1: HYPERMOBILITY: PERSPECTIVES ON PHYSIOTHERAPY (HPoP) STUDY & DEVELOPMENT OF A COMPLEX PHYSIOTHERAPY INTERVENTION 
 
2.1 AIMS 
The aims of this first stage of the research included examining the views and experiences of 
individuals with JHS and health professionals of physiotherapy for the management of JHS 
(Component 1). This was to inform the development of a comprehensive physiotherapy 
intervention for adults with JHS (Component 2).  
 
2.2 COMPONENT 1: FOCUS GROUPS WITH PATIENTS AND HEALTH 
PROFESSIONALS TO DETERMINE THEIR PERSPECTIVES ON 
PHYSIOTHERAPY FOR JHS AND THE PROPOSED TRIAL (HPoP STUDY) 
 
2.2.1 Introduction 
In order to examine the views and experiences of physiotherapy for JHS, we conducted a 
series of focus groups with patients and health professionals. Qualitative methods were 
chosen as the most appropriate means of gathering data regarding beliefs, experiences and 
perceptions of physiotherapy interventions.38-39 Qualitative methods are also valuable in the 
pre-trial development phase to both help develop and refine the trial and improve 
understanding of the experiences of patients receiving, and staff delivering, interventions.40-42 
Such use of qualitative methods in randomised controlled trials as part of pre-intervention 
development is well established.43-46 Focus groups permit sharing and comparing of ideas 
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amongst group members, which then facilitates the evaluation and interpretation of those 
ideas and the exploration of areas of consensus and disagreement. This component of the 
study was conducted under the acronym ‘Hypermobility: Perspectives on Physiotherapy’ 
(HPoP). Findings from this component have previously been published as peer reviewed 
journal articles.47-48 
 
2.2.2 Objectives 
Specific objectives were as follows: 
• To investigate the lived experiences of individuals with JHS. 
• To explore patients’ and health professionals’ views on current ‘usual care’ physiotherapy 
management of JHS. 
• To examine what would be considered the optimal content and delivery of a physiotherapy 
intervention for adults with JHS. 
• To investigate the how to measure success of a physiotherapy intervention.   
• To describe the attitudes and opinions of individuals with JHS and health professionals to 
the design of a pilot RCT of a physiotherapy intervention. 
 
2.2.3 Methods 
Seven focus groups were conducted with people with JHS and health care professionals with 
a special interest in managing patients with JHS between January and February 2013 in four 
UK locations. Participants were recruited via mailed invitations to health professionals and 
patients from physiotherapy services at two NHS trusts, as well as to local members of the 
Hypermobility Syndrome Association (HMSA) and patients who had previously expressed an 
interest in assisting with research activity at two University locations. 
 
Eligible patient participants were aged 18 years or over, had previously received a diagnosis 
of JHS, had attended physiotherapy within the preceding 12 months and were able to speak 
English. Individuals with other known musculoskeletal pathology causing pain, particularly 
osteoarthritis and inflammatory musculoskeletal disease such as rheumatoid arthritis, were 
excluded. Eligible health professionals were post-qualification who had some interest or 
involvement in treating people with JHS. The purposive sampling strategy aimed for 
diversity with regard to age, gender, socio-economic situation and geographical location to 
capture maximum variation in views and experiences. Ethical approval was obtained from the 
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North East NHS Research Ethics Committee (12/NE/0307) and all participants gave written 
consent. There was a substantial delay to securing appropriate NHS approvals for this stage 
of the research which ultimately shortened the recruitment period available for the later pilot 
RCT (Stage 3) by four months. 
 
Separate focus groups were conducted with patients and health care professionals. All focus 
groups were conducted in non-clinical settings. The focus groups were facilitated by two 
researchers (SP, JH). One researcher led the discussion using open-ended questioning 
techniques to elicit participants’ own experiences and views and to ensure all participants had 
an opportunity to take part. The other researcher summarised the discussion, audio-recorded 
the session and noted down who was speaking to aid transcription. Focus groups lasted 
between 71 and 100 minutes. 
 
Topic guides were used to facilitate discussions and, in line with an inductive approach, were 
revised in light of emerging findings (see Appendix 1 and 2). Topic guides explored 
experiences of physiotherapy for JHS and views regarding physiotherapy treatment for JHS, 
including the optimal content and delivery of education, advice, exercises and support 
packages. In addition focus groups explored attitudes to the proposed trial design and views 
on the most appropriate outcomes for the intervention. 
 
In addition to the focus groups, patient participants were asked to complete a Physiotherapy 
Outpatient Satisfaction Questionnaire49 to capture information about their last course of 
physiotherapy. Patients are asked to indicate their agreement to a total of 38 statements on a 5 
point Likert scale, with higher scores indicating higher levels of satisfaction. An average 
score out of 5 was produced for 6 subscales: Expectations, Therapist, Communication, 
Organisation, Clinical Outcome, and Satisfaction. 
 
Analytic procedures 
With written informed consent from participants, all focus groups were audio-recorded, fully 
transcribed and anonymised, checked for accuracy and then imported into the qualitative 
software package NVivo 10 to aid data analysis. Analysis began in parallel with data 
collection and was ongoing and iterative. Thematic analysis,50 using the constant comparison 
technique51 was used to scrutinise the data to identify and analyse patterns across the dataset. 
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Transcripts were examined on a line-by-line basis with codes being assigned to segments of 
the data and an initial coding frame developed. An inductive approach was used to identify 
participants’ perceptions of their experiences. To enhance analysis and enable team 
discussion and interpretation, team members (RT and JH) independently coded transcripts; 
any discrepancies were discussed to achieve a coding consensus and maximise rigour. 
Scrutiny of the data showed that data saturation had been reached at the end of analysis, such 
that no new themes were arising from the data.52 All participants were assigned a letter as a 
pseudonym. 
 
2.2.4 Findings 
In total 4 focus groups were conducted with 25 patients (3 men and 22 women; aged 19-60 
years) and 3 focus groups were conducted with 16 health professionals (3 men and 13 
women; 0-30 years post qualification; 14 physiotherapists and 2 podiatrists) (Table 2).  
 
Table 2. Focus group participants’ demographic characteristics. 
Patients (total n=25) n (%) 
Age  18−29  
30−39  
40−49  
50−59  
>60 
mean, (median) 
8 (32) 
7 (28) 
6 (24) 
2 (8) 
3 (12) 
33 years, (36) 
Gender Female 
Male 
22 (88) 
3 (12) 
Ethnicity  ‘White’ 
‘Other’ 
23 (92) 
2 (8) (both self-reported  
as ‘British White and Chinese’)  
Socio-Economic Status 
(SES)*  
1 (affluent) 
2 
3 
4 
5 (most deprived) 
8 (32) 
8 (32) 
4 (16) 
3 (12) 
1 (4) 
Education  Schooling to 16 years 3 (12) 
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College diploma/equivalent 
University degree/equivalent 
Post graduate degree 
6 (24) 
10 (40) 
6 (24) 
Employment Employed full time 
Employed part time 
Student full time  
No paid job 
Retired 
7 (28) 
8 (32) 
4 (16) 
5 (20) 
1 (4) 
Health Professionals (total n=16) N (%) 
Gender Female 
Male 
13 (81) 
3 (19) 
Role Physiotherapists  
Podiatrists 
14 (88)  
2 (13) 
Years since qualifying Newly qualified (<1 year) 
1-4 years 
6-20 years 
>20 years 
1 (6) 
1 (6) 
7 (44) 
7 (44) 
* Measured as Index of Multiple Deprivation (IMD) quintile from home post code.53  
 
24 of the 25 patient participants completed the Physiotherapy Outpatient Satisfaction 
Questionnaire. Table 3 presents the median scores for each of the subscales. 
 
Table 3. Median scores for the Physiotherapy Outpatient Satisfaction Questionnaire 
(n=24).49 Individual statements were scored as follows: 5 = strongly positive, 4 = positive, 3 
= neutral, 2 = negative, 1 = strongly negative. 
Subscales Median Rating (IQR) (max 5) 
Expectations 2.80 (0.80) 
Therapist 4.17 (1.33) 
Communication 3.60 (2.00) 
Organisation 3.50 (0.88) 
Clinical Outcome 2.33 (0.33) 
Satisfaction 3.00 (1.57) 
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Table 3 suggests that, in general, ‘satisfaction’ with physiotherapy was rather neutral (median 
rating 3.00/5), with median ratings of ‘clinical outcome’ (2.33/5) and ‘expectations’ (2.80/5) 
of treatment tending towards negative ratings. More positively rated were the ‘therapist’ 
(median rating 4.17/5), ‘communication’ (3.60/5) and ‘organisation’ (3.50/5). So, the 
expectations of physiotherapy and the perceived outcome of treatment were rated as lowest of 
the six subscales. 
 
Six themes, developed from the qualitative analysis, related to: ‘The impact of JHS’, ‘JHS as 
a difficult to diagnose, chronic condition’, ‘Physiotherapy to manage JHS’; ‘Optimising 
physiotherapy as an intervention for JHS’; ‘Measuring success, and managing expectations, 
of physiotherapy’ and ‘Patients’ and health professionals’ views on the proposed 
physiotherapy trial design’. 
 
Theme 1: ‘The impact of JHS’   
Figure 2 below illustrates the sub-themes related to this main theme.  
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Figure 2. Sub-themes associated with ‘The impact of JHS’.
 
 
All patients reported JHS symptoms including fatigue, pain, proprioception problems, 
recurring joint dislocation and ‘cycles’ of injury and recovery (Table 4), although there was 
wide agreement that the impact and consequences of these symptoms was different for each 
patient. The diverse nature of the symptoms was also noted by both patients and health 
professionals. 
 
The impact of JHS
Pain
Repeated cycles of injury, pacing or 
activity restriction and recovery
Impact of JHS on recovery
Fatigue
Proprioception issues
Anxiety
Catastrophising
Fear of the future
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“All of us are probably so different yet we’re categorised as the same” [Female patient A, 
age 60, FG2]. 
 
“It’s the heterogeneous group that makes it very interesting” [Female health professional D, 
22 years post-qualification, FG4]. 
 
Table 4. Illustrative quotes relating to patients’ reported features of JHS 
Feature of JHS Illustrative Quote 
Pain “Most days I’m in some sort of pain, it’s always there, it never 
actually goes” [Female patient A, age 35, FG5]. 
 
“Every second, that’s the ankle, the knee, the back, the head” 
[Female patient B, age 32, FG1]. 
Repeated cycles of 
injury, pacing or 
activity restriction 
and recovery 
“...it’s difficult to know how much to push yourself because then 
you are worried about injuring and then you’re setting yourself 
back, well it’s a vicious cycle really” [Female patient B, age 27, 
FG5]. 
 
“I find that I get to a level with exercise and then I’ll have a bad 
day or I’ll injure myself and so you kind of step back, you have 
to go backwards, and you never seem to go that far forward” 
[Female patient G, age 42, FG5]. 
Impact of JHS on 
activity 
“I will only go out if I know that we’re going somewhere where I 
can sit down” [Female patient D, aged 32, FG5]. 
 
“I think it was one of the questions in there, it was about how 
much how much pain have you been in, well loads, has it 
stopped you doing anything, no, because we all sort of pushed 
through it and we still do it anyway” [Female patient D, age 21, 
FG1]. 
Fatigue “You’re managing your pain and it’s a lot of pain, it’s a dull 
ache and it makes you sleepy and it makes you tired and you’re 
exhausted” [Female patient G, age 30, FG1]. 
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Proprioception issues “It’s on your mind the whole time, because I’m constantly 
thinking about where my hands and feet are” [Female patient G, 
age 48, FG2]. 
 
Patients described difficulties in making the distinction between chronic and acute pain, and 
that it was challenging for them to understand how - or if - injuries had occurred.   
 
“Well, how do we know whether we’ve injured something, because we’ve got pain all the 
time?” [Female patient C, age 40, FG1]. 
 
However, patients also observed that their pain thresholds appeared to be unusually high and 
that their perception and interpretation of pain is somehow altered. 
 
“That would be the first problem, I can’t feel pain.  I snapped some bones in my wrist, and up 
here somewhere, and it was ‘oh that’s not quite right’ and the doctor went ‘aren’t you 
screaming’, and I was like ‘why?’, and he said ‘that should really hurt’, oh okay, it’s a bit of 
a whinge, until he took me through into the hospital and he was going ‘painkillers’, no, don’t 
take them, doesn’t hurt that much, he did the operation and came through okay and they said 
‘you can have the morphine if you want it’, and I didn’t bother, it didn’t hurt” [Male patient 
A, age 50, FG1]. 
 
Repeated injuries were common and patients frequently talked about cycles of injury and 
recovery in which periods of injury required participants to pace and restrict activity. 
Consequently, some participants found living with JHS to be “very debilitating”, limiting the 
type of activities they could engage in and severely impacting on their engagement with the 
social world.  Patients also described how prior experiences of repeated injuries led to 
heightened levels of anxiety and catastrophising about future injuries, or extrapolating their 
current or prior experiences to an imagined future (Table 5). 
 
Table 5. Illustrative quotes relating to psychosocial impact of JHS pain. 
Psychosocial 
Impact 
Illustrative Quote 
Anxiety “I feel like I’m in a constant state of anxiety, waiting for the next 
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injury and trying to pre-empt anything that’s going to cause it” 
[Female patient G, age 48, FG2]. 
Catastrophising “I think also there’s an element of fear, I worry dreadfully and I’m 
frightened of what will come next [… ] There’s all these ‘what ifs’ 
that boil up into this massive pile of anxiety inducing terror. What’s 
happened in reality is you’ve got a slightly aching wrist, but what’s 
actually happened is it’s gone from if that’s gone the next thing’s 
going to go, what if this and what if this, and what if I let everyone 
down and this sort of awful …” [Female patient E, age 34, FG2]. 
Fear of the future  “Oh my god is this going to be like this for the next 60 years of my 
life” [Female patient B, age 27, FG5]. 
 
“I’m going to have it forever and it’s never going to get better” 
[Female patient E, age 19, FG6]. 
 
 
Theme 2: ‘JHS as a difficult to diagnose, chronic condition’ 
A number of sub-themes were associated with this main theme (see Figure 3).  
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Figure 3. Sub-themes associated with ‘JHS as a difficult to diagnose, chronic condition’.
 ‘The chronic, heterogeneous nature of JHS’ 
Both patients and health professionals described the chronicity of JHS and its symptoms. 
Patients recognised that they were “going to have it forever” [Female patient E, age 19, FG6] 
and that “you won’t be fine, not completely” [Female patient C, age 40, FG1]. Similarly, one 
health professional described having JHS as “almost like a recovering alcoholic, you are 
always a recovering hypermobility person” [Female health professional B, 28 years post-
qualification, FG4].  
 ‘Scepticism and lack of understanding amongst health professionals’ 
Both patients and health professionals felt that JHS is not a widely understood condition and 
sometimes not recognised as a syndrome amongst health professionals. Patients described a 
JHS as a difficult to 
diagnose, chronic condition
The chronic, 
heterogeneous nature 
of JHS
Scepticism and lack of 
understanding amongst 
health professionals
Diagnosis of JHS and 
subsequent referral
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lack of understanding of JHS in health settings and reported feeling that sometimes their 
symptoms were not believed or understood by health professionals. 
 
“I think I was described as a biomechanical conundrum by one of the physiotherapists I saw 
… and this is what I found repeated over and over again, that hypermobility shouldn’t be 
causing pain, it’s just the way you are … you shouldn’t be in pain because you have 
mobility” [Female patient C,  age 53, FG2].  
 
“when I went back to physio for strengthening exercises to help my joints after the 
hypermobility diagnosis, there was … I got that a little bit, ‘I’m not sure about this 
hypermobility …’” [Female patient B, age 34, FG2]. 
 
“I work in a rheumatology department who don’t recognise joint hypermobility as an entity 
and in fact, probably a lot of people tend to get diagnosed with things like fibromyalgia more 
than normal” [Female health professional E, 30 years post qualification, FG3]. 
 
As joint laxity often causes no problems, and JHS symptoms vary, the unpredictable, diverse, 
evolving and fluctuating nature of their symptoms exacerbated others’ misunderstanding of 
the nature of JHS and patients’ reports of problematic symptoms to health professionals were 
often met with scepticism. 
 
“And if you’re inconsistent as well, they sort of go, she was alright with that last week, why is 
it this week she’s saying that, you know, that’s going to be difficult for her today”  [Female 
patient C, age 53, FG2]. 
 
Consequentially, health professionals perceived “a lot of mismanagement” [Female health 
professional E, >20 years post qualification, FG4] of JHS by health professionals and that 
patients may be given erroneous information by some health professionals. One patient 
described a rheumatologist who had said “in his opinion, his professional opinion, that 
hypermobility doesn’t cause pain” [Female patient C, age 53, FG2]. JHS trained health 
professionals felt that they were required to “undo misconceptions, other health 
professionals’ understanding and what they have taught or implied to the patient about their 
condition. So for us we sort of have to unravel an onion so to speak, and it’s quite hard, yeah 
challenging I think” [Female health professional E, >20 years post qualification, FG4].   
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Patients felt that JHS does not generally fit with health professionals’ models of acute injury 
and recovery and that this may be a source of frustration for health professionals. 
 
“[physiotherapists] get frustrated because their model of physiotherapy and what they’re 
taught and how joints move and how they get better, hypermobility is totally the opposite of 
what they’re expecting and they can’t understand that. I’ve had physios before say well stop 
the shoulder dislocating” [Female patient B, age 32, FG1]. 
 
‘Diagnosis of JHS and subsequent referral’ 
The heterogeneous nature of JHS symptoms, lack of recognition of the syndrome amongst 
health professionals and subjective diagnostic criteria were seen to contribute to often slow 
and convoluted diagnostic trajectories. Patients commonly remarked that “it takes so many 
years to get diagnosed” [Male patient E, age 36, FG5]. Patients felt that education for health 
professionals was required, particularly, in order to facilitate timely diagnosis and referral. 
 
“I think it sounds like we’ve all been passed from pillar to post where people don’t recognise 
it or they just attribute the pain to something else, when a kind of snap diagnosis just comes 
out of the air and you know you progress from there, I don’t know, I mean there’s lots of 
things I still need to know about hypermobility but on the flip side I do think it’s the health 
professionals that need to know more” [Female patient G, age 42, FG 5]. 
 
Health professionals highlighted the difficulties in diagnosing JHS using the criteria 
available. 
 
“I think it’s the diagnostic criteria for hypermobility syndrome that’s actually part of the 
problem […] So it’s almost going right back to the start, finding a slightly more sensitive 
diagnostic criteria that can help us to then manage it” [Female health professional F, 11 
years post-qualification, FG7]. 
 
Both physiotherapists and patients recognised that if JHS remained undiagnosed, chronic pain 
may develop which may be less likely to be responsive to physiotherapy. The 
biopsychosocial impact of living with untreated or inappropriately treated symptomatic 
hypermobility may lead to a more multidisciplinary approach being required. 
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“And you see by the time - for me they come with quite a lot of psychological baggage, and 
you know, they are difficult patients. And then you’re trying to unravel what’s the primary 
and secondary issue here, is it that your mental health is actually what’s driving your 
hypermobility, or is it the fact you have such debilitating joints is making you mentally 
unwell. But by the time they get to us that’s so hard to deal with, [….] and they almost then, 
it’s a cry for help. So they’re desperate to get help so the psychological side comes out 
because the physical manifestation of what they’re suffering with is just so severe” [Female 
health professional E, >20 years post qualification, FG4]. 
 
“Actually, there’s some that do quite well [with physiotherapy] as well in terms of …. 
especially I think if you catch them early, really the key is, before they develop a lot of the 
chronic pain” [Male health professional B, 8 years post qualification, FG 7]. 
 
Patients also recognised that delays in diagnosis may result in the development of 
maladaptive responses to JHS, for example, compensatory postures, which are then difficult 
to rectify. 
 
“I was 15 when I was diagnosed and that was even too late really for me because the way I 
stand, the way I move, everything, my Pilates teacher - her grandson was 3 when he was 
diagnosed and he has Pilates, and physiotherapy now so he will get into habits of a life time” 
[Female patient G, age 30, FG 1]. 
 
For patients, receiving a diagnosis was considered to be essential in order to access 
appropriate treatment and patients felt that “the sooner you get the treatment the less likely it 
is that it is going to have such a great impact on your life” [Male patient E, age 36, FG5].  
However, physiotherapists felt that care pathways for JHS were not well defined and 
intimated that, as a result, patients may develop more complex problems or chronic pain 
issues. 
 
“I see the other end.  I think we don’t have a structured pathway of care for hypermobiles, 
which is what I’m interested in developing, but we don’t have it.  So there’s no 
rheumatologist in the trust that has a special interest in hypermobility, and my god I've tried 
to find one […]  So there isn’t a defined pathway of care for someone with generalised - with 
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hypermobility syndrome, so” [Female health professional C, 25 years post qualification, 
FG4]. 
 
“So for me I feel that’s a key problem because I think we end up getting them too late, and if 
((name)) had the support I feel to get these pathways better earlier” [Female health 
professional E, >20 years post qualification, FG4]. 
 
A diagnosis of JHS was considered to be necessary in order to access appropriate care 
pathways, for example, to be referred to secondary care for JHS rather than for a single joint 
problem. Once patients had been diagnosed and referred to JHS trained physiotherapists, 
many participants reported that their treatment was beneficial. 
  
“I found that once I was diagnosed with hypermobility the physio I received (has) been really 
good” [Female patient G, age 42, FG5]. 
 
“I was originally seen by a physio who hadn’t diagnosed with the hypermobility and then 
went back to a musculo-skeletal specialist who then put me forward to specialist 
hypermobility physiotherapist and since then it’s been amazing; I feel like it’s been 
worthwhile and it felt like the right thing to do and I’ve been really enjoying it” [Female 
patient B, age 27, FG5]. 
 
Theme 3: ‘Physiotherapy to manage JHS’  
Both patients and physiotherapists emphasised that physiotherapy would not be effective if 
individual joints were being treated in isolation and described difficulties in treating JHS 
within some National Health Service (NHS) constraints, for example, where patients are 
generally referred for a single problematic joint. 
 
“Because of, I think, the way - at least in my experience – that the NHS seems to approach 
things, they have a sort of, ‘you’re here for one joint’ approach, which is quite difficult, 
because you go: ‘Well, I’m floopy all over’.  And then you have to have the conversation 
about ‘Well, which is the most difficult?’ You’re like ‘Well, it’s kind of all related’, so if, like, 
if my knee is stronger and I’m doing less weird things with my knee, then my hip will feel 
better because - and I can say that, and to me it’s obvious, that if you fix - just because it’s 
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your hip that hurts it doesn’t mean that it is actually the problem. It could well be that your 
knee is the issue, making you do weird things with your hip, but there’s this, ‘This is the joint, 
and we will deal with this joint,’ when that isn’t really …” [Female patient C, age 53, FG2]. 
 
Patients and health professionals reported that in the NHS, ‘usual care’ was normally up to 
six physiotherapy sessions to treat a specific joint. However, it was felt that this specific 
number of sessions was not necessarily appropriate for treating JHS. 
 
“They’ve got us as their clinical leads telling them to look at people globally, pick up this 
diagnosis, but then they’ve got their managers telling them you have to do six sessions [….] I 
should really be saying ‘I know you’ve got hypermobility, I know it’s all related, but actually 
I need six sessions with your back, I need six sessions with your shoulder and I need six 
sessions with your knee, and we need to negotiate that with your PCT because otherwise 
((place name)) is not going to get paid’” [Female health professional E, 30 years post 
qualification, FG4]. 
 
In all focus groups, the need for continuous, ongoing access to physiotherapy was 
highlighted, whether or not the patient was experiencing problematic symptoms. One patient 
felt: “the difficulty is, it’s a chronic condition and the only time you are actually able to 
access any care in the NHS is when you have an acute incident from it” [Female patient G, 
age 48, FG2]. Health professionals, unless practicing privately, were equally frustrated by the 
lack of flexibility in the number of treatment sessions that could be offered. 
 
“And I think the limitations of, like, if you were receiving NHS treatment, then you’re only 
going to get so many sessions” [Female health professional D, newly qualified, FG3]. 
 
In addition to the perceived limited number of sessions, physiotherapy may also be unsuitable 
and exacerbate symptoms if it ignores the complexity of JHS symptoms. 
 
“Then, as you say, being given some more exercises that weren’t helpful because they did 
seem to cause more pain which then sets you back even more and then you seem to get into 
the cycle of never sort of making any progress and then the treatment’s over because you 
only get a few sessions” [Female patient G, age 48, FG2]. 
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Theme 4: ‘Optimising physiotherapy as an intervention for JHS’ 
Figure 4 below illustrates the sub-themes associated with this theme. 
 
Figure 4. Sub-themes associated with ‘Optimising physiotherapy as an intervention for 
JHS’. 
 ‘An ‘ideal’ physiotherapy service’ 
All focus groups were able to provide descriptions of an ‘ideal’ physiotherapy intervention or 
suggested improvements which were based upon their own previous experiences of giving or 
receiving treatment. Health professionals’ and patients’ descriptions of ideal physiotherapy 
were notably similar (Table 6). Both felt that it was important to have continuity of therapist, 
who was trained in JHS and who provided reassurance to the patient. Both patients and health 
professionals described the importance of flexible treatment, ensuring the treatment is patient 
led, meeting and managing goals and expectations, taking a holistic, long term approach and 
treating JHS rather than acute manifestations of the syndrome. The importance of ongoing, 
‘maintenance’ physiotherapy for patients was also highlighted. 
 
Table 6. Suggestions for an ‘ideal’ physiotherapy service. 
Suggested Illustrative quote from patient Illustrative quote from health 
Optimising physiotherapy 
as an intervention for JHS
An 'ideal' physiotherapy 
service
Measuring success, and 
managing expectations, 
of physiotherapy
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improvements  professional 
Therapist 
Continuity of 
therapist to improve 
patient-therapist 
interaction/ 
relationship 
“They get to know you as well, don’t 
they, and they know your lifestyle 
and they know what you do day in 
day out and therefore they can start 
to understand any triggers, ... they 
get to know you as a person” 
[Female patient G, age 30, FG1]. 
“For everybody, all patients, is 
continuity. But it’s especially difficult 
[for JHS patients] because they have so 
many different problems” [Male health 
professional A, 6 years post 
qualification, FG3]. 
Therapist should be 
JHS expert 
“… the two physiotherapists I’ve had 
who’ve known about [erm] 
hypermobility have been a lot better 
than ones I’ve had in the past where 
they obviously haven’t had a clue” 
[Female patient C, age 60, FG 6]. 
 
“... if they see somebody who hasn’t had 
an interest in that then they’re learning 
along with the patient at the same time.  
… So that’s quite difficult.  It’s much 
better, isn’t it, to be seen by a specialist 
straight away who has got a broader 
knowledge base to be able to tap into 
their tools and skills” [Female health 
professional E, 30 years post 
qualification, FG 3]. 
Therapists should 
provide reassurance 
and encouragement 
“quite often I’ll come out of the next 
physio feeling much happier because 
they’ve reassured me that it’s not the 
end of the world and you know 
sometimes you have a bad week but 
it doesn’t mean that you won’t then 
have a good week” [Female patient 
F, age 44, FG1]. 
“I think you’ve got to set achievable 
goals, then you’ve got to give a lot of 
reassurance and positive feedback” 
[Female health professional B, 28 years 
post qualification, FG 4]. 
 Physiotherapy 
Flexibility in  
treatment,  (e.g. 
number of sessions, 
content, specific 
techniques, mode of 
“… Or consider the person’s life 
style, … and that sort of flexibility, 
not just on what they’re asking the 
patient to do, even being flexible on 
the times of day or you know when 
“Ideally, you’d want to have a service 
offer where they could tap into the 
service where they wanted to. If they 
suddenly got a flare up of something, 
say their hands started to give way or 
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delivery, structure 
and focus) 
these things can happen, you know 
make it interesting, you know we 
can’t all get in at 11 o’clock in the 
morning or 2 o’clock in the 
afternoon, we do need the half past 
7’s the 8 o’clock in the morning, and 
the evening appointments” [Female 
patient C, age 40, FG1]. 
become more of a problem, then they 
could come back to you” [Female health 
professional E, 30 years post 
qualification, FG3]. 
Patient led treatment, 
whilst managing and 
understanding 
patient expectations. 
“I think being patient led, … what it 
is that they want to achieve out of it 
and how the best way they can do 
that, and you know with a bit of 
guidance, like...” [Female patient B, 
age 32, FG 1]. 
“You try and tease out, you know, what 
are your expectations? No idea. So your 
hopes? No idea. I don’t know what I’m 
supposed to be doing … Forget that, 
what would you like to be doing? …. 
Then you start to offer things and start 
to treat or start to address …” [Male 
health professional D, 5 years post 
qualification, FG 7]. 
Meeting individual 
goals, to manage 
rather than cure 
“Or consider the person’s life style, 
you know consider what is going to 
be feasible, what they need to be able 
to get to in terms of achievement and 
you know and that sort of flexibility 
not just on what they’re asking the 
patient to do …” [Female patient C, 
age 40, FG1]. 
“Because we’re very good at having 
goals, but you know, it’s making sure 
that the patients, they are the patients’ 
as well” [Female health professional G, 
23 years post qualification, FG4]. 
Holistic, long term 
approach  
“It’s not just your joints, it is all the 
other bits around it and that sort of 
slightly bigger picture, you're 
probably going to be like this always, 
you need to think of different ways to 
manage different things” [Female 
patient E, age 34, FG2]. 
“… obviously if there’s a mechanical 
element to it we’d have to go into that, 
but as I say, the hypermobility is 
something that needs to be addressed 
more holistically” [Female health 
professional E, 19 years post-
qualification, FG7]. 
Recognition of the “I think they need to take notice that “If it was classified as a condition, 
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need to treat multiple 
joints for JHS rather 
than individual 
problematic joints 
it is a full body condition rather than 
just individual, rather than just like 
one area, it is individual parts but 
they often concentrate on one area 
and then forget that the rest of the 
body hurts as well and that the pain 
can be interlinked” [Male patient E, 
age 36, FG5]. 
 
[unclear 31:00] spondylitis or all those 
other rheumatological conditions which 
are, extend beyond one section, it’s 
treated differently isn’t it, so it’s got to 
do with its recognition presumably. It’s 
multi systemic, therefore you can treat 
multiple sites and therefore it may take 
longer in the end” [Female health 
professional D, 22 years post 
qualification, FG 4]. 
Focus on core 
strengthening and 
‘correct’ movement 
“basically you’ve really got to give 
them a comprehensive set of useful 
exercises that will cover a whole 
range of joints, you know because 
most of our joints are affected, but 
particular core stability” [Female 
patient E, age 44, FG1]. 
“but really just concentrating on … on 
kind of core, and … good posture .. 
concentrate on how they’re exercising, 
what they’re doing, technique rather 
than just exercising.  Because a lot of 
them just … they find the most bizarre 
ways of doing things that I could never 
do in a million years” [Male health 
professional B, 8 years post 
qualification, FG7]. 
Maintenance 
physiotherapy for a 
chronic condition 
rather than acute 
problems arising 
from JHS 
“If it’s like say the diabetic clinic, 
where you get called every year to 
see them. …  So could they not do a 
package where you actually went 
back every six months to see 
somebody regardless of how you 
were feeling” [Female patient A, age 
60, FG2]. 
“So what we’ve tried to do is …a sort of 
self-referral back into the service, so 
they’re not having to go round the 
houses, and we pick them up quickly 
when they’re starting to get a flare up 
or a deterioration” [Female health 
professional E, >20 years post-
qualification, FG4]. 
 ‘Central role of education in managing JHS’ 
Education for patients and health professionals and raising awareness of JHS within wider 
society was seen to be a key issue for participants in this study. Both patients and health 
professionals considered education to be a key underlying requirement to optimise the 
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viability of physiotherapy for JHS. Because of the lack of understanding that patients 
perceived to be common amongst health professionals, patients felt that health professionals 
required more training in JHS. Some patients felt that they faced a situation where they were 
providing education for the health professionals, and felt that this was not necessarily 
beneficial for them. 
 
“there’s lots of things I still need to know about hypermobility but on the flip side I do think 
it’s the health professionals that need to know more” [Female patient G, age 42, FG 5]. 
 
“So there’s this odd situation where I’m explaining how it works to them and I think that it 
isn’t ideal and I think there does need to be better education for the physios because I think 
that is quite important that they tell you how and why things are happening to you, rather 
than vice versa because that’s unhelpful” [Female patient E, age 21, FG2]. 
 
Health professionals also highlighted the need for education amongst health professionals and 
suggested a variety of educational sources, including websites, special interest and support 
groups and further professional training. One health professional highlighted the value of 
evidence based guidelines.  
 
“because if you get a patient in front of you, you need to be able to think, okay, what can I 
look at? What is the most effective? So guidelines that you were talking about, or maybe you 
can do, would be very helpful” [Female health professional E, 30 years post qualification, 
FG3]. 
 
Health professionals felt that education was necessary for patients in order to facilitate a 
greater understanding of the condition. 
 
“I think a large part of it, as well, is to the education. To think that the patients don’t 
necessarily understand the condition. [….] Sometimes they don’t actually, nobody has never 
actually sat down and explained to them what that is and the implications. And what can 
actually be done to help them. So I think that’s a large part of it” [Female health professional 
D, newly qualified, FG3]. 
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Health professionals felt that education is necessary for patients develop realistic expectations 
of treatment and a better understanding of the rationale for particular treatment plans. 
 
“A lot of … I think what is … is education, “this is why I’m doing it”, and making sure they 
understand why I’m getting them to do these exercises […] … even if it doesn’t work and 
goes horrendously wrong, that’s fine, we can change that, but they’ve got to have an 
understanding of what we’re asking them to do and why we’re asking them to do it” [Male 
health professional B, 8 years post qualification, FG7]. 
 
Patients similarly recognised that education helped them to fully engage with a prescribed 
treatment. 
 
“I think probably a third of my physio session is me quizzing my physio about what it is that’s 
hurting and why and what I can do about it and the way forwards, how I can perhaps do 
things slightly differently.  So I think I get a huge amount of enlightenment from her… So I 
think education is really important and it needs to be part of what’s delivered to the 
hypermobile patient” [Female patient D, age 54, FG2]. 
 
Theme 5: Measuring success, and managing expectations, of physiotherapy 
All participants recognised that the aim of physiotherapy was to manage, rather than cure, the 
symptoms of JHS; that ‘successful’ therapy did not mean the patient would be pain free; 
rather, the aim was for the patient to be able to manage their pain.    
 
“I think measuring success should be more about reaching a point of continuity where you 
know you might not be great all the time or you might not be really bad all the time but 
you’re manageable” [Female patient G, age 30, FG1]. 
 
“… you may not be expecting to get them pain free, but if they’re happy and if they’re 
managing the problem better, you know what to do to manage it, then you’re there” [Female 
health professional C, 19 years post qualification, FG3].   
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Some health professionals raised concerns about patient expectations; that patients were 
expecting to gain more than the treatment could realistically offer. For example, one health 
professional felt that some patients often wanted, and expected, a ‘cure’. 
 
“I don’t want them to go away and think, well, she’s done nothing, when they expected me to 
fix it.  So I have to say from the beginning, well, I can’t fix it, but this is what I can do.  And to 
a point, that’s all you can do, isn’t it, really?” [Female health professional E, 19 years post 
qualification, FG7]. 
 
Some patients considered that physiotherapy would be successful if it resulted in some 
reduction in pain intensity, in some parts of their body.  But contrary to some health 
professionals’ perceptions, patients did not appear to hold unrealistic expectations about the 
treatment that was being offered to them.   
 
“You can measure it [i.e. the success of physiotherapy] by parts of body I guess because I, 
although I don’t feel remotely better in many parts I still say that my last physiotherapy was a 
success because it significantly helped me with my shoulders so that I, I like suffer a lot less 
pain in that area of the body now, so I call it a success but when you get to my knees and 
ankles and neck and back it did do that much, the neck surgery was a success because that 
significantly reduced the neck pain although I still get probably more muscular now than any 
joints but that’s still again one part of it, so there’s lots of other areas that are still very bad, 
so erm I guess that in order to say that I’m better every bit would have to have improved 
significantly to say that they didn’t affect my day to day life, but to have individual parts 
improve is still a success” [Female patient F, age 19, FG5]. 
 
Both patients and health professionals considered physiotherapy would be successful if it 
resulted in patients having a positive attitude, increased confidence and the ability to cope 
with daily activities relevant to the individual. 
 
“…. whether that is feeling better equipped to handle your body going forwards, feeling like 
you’ve got the tools or feeling like you actually physically can do more, but I think it’s a little 
bit … it’s so subjective and almost impossible to measure.  I think feeling better about your 
situation and your body, because I’m never going to feel brilliant.  I think there are definitely 
ways you do feel better, whether that’s feeling better equipped or feeling you actually can 
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now, I don't know, walk 200 yards rather than one hundred without having to stop, or 
whatever, the feeling that you can or the feeling that you will be able to” [Female patient E, 
age 34, FG2]. 
 
“Because you may not be expecting to get them pain free, but if they’re happy and if they’re 
managing the problem better, you know what to do to manage it, then you’re there” [Female 
health professional C, 19 years post qualification, FG3]. 
 
“I feel more able to cope with my condition that I did before, and be able to measure that. 
Some kind of functional measure that might be patient specific functional scale” [Female 
health professional D, 22 years post qualification, FG4]. 
 
Theme 6: ‘Patients’ and health professionals’ views on the proposed physiotherapy 
trial design’ 
During the focus groups, patients and health professionals were presented with a proposed 
design of a physiotherapy intervention RCT (an assessment and advice session versus an 
assessment and advice session plus six 30 minute physiotherapy sessions) as a means of 
creating debate to examine the range of opinions expressed on issues salient to the 
acceptability and feasibility of the proposed trial.  
 Views of proposed trial design 
Trial inclusion/exclusion criteria and the implications of these were discussed by health 
professionals, in particular the potentially heterogeneous nature of the patient group which 
may include chronic pain co-morbidities. 
 
“My thought is something that might skew the kind of outcome is if they were… if they’d 
come through a consultant pathway into this trial quite a lot of them are referred with dual 
diagnosis of hypermobility and fibromyalgia, and if they are referred with, you 
know…hypermobility may be the diagnosis, but if they’re referred for their fibromyalgia and 
they end up on a fibromyalgia coping skills programme they’ll get an awful lot of kind of 
input in that respect on how to manage a long term condition, so it may not be that the input 
they’ve had for hypermobility is what’s been affected.  So I don’t know how you would screen 
that, if you make that an exclusion criteria?” [Female health professional A, 12 years post 
qualification, FG 7]. 
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A minority of patients felt the control arm, which consisted of a one off advice session with a 
physiotherapist, would be acceptable to some patients due to the lack of current advice and 
information available. 
 
“I think it is a little bit of a case of … anything that makes you feel like you’re not on your 
own or anything that gives you any more information, or any more tips, or any ideas of things 
that might help.  It’s that thing of feeling that you’ve got tools to help yourself, because you 
don't want to be dependent on having to go and see a physio every week or every month or 
however.  I mean having someone who you can go back to check up on you and make sure 
everything is okay, that I think is ideal, but obviously difficult funding-wise in the NHS” 
[Female patient E, age 34, FG2]. 
 
The majority of patient and health professionals however, highlighted a number of concerns 
with the content of the control arm. Some health professionals felt that patients would require 
more than just advice. 
 
“I don’t think people generally like, what they would term, as being talked to. So if the advice 
was just talking, information giving but no hands on or assessment of looking or something 
specific to their problem, I don’t think they would buy into that”  [Female health professional 
B, 29 years post qualification, FG3]. 
 
Some patients felt that they would not be willing to take part in the trial if they were 
randomised to the control arm due to that the lack of ongoing physiotherapist support to 
ensure exercises are done correctly.  
 
“You then think ‘okay I can do this’, and whatever you do, you could be doing it completely 
wrong which could be then be making you even worse, so then without, obviously you’ll then 
know that but you’ve just then wasted all that time just to know, okay, that was wrong.  So I 
know with the physios that can happen as well but at least they got some sort of background 
to maybe steer you in the right place, so I think just straight out physio’s going to be better” 
[Female patient D, age 21, FG1]. 
 
53 
 
“I definitely would go no thanks I’m going to go down the physio route because like you said 
you want constantly reassuring that you’re doing things the right way because someone 
would say that the diagrams with you know lean on the side, do this, do that, you could be 
doing it, but not doing it right, so you do need someone to say you’re doing it wrong and 
show you how to do it right, so I would definitely say no” [Female patient B, age 27, FG5]. 
 
Patients felt that the control arm may not be viewed as equitable treatment in comparison to a 
physiotherapy intervention arm. Patients felt that those who were in enough pain to seek 
healthcare would require an active intervention to treat their symptoms and therefore may be 
reluctant to consent to the trial if the arms were not seen to be balanced. 
 
“I still think to leave everyone, if you told in that group ‘right half of you are going to go to 
physio and half advice.’ I think wouldn’t you feel a little bit jipped, knowing ‘wait a minute 
how come I’m not going to get anything?’” [Female patient A, age 36, FG 5]. 
 
“If you’re in that much pain to actually go to the GP to be referred. You need something…” 
[Female patient B, age 27]. “Yeah, I think you definitely need something there that’s an 
alternative but obviously isn’t physio but is something otherwise people are generally not 
going to be interested because they want to have something that they think might help them” 
[Female patient D, age 32] [both FG5]. 
 
Patients and health professionals stated that if patients had specific problems which they felt 
needed treatment, they may be likely to withdraw from the trial if randomised to the control 
arm.   
 
“The only thing I would say is if I got … I would sign up, but if I got referred for the advice 
session and usual GP care I may well go back to my GP and ask for another referral. 
Because if you had a problem, you’d want some physio … Depending on what level I was at 
when I … you know, if I felt I really needed it then obviously I’d be like, well, that’s a bit 
annoying” [Female patient A, age 30, FG6]. 
 
“See, because I think you might get people dropping out. Because if I had a problem and I 
was only being talked to and my problem wasn’t being identified and it was just general 
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knowledge, I would soon seek somebody else, if I had the ability to do that” [Female health 
professional E, 30 years post qualification, FG3]. 
 
Both patients and health professionals felt that the willingness of individuals to participate in 
the trial would be influenced by patients’ severity of symptoms and personal requirements 
and treatment expectations.   
 
“I think it depends on how bad you are and your symptoms are at the moment and myself is 
relatively manageable at the moment so I’d be willing to do that, I’d be happy to do that” 
[Female patient D, age 32, FG5]. 
 
“It depends on the individual to, wouldn’t it? If you’ve got somebody who’s got good feelings 
of self-ethnicity [sic] and internal locus for control, they might well go for it, because they 
think that’s fine, all I need is some good advice. For those who were thinking they might be 
getting treatment, they might well drop out if you were to allocate them” [Female health 
professional C, 19 years post qualification, FG3]. 
 
Although more preferable to many patients than the control arm of the trial, some felt that the 
intervention arm of six physiotherapy sessions would not be enough to be beneficial: 
 
“I think you’ve also got to be realistic about what success you can get out of the group that 
had the physio on just 6 half hour session because I don’t think in a four month period you 
will get much success I think you will be needing to look at it on a much longer term” 
[Female patient F, age 44, FG1]. 
 
“That is very quick, I mean even by the standards of what I’ve had into them, so ... when I felt 
rushed with 10 sessions.” [Female patient G, age 30, FG1]. 
 Suggested changes to trial design 
Patients and health professionals offered a number of suggestions for augmenting the content 
of the control arm, including providing on-going support through group meetings, gym 
membership and the provision of general, not targeted, exercises, so the two arms were 
perceived as more equitable.  
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“So I think it has to, something else has to be, whether you do just get offered a holistic 
approach so they only, you meet with someone, the same number of sessions and talk about it 
or you just go to groups about it”  [Female patient A, age 36, FG5]. 
 
“Can you give them 6 sessions of Pilates instead of the, with the advice leaflets and then they 
can come back to physio, you know does just going off and doing a Pilates class on your own 
help you manage it better than a physio”  [Female patient B, age 32, FG1].  
 
“What about one group has the specific one to one intervention and another group, basically, 
referred with exercise prescription to a gym?  They’re still exercising, but it’s non targeted, 
isn’t it?”  [Female health professional C, 19 years post qualification, FG3]. 
 
“I think if you gave an advice session plus like a free gym pass that you can use somewhere, I 
think that might be more of an incentive” [Female patient B, age 32, FG1]. 
 
Both patients and health professionals suggested that having a delayed intervention for the 
control arm may be seen as more acceptable and could possibly encourage trial participation. 
 
“Maybe you could encourage more people, I think they’d be willing to do it anyway, ‘I’m not 
getting physio right away although I was expecting to have some, at some point fairly soon’, 
you could try and get over the objections by saying that after this has completed then the 
people that were sent down the not doing anything route will just get referred onto 
physiotherapy anyway so they still get the physiotherapy they require” [Female patient D, 
age 21, FG 1]. 
 
“Would they be able to receive, if you approve that having the six sessions [of physiotherapy] 
is beneficial, would they be then guaranteed to receive that at a later date?” [Female health 
professional D, newly qualified, FG3]. 
 
2.2.5 Conclusion  
Both patients and health professionals described JHS as a painful, chronic condition with 
heterogeneous, fluctuating and evolving symptoms. Patients and health professionals reported 
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a lack of recognition and understanding about JHS and even some scepticism. Patients 
reported difficulties in being diagnosed and how they had encountered health professionals 
who they felt didn’t believe or understand their descriptions or their experiences of JHS.47 
The data indicates the importance of a timely diagnosis of JHS and referral for specialist care 
in order to facilitate effective treatment of JHS. Physiotherapy was viewed as beneficial if 
used to manage JHS holistically rather than to treat acute injuries in isolation. Patients valued 
physiotherapy when delivered by therapists who had an understanding of the chronic nature 
of JHS so appropriate management could be delivered. The aim of physiotherapy should be 
considered to be long term injury prevention and symptom amelioration.48 Education for 
health professionals and patients and raising awareness of the condition was seen as essential 
in order to optimise physiotherapy provision for JHS.  
 
In relation to the proposed trial design, both patients and health professionals felt that the 
content of the control arm, consisting of a one off advice session, may not be perceived as 
equitable to the physiotherapy intervention arm and concerns were raised that this may 
impact on trial recruitment and retention. 
 
Strengths and limitations 
The use of a qualitative methodology is a key strength in the current study, which is the first 
to our knowledge to undertake an in-depth investigation of the day to day experiences of 
managing JHS from both patients’ and health care professionals’ perspectives. Employing 
focus group methodology allowed consensus to be gained regarding physiotherapy treatment, 
although it is recognised that using focus groups as a method of data collection did not permit 
as much in-depth exploration of some of the issues raised as other forms of data collection, 
for example, one to one interviews. The congruence between patients’ and health 
professionals’ descriptions and perceptions of JHS was notable. 
 
Our participants were recruited from four different geographical locations the UK and 
therefore had experiences of different health care services. A diverse range of individuals in 
terms of demographics participated and analysis showed commonality in views and 
experiences. However, the research findings may be limited by the fact that our patient 
participants were already using the health system and the health professionals in these focus 
groups were experts in the field, providing specialist care for JHS. 
57 
 
 
The authors recognised that the participants cannot provide accounts of their experiences 
which are not influenced by the research act (the focus group) and that this represents a 
particular kind of social interaction which plays a role in shaping the participants’ dialogue.  
The researchers were aware of this issue and it is hoped that any negative effects were 
ameliorated where possible, for example, by the fact that multiple authors, from diverse 
methodological backgrounds, were involved in the data analysis. 
 
2.3 COMPONENT 2: DEVELOPMENT OF THE PHYSIOTHERAPY 
INTERVENTION 
2.3.1 Aim 
Using the findings from Component 1, the overall aim of this component of the study was to 
develop a comprehensive physiotherapy intervention package and associated training 
materials. 
 
2.3.2 Methods 
Development of the advice intervention 
The research team were very conscious of some of the feedback from patients and health 
professionals as part of the HPoP study regarding the design of the control intervention. 
There was a concern that an advice only intervention would have a negative impact on 
recruitment and retention. The initial preferred design of the study was to include a delayed 
intervention control arm. However the HTA funding committee convincingly argued that this 
would cause problems for establishing the long-term effectiveness of the physiotherapy 
intervention in any future definitive RCT. In the absence of any convincing research evidence 
for the effectiveness of physiotherapy the research team agreed that there was an argument 
for clinical equipoise between physiotherapy and an advice only control. It was therefore 
agreed that all patients would receive a one-off advice session, supplemented by advice 
booklets from the Hypermobility Syndromes Association54 and Arthritis Research UK55. It 
was also agreed that some specific key issues from the Arthritis Research UK booklet would 
be discussed in detail but that all participants would also be given the opportunity to ask for 
specific advice related to their own circumstances. The research team agreed that the key 
topics for discussion from the Arthritis Research UK booklet55 should be as follows: 
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• What is hypermobility? (p5) 
• How is hypermobility diagnosed? (p10) 
• Drugs (p11-13) – although patients would also be advised to consult their General 
Practitioner if they wanted a review of their medication 
• Self-help and daily living (p14) 
 
This one-off advice session and the advice booklets would act as the control intervention for 
those patients randomised to the control arm of the trial in the later pilot RCT (Stage 3) but 
would be piloted as part of Stage 2. 
 
Development of the physiotherapy intervention 
A comprehensive 'whole body' physiotherapy intervention was developed using a working 
group of researchers, health professionals and patient research partners. The group included 
three physiotherapists, a consultant rheumatologist, a clinical psychologist and two patient 
research partners with JHS.  
 
Discussion took place within the context of a number of guiding principles. These were 
related primarily to the resource context within which most physiotherapy services operate37 
but also mirrored best practice as conducted at North Bristol NHS Trust. Firstly, it was 
agreed that the intervention would be delivered on a one-to-one basis as the needs of 
individual patients were considered to be so varied. Secondly, it was agreed that the 
intervention should be easy to implement in any outpatient department (and would therefore 
exclude complex or resource-intensive interventions such as hydrotherapy). Thirdly, it was 
agreed that the intervention should include a maximum of six 30 minute treatment sessions 
over four months. 
 
Two half-day meetings were held, the first of which reviewed the findings from Component 1 
of the research (the HPoP study) and discussed the implications of these data for the design of 
the intervention. At this meeting it was also agreed to adapt an existing supported self-
management intervention with proven clinical and cost-effectiveness, rather than starting 
from scratch. The Enabling Self-management and Coping with Arthritic knee Pain through 
Exercise (ESCAPE) programme56 was originally developed for chronic knee pain and is 
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based on a self-efficacy theory of behaviour change.57 The theory of self-efficacy is central to 
Bandura’s social cognitive theory, with self-efficacy describing the confidence one has is 
one’s ability to complete tasks or reach goals. The premise is that increased self-efficacy 
makes it more likely that one can successfully achieve one’s goals. In the context of JHS, 
goals might include being more active and managing the condition more successfully. There 
are a number of key factors that regulate self-efficacy, with learning by results a crucial 
component (i.e. past successful experiences can enhance self-efficacy). Also important are 
attitudes and subjective norms (from vicarious experience and social persuasion), and these 
drive intentions and behaviour. Experience of the outcomes from that behaviour then inform 
further self-efficacy judgements.57 Both the ESCAPE programme and the new physiotherapy 
intervention for JHS therefore aim to enhance self-efficacy by positively influencing 
attitudes, subjective norms, intentions and behaviour. 
 
The research team already had experience of using an adapted version of the ESCAPE 
intervention package58 in a previous sham-controlled randomised controlled trial of exercise 
and Transcutaneous Electrical Nerve Stimulation.59 We are also currently investigating its 
adaptation and application to a wider population of patients with chronic knee, hip and low 
back pain in a cluster RCT.60 The general approach is to help patients to become more 
physically active through developing the knowledge, understanding and skills to better 
manage their condition. This is achieved through a process of education, problem solving, 
reflection and planning, along with gaining experience of exercise and learning from 
accomplishments. A key component of the original ESCAPE programme is learning through 
vicarious experience and social persuasion by conducting group education and group 
exercise. This is a key difference between ESCAPE and the current intervention (which was 
conducted on a one-to-one basis) and for this reason we are careful not to draw too many 
comparisons. However it was agreed that the broad approach and patient materials were 
considered to be an excellent starting point.  
 
Following the first meeting the Chief Investigator drafted a patient handbook. This was 
adapted from that used for our previous TENS study59 and involved a process of mapping 
content against some of the key themes raised in the HPoP study, removing topics irrelevant 
to JHS, developing new sections to address issues specific to JHS, and generally reviewing 
and refining the handbook so that it was specific to JHS rather than chronic knee pain. 
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Ongoing advice was taken from members of the working group through e-mail and telephone 
consultation.  
 
The draft patient handbook was then discussed in depth at a second working group meeting 
where further changes and amendments were recommended. Patient research partner input 
was particularly important in ensuring that the language and layout was as user-friendly as 
possible. Following this meeting the requested changes were made a final draft of the patient 
patient handbook was agreed by e-mail. A key new section was developed relating to ‘Taking 
Control’ and this addressed many of the psychological issues raised by participants in the 
focus groups. This section was developed in close consultation with our clinical psychologist. 
‘Posture’ and ‘Movement Quality’ were also developed as new sections, led by 
physiotherapy colleagues. The ‘Medication’ section was completely revised by our consultant 
rheumatologist and a further section on ‘Sleep Hygiene’ was added on the advice of our 
clinical psychologist to address some of the issues related to fatigue reported by focus group 
participants. A ‘menu’ of exercises was developed in consultation with physiotherapy 
colleagues. Other sections such as ‘Aims’, ‘Benefits of Exercise’, ‘Goal Setting’, ‘Pacing of 
Activity’, ‘Long Term Management’, ‘Staying Active’ and the tools to support reflection and 
planning remained very similar but the content and wording was updated to make them 
specific to JHS. A section related to diet was removed as this was not raised by focus group 
participants.  
 
The handbook was designed to support the face-to-face physiotherapy sessions. To maximise 
the use of time within the physiotherapy sessions, the handbook encouraged patients to reflect 
following sessions and to read information and to prepare in advance of the next session. 
Time was allocated at the beginning of each session to allow participants to discuss any 
specific issues that they might have in relation to the educational topics. The majority of the 
session was then dedicated to exercise, with the physiotherapist selecting specific exercises 
from the ‘menu’ available at the end of the booklet. Exercises were selected on the basis of 
findings from the initial clinical assessment and were adapted as necessary over time. Space 
was provided for notes to be added regarding exercise adaptations or progressions. Patients 
were also encouraged to increase their general physical activity, choosing an activity that they 
enjoyed and that could form part of their daily routine. A physical activity action plan and 
activity diary was included in the handbook to assist with planning and self-monitoring. 
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Reflection encouraged problem solving in relation to the topics, exercises and physical 
activity. 
 
The final draft handbook was prepared as an A5 booklet. It included six sections, one for 
each session, covering the following topics: 
• Session 1: Aims, benefits of physical activity, posture, movement quality, pain relief 
• Session 2: Medication, sleep hygiene, goal setting, exercise, physical activity 
• Session 3: Pacing of activity, exercise, physical activity 
• Session 4: Dealing with set-backs, exercise, physical activity 
• Session 5: Taking control, exercise, physical activity 
• Session 6: Long term management, staying active 
 
A training package for physiotherapists was also subsequently developed by the chief 
investigator, composing a slide show presentation addressing the following areas: definition, 
diagnosis and prevalence of JHS; an overview of the impact of JHS and its management, 
including theoretical aspects and evidence for the effectiveness of physiotherapy; patient and 
health professional perspectives on physiotherapy; the process of developing the 
physiotherapy intervention package and its guiding principles; an introduction to JHS 
assessment; an overview of the advice intervention; and a session by session overview of the 
physiotherapy intervention. This was followed by an introduction to the design of Stage 2 of 
the research (the pilot of the intervention) and relevant study procedures including screening 
of referrals, assessment and consent, treatment and questionnaire administration. The training 
was designed to be delivered in five hours, which included a 15 minute break for coffee and 
45 minutes for lunch. 
 
This final draft intervention and training package was evaluated as part of Stage 2 of the 
research and will be reported in the following chapter. The draft patient handbook and 
training package are not included in this report as they underwent further revision after Stage 
2. The final versions are reported later in this report. 
 
Strengths and limitations 
The process of developing the interventions had a number of strengths, including being very 
collaborative and informed by findings from the patient and health professional focus groups. 
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The design of the Physiotherapy intervention was underpinned by the theory of self-efficacy 
and built upon an existing intervention package with proven clinical and cost effectiveness in 
another musculoskeletal condition. It is recognised, however, that the decision to deliver the 
Physiotherapy intervention on a one-to-one basis as opposed to a group format might limit 
the proposed effectiveness of socialisation57. The Advice intervention made use of existing 
resources developed by a major charity and a patient organisation54-55 and again this was seen 
as a strength. 
   
2.4 CONCLUSIONS & IMPLICATIONS 
Overall Stage 1 of the research provided an important insight into patients’ lived experiences. 
It also provided important patient and health professional perspectives on the physiotherapy 
management of JHS. This information was instrumental in informing the development of a 
draft physiotherapy intervention and associated training package. 
 
The findings also informed the design of the subsequent pilot RCT. Of note were the 
concerns from patients and health professionals about the proposed use of an advice only 
control arm. On discussion the research team decided to maintain this study arm but to ensure 
that there was an opportunity for patients to received personally tailored advice in addition to 
issuing advice booklets. Patients could therefore generate their own questions that could be 
addressed by the physiotherapist. The potential impact on recruitment and retention of a 
perceived lack of equipoise between study arms remained a concern however.   
  
63 
 
CHAPTER 3  STAGE 2: PILOT OF THE PHYSIOTHERAPY INTERVENTION 
 
3.1 AIMS & OBJECTIVES 
The primary aim of this stage of the research was to evaluate the physiotherapy intervention 
by implementing it with a small sample of patients from two NHS Trusts (North Bristol NHS 
Trust and the Royal National Hospital for Rheumatic Diseases NHS Foundation Trust). A 
qualitative evaluation from the perspectives of patients who received the intervention and 
physiotherapists who received training and delivered the intervention was therefore the main 
focus. Secondary aims included gathering information related to patient referrals, application 
of the inclusion and exclusion criteria, recruitment rates and acceptability of the study 
questionnaires.  
 
Specific objectives were to:  
• Deliver a comprehensive physiotherapy intervention for adults with JHS in two NHS 
Trusts. 
• Interview patients about their views and experiences of receiving the intervention and the 
acceptability of the study questionnaires. 
• Interview physiotherapists about their experiences of receiving training and delivering the 
intervention. 
• Gather information about referral rates, application of the inclusion and exclusion criteria 
and recruitment rates. 
• Refine the intervention package, training and study procedures for the forthcoming pilot 
RCT. 
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3.2 METHODS 
The physiotherapy intervention was delivered to people with JHS referred to the 
rheumatology physiotherapy services within the two NHS Trusts. Recruitment took place 
across a one month period (August 2013), with subsequent treatment lasting four months 
(until the end of December 2013). Qualitative interviews were undertaken with 
physiotherapists and patients to determine the issues involved with the content and delivery 
of the intervention and its acceptability, and to help refine the design and content of the pilot 
RCT. This study and the subsequent pilot RCT were conducted under the acronym 
‘Physiotherapy for Hypermobility Trial’ (PHyT) and received ethical approval from the 
National Research Ethics Service Committee South West – Exeter (13/SW/0083). 
 
3.2.1 Physiotherapist recruitment 
Four physiotherapists (two from each NHS Trust; one man and one woman at each site) were 
trained to deliver the intervention. All physiotherapists had extensive experience and a 
particular interest in treating JHS patients. A principal investigator (the lead physiotherapist) 
was appointed at each site.  
 
3.2.2 Patient recruitment 
Patients referred for physiotherapy within the two NHS Trusts who had a suspected diagnosis 
of JHS were invited to participate. Both NHS Trusts had rheumatology physiotherapy 
services with expertise in managing JHS and received referrals mainly from General 
Practitioners and Rheumatology consultants. Potential participants were identified by the 
principal investigator from their referrals (looking for specific reference to hypermobility) 
and were sent a study information pack and a reply slip to be returned if they were interested 
in taking part. An initial physiotherapy assessment was then arranged, during which the 
inclusion and exclusion criteria were confirmed. Those eligible and consenting to take part 
then received the physiotherapy intervention. Participants included both those with a new and 
more established JHS diagnosis.    
 
Inclusion criteria 
More than 18 years old; able to give informed consent; able to understand and communicate 
in English (with the assistance of an interpreter as necessary); fulfil the Brighton criteria for 
JHS (see Table 1, Chapter 1).  
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Exclusion criteria 
Other known musculoskeletal pathology causing pain, particularly osteoarthritis and 
inflammatory musculoskeletal disease such as rheumatoid arthritis; other serious pathology 
including malignancy; conditions affecting ability to exercise e.g. uncontrolled 
cardiovascular disease; recent physiotherapy for JHS (within the last year); pre-existing 
psychological distress or psychiatric conditions. 
 
3.2.3 Quantitative aspects  
A screening proforma assessing the Brighton diagnostic criteria and the other inclusion and 
exclusion criteria was completed by the physiotherapist at the baseline assessment (Appendix 
3). The baseline study questionnaires were also piloted with patient participants. This 
included a biographical questionnaire (Appendix 4A); a questionnaire booklet (Appendix 4B) 
containing the MDHAQ, a draft version of the BIoH questionnaire, pain VASs, the ESE scale 
and the EQ-5D-5L; and the Measure Yourself Medical Outcome Profile (MYMOP) 
(Appendix 4C). The biographical questionnaire and questionnaire booklet were mailed to 
potential participants prior to the baseline assessment and they were asked either to complete 
and return them in advance or to bring them to their appointment. Completed questionnaires 
were returned to the chief investigator using pre-paid return envelopes. 
 
The MDHAQ is a rheumatology specific outcome measure61 which has been used 
successfully in a wide range of other rheumatological conditions, including Behcet’s 
syndrome, Cutaneous Lupus Erythematosus, Fibromyalgia, Gout, Osteoarthritis, Psoriatic 
Arthritis, Rheumatoid Arthritis, Scleroderma, Spondyloarthropathy, Systemic Lupus 
Erythematosus and Vasculitis. It has demonstrated good test-retest reliability and face 
validity.61 It contains items related to physical function (scored 0-10), pain (0-10), patient 
global rating (0-10), fatigue (0-10), and self-reported joint count (0-10). The function, pain 
and global rating scores can be summed to provide a Routine Assessment of Patient Index 
Data (RAPID3) score (0-30) which has been shown to compare favourably with other scores 
such as the DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index).62 
The self-reported joint count item is also known as the Rheumatoid Arthritis Disease Activity 
Index (RADAI). Higher scores on all MDHAQ items represent increasing condition severity. 
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Although the MDHAQ has not previously been used in JHS patients it was considered 
potentially useful by the research team due to its focus on multiple joint pathology. 
 
The BIoH questionnaire is the first condition-specific outcome measure developed for JHS. It 
was still undergoing development by the research team at the time of this pilot. The version 
administered to participants as part of the pilot had 104 items, 94 of which were scored. It has 
since undergone a process of item reduction and the final version has 55 scored items and this 
version was administered as part of Stage 3 of the present research. It incorporates the Bristol 
Rheumatoid Arthritis Fatigue (BRAF) numerical rating scales which have demonstrated good 
reliability and responsiveness.63 The final version of the BIoH questionnaire has been shown 
to validate very well against the Short Form (36) Health Survey (SF-36), particularly the 
physical function component score.64 The final BIoH questionnaire produces a score out of 
360, with higher scores representing a more severe impact of JHS. The questionnaire is 
currently undergoing further testing with patient and health professionals to determine its 
test-retest reliability, sensitivity, appropriateness, validity, acceptability, feasibility and 
interpretability.  
 
The wording of the anchors for the four pain VASs was adapted very slightly from those used 
in a previous study of exercise for JHS.34 VASs are generally considered to be valid, reliable 
and responsive instruments for the measurement of pain, although they are unidimensional.65 
Each scale was measured on a 0-100mm horizontal line, with higher scores representing 
higher pain intensity. 
 
Bandura’s ESE scale66 was the version adapted by Everett et al.67 It has been well validated 
in patients undergoing cardiac rehabilitation and we have previously successfully used this 
scale to assess self efficacy for exercise in knee osteoarthritis.59 The scale asks participants to 
rate how confident they are (on a 0-10 scale) that they can exercise regularly in 18 different 
circumstances. The scale is converted to scare out of 100, with higher scores representing 
higher exercise self efficacy. 
 
The EQ-5D-5L is an established health outcome measure applicable to a wide range of health 
conditions and treatments which can be used to produce health economic estimates. It 
produces a single summary index on the basis of responses to 5 dimensions related to 
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mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Its validity and 
responsiveness has been well established in a range of chronic pain conditions.68 
 
The MYMOP aims to assess the outcomes that each individual patient identifies as being 
most important to them69 and was adopted to address the comments of some focus group 
participants that the success of physiotherapy might be very individual. The MYMOP was 
completed with the patient as part of the baseline assessment. 
 
Due to the substantial delay to the start of the research reported in section 2.2.3 (Chapter 2), 
follow up questionnaires were not administered in an attempt to recoup some lost time. Data 
is presented using descriptive statistics. Due to the ongoing development of the BIoH 
questionnaire, those results have not been reported in this chapter. 
 
3.2.4 Qualitative aspects 
During the pilot implementation of the intervention face-to-face interviews were conducted 
with patients four months after starting treatment to consider their experiences of JHS and 
physiotherapy. We also sought to gather the views and experiences of physiotherapists and of 
patients that did not complete the intervention. 
 
Procedure  
All patients and physiotherapists participating in the physiotherapy intervention were asked if 
they were willing to be contacted about taking part in an interview at the time of consent. All 
participants provided written, informed consent prior to the interview. Topic guides were 
used to facilitate the interviews and, in line with an inductive approach, were revised in light 
of emerging findings. Patient interview topic guides (Appendix 5) focused on their 
experiences of the advice and physiotherapy interventions; changes experienced or made 
following participation; what worked well; and any aspects of the intervention where 
improvements could be made. Physiotherapist topic guides (Appendix 6) focussed on 
training; the content, delivery and acceptability of the advice and physiotherapy 
interventions; and suggestions for improvements. Patient interviews took place in the 
patients’ home or in the hospital where they were receiving their physiotherapy treatment. 
Physiotherapist interviews took place in the hospital where the physiotherapist normally 
worked. Open-ended questioning techniques were used to elicit participants’ own experiences 
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and views. Interviews lasted between 30 and 62 minutes and were conducted by an 
experienced qualitative researcher (RT) employed on the project. 
 
Data Analysis 
All interviews were audio-recorded, fully transcribed, and anonymised. Transcripts were 
coded using Framework methodology.70 Analysis began shortly after data collection started, 
and was ongoing and iterative. Each transcript was read and re-read and then coded on a line-
by-line basis, so that salient content was integrated into the coding framework under pre-
determined codes or new codes generated by the data. Pre-determined codes included 
patients’ and physiotherapists’ views on the study information, trial recruitment, 
information/advice session, physiotherapy session, trial information booklet, homework and 
suggestions for improvements in the trial design. Emergent codes generated by the data 
included patients’ expectations and comparisons to previous physiotherapy. Coding aimed to 
classify all of the data so that it could be compared systematically with other parts of the data 
set. The emergent themes were discussed by the multi-disciplinary research team to ensure 
credibility and confirmability. 
 
3.3 RESULTS 
3.3.1 Quantitative results 
A total of n=42 referrals were assessed for eligibility. n=23 did not meet the inclusion 
criteria. A further n=11 did not respond or failed to attend within the recruitment period. All 
other eight participants consented to take part in the pilot of the physiotherapy intervention 
(19% of all referrals) (see Figure 5). One participant withdrew following consent because she 
was too busy (this participant also did not return a baseline questionnaire). Another 
participant withdrew after she had received four physiotherapy sessions as she was diagnosed 
with systemic lupus. This participant was still happy to be interviewed about her experience 
of being involved with the study and her baseline questionnaire was also analysed. One 
participant failed to return a baseline questionnaire despite receiving a reminder. A further 
participant was not able to be contacted to arrange an interview. 
 
The main reason for exclusion was other musculoskeletal conditions (n=14). Closer analysis 
of this data showed that n=6 of these were excluded on the basis of fibromyalgia syndrome, 
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which is a common concomitant diagnosis. Of those excluded on the basis of psychological 
conditions (n=3), all had received a diagnosis of anxiety or depression. 
 
Figure 5. Abbreviated CONSORT flow diagram. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7 summarises the participant characteristics and baseline outcome measure scores. All 
participants were women and the mean Beighton score approached 6/9. Pain scores were 
moderate (in the region of 50%) and the mean RAPID3 score also fell within the ‘moderate 
severity’ category. Mean exercise self-efficacy was relatively high in this group, approaching 
60/100.  
 
Table 7. Participant demographics and baseline characteristics.  
Demographics and Baseline Characteristics  
Age [years], mean (SD), n=8 33.5 (7.4) 
Sex [M : F], n=8 0 : 8 
Beighton Score [max=9], mean (SD), n=6 5.8 (2.0) 
Assessed for eligibility (n=42) 
Excluded (n=34) 
• Not meeting inclusion criteria 
(n=23) 
- Other musculoskeletal conditions (n=14) 
- Psychological conditions (n=3) 
- Too young (n=3) 
- Physiotherapy within last 12 months (n=2) 
- Not JHS (n=1) 
• Other reasons (n=11) 
- No response or did not attend (n=11) 
 
Consented (n=8) 
Enrollment 
Interviews (n=6) 
Lost to follow up (n=2) 
- Did not receive physiotherapy (n=1, withdrew after consent - too busy) 
- Unable to contact (n=1) 
 
Baseline questionnaires (n=6) 
Lost to follow-up (n=2)  
- Withdrew after consent (n=1, too busy) 
- Did not return questionnaires (n=1) 
 
Analysis 
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MDHAQ, mean (SD), n=6 Function [max=10] 1.2 (1.1) 
Pain [max=10] 5.8 (2.1) 
Patient Global [max=10] 4.0 (3.3) 
RAPID3 [max=30] 11.0 (6.0) 
RADAI [max=10] 1.9 (1.1) 
Fatigue [max=10] 4.3 (3.3) 
Pain [max=100mm], mean 
(SD), n=6 
Most affected joint at rest 56.7 (26.3) 
Most affected joint on 
movement 
55.7 (34.3) 
Joints in general at rest 51.0 (29.1) 
Joints in general on movement 48.2 (33.6) 
ESE Scale [max = 100], mean (SD), n=6 59.7 (26.2) 
EQ5D-5L Index, mean (SD), n=6 0.5515 (0.2858) 
 
3.3.2 Qualitative findings 
Four physiotherapists, (two male, two female) were interviewed. At the time of interview, 
three physiotherapists had treated two patients using the physiotherapy intervention. Two of 
the physiotherapists had initially recruited three patients, although two patients withdrew as 
the study progressed. One therapist had not treated any patients using the trial intervention, 
but had discussed the booklet and its contents with patients not involved in the trial. All 
physiotherapists had extensive experience and a particular interest in treating JHS patients. 
Six JHS patients who had participated in piloting the intervention conducted an interview 
(see Table 8). One patient withdrew from the study as they were too busy and it was not 
possible to contact another patient regarding participating in an interview. One patient 
withdrew from treatment as she received a diagnosis of systemic lupus but she still consented 
to be interviewed. 
 
Table 8. Demographics of patient interview participants (with additional comments 
regarding interviews). 
Participant  Site Age Sex Interviewed Comment 
101 1 22 Female No Unable to contact 
102 1 35 Female Yes  
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103 1 31 Female Yes  
104 1 42 Female No Withdrew after consent – too busy 
106 1 41 Female Yes  
201 2 29 Female Yes  
202 2 27 Female Yes  
203 2 41 Female Yes Withdrawn after four treatments – 
diagnosed with systemic lupus. 
Consented to be interviewed. 
 
Physiotherapist views on initial training  
Physiotherapists felt that the training was based on the current practice at the two research 
sites and that it was aimed at physiotherapists who were less experienced in managing JHS. 
 
“Yeah, I think that’s the task, is taking the practice from ((city name)) and from here, and, 
and also ((city name))[ …] generally the practice there is very good and that’s what we built 
the, the treatment on, which is, which is fine. Um, it’s, I suppose, teaching other people to do 
that and those sorts of things” [Physiotherapist 102]. 
 
The focus of the training was on the assessment of JHS, the theoretical background of JHS, 
the paperwork involved in the trial, the use of the booklet and the content of the 
physiotherapy intervention. 
 
“So it was quite formulated and quite er, specific with the intervention, ‘cause they didn’t 
want us to, erm, freestyle too much, because you need to be able to compare and contrast, I 
guess” [Physiotherapist 202]. 
 
It was suggested that the training package could be enhanced, particularly for less 
experienced physiotherapists, by the addition of more practical training and a greater focus on 
JHS assessment. 
 
“And it’s, um, necessarily getting them comfortable treating hypermobility. [….] I think, 
again, a little bit more in terms of, sometimes, teaching on practical aspects of teaching of, of 
hypermobility and common things they do, and how they do it, and exactly what we’re 
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looking for. Um, I, that’s what I want, depending on who else was in the trial [….] but I think 
we do need to, probably, in terms of assessment wise, apart from hypermobility, what are we 
looking at muscle control wise […] And sometimes that’s the bit, if I didn’t have any 
experience of treating hypermobility and came in, and I had one of our junior physios and 
said, ‘There you go, do this’. That’s the bit I’d be slightly concerned they don’t necessarily 
do so well” [Physiotherapist 102]. 
 
One physiotherapist felt that a particularly positive aspect of the training was the opportunity 
to revisit the evidence base for the use of physiotherapy to treat JHS. 
 
“I think it was good to have the recap of the evidence base, and obviously the reason why 
we’re there and things like that, that’s always good as a reminder more than anything else” 
[Physiotherapist 101]. 
 
The training may have been influenced by the assumption that those undergoing training 
were already experienced in treating JHS patients.  
 
“Well, there was an assumption that we already knew quite a bit about it. Erm, because this 
is a pilot trial, I think they want to know if we can’t deliver it, then somebody who has no 
experience of hypermobility might really struggle” [Physiotherapist 202]. 
 
Patient feedback relating to the study information 
Patients had a clear understanding of the aims of the trial from the information provided.  
Participants described the information positivity and appreciated that JHS was being 
recognised and the topic of empirical investigation. 
 
“Yes it [the information] was really useful. It was fine, really clear. […] it was really good. It 
was just really helpful. I think it was just that initial thing of it being recognised. The idea 
that something was happening for that and that was, you know - yes, it was really good” 
[Patient 102]. 
 
One participant, however, found the information provided and the completion of the 
questionnaires “a bit depressing” on realising the extent to which JHS had impacted upon 
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her life.  Nonetheless, the information also made her realise that things were not as bad for 
her as they could be: 
 
“Yes, I think for me it was a bit depressing because I didn’t really realise how much this 
impacted on my life when I filed it in. Then I thought oh okay, yes, it does impact a bit. I was 
glad I could do my buttons up and things like that. It would give you a context of other people 
and their issues. But then realising, I suppose it made me realise it was a good visual 
demonstration, variations, because when you’re in the middle of a really bad flare up, you 
kind of forget that it’s not always that bad. If you’ve had six weeks of feeling awful, you’re 
just ‘Oh, it’s always like this, it’s terrible’. Then it isn’t” [Patient 106]. 
 
Trial recruitment 
Patient views 
Potential patient participants were informed about the study via their GP, rheumatologist or 
JHS specialist physiotherapist. All who took part were happy to participate in the study, keen 
to be involved in research, and to try something that they felt might help their symptoms or 
that they could learn from. 
 
“I did kind of jump at the chance for a trial ‘cause I knew it would be much more focused in 
its approach” [Patient 203]. 
 
One participant described feeling frustrated by previous physiotherapy, and therefore keen to 
be involved in a trial of specialist JHS care. 
 
“I think because it was frustration that ((Physiotherapist’s name)) was probably the only 
person that’s ever actually paid attention to what I was saying and appreciate it, and had 
seen other people with the same problems. She knew it was an issue, and they’d been 
researching it, it made me want to partake in it more than maybe just going to see a different 
physio who didn’t, necessarily, think hypermobility was an issue and that it was just achy 
joints” [Patient 103]. 
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Physiotherapist views 
Therapists felt that patients most likely to benefit from the intervention were those without 
co-morbidities such as chronic pain or depression and felt that the inclusion/exclusion criteria 
were therefore appropriate. 
 
“I actually think the inclusion/exclusion criteria is very good. Um, in terms of, um, actually 
purely getting the hypermobile type people that will, will benefit. Um, what they’re probably 
is, is there’s a, in terms of the ones that are depressed, have other surgery and other 
particular problems that aren’t going to do so well. Um, there is a group of those that aren’t 
really covered by this and they will take longer and those sorts of things. So in a way 
probably the exclusion criteria is probably slightly biased to showing, getting the people that 
we will help” [Physiotherapist 102]. 
 
Initial Information/Advice Session 
Patient views 
The topic guide aimed to ask patients to distinguish between the first advice session and 
subsequent sessions. However, it may have been difficult for some participants to dissociate 
recollections of the first session having then undergone subsequent physiotherapy sessions.  
Generally, the advice session was recalled positively and patients appreciated the opportunity 
to discuss their experiences in some depth with a health professional. 
 
“It was very thorough as well, so it meant, even though I was pointing out 100 things that 
were causing me grief, it was nice to have that time to be able to go through everything 
knowing that’s what would actually help with the solution and the physio afterwards.  So it 
wasn’t daunting or anything like that. It was just quite nice to sit down with someone who 
knew what I was talking about. When I was saying, ‘I click all the time’ it wasn’t like, ‘Well 
stop clicking’” [Patient 103]. 
 
One participant described feeling ‘optimistic’ after the first session. 
 
“And, actually, I think I came away thinking, probably, more optimistic because again, 
because I think I know under, essentially I do know the underpinning stuff, I know I need to 
keep myself well, which is core strength.  Actually it’s all the other bits that I need somebody 
to unpick my life and actually go, ‘You’re doing too much here. …. You’re doing too much 
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one day, so no wonder you don’t feel that great.’ And actually take a, take a step back kind of 
thing.  Um, but also speaking to somebody who’s doing that research who actually 
understands, that actually life doesn’t work like that” [Patient 203]. 
 
Physiotherapist views 
Physiotherapists felt that there was a lot to cover in the first session. They felt that although 
an hour and a half was probably realistic, there may be a slight danger of ‘losing’ patients if 
physiotherapists tried to cover too much in this session. 
 
“So, time wise, it’s not too bad, just a lot of content and I think slight danger of losing people 
at the opening stage” [Physiotherapist 202]. 
 
One therapist suggested splitting the initial session into two, although it was recognised that 
this would result in repeated journeys for the patient. 
 
“I think practically speaking, that’s almost like bringing them back twice to do the same 
thing. So you could be considered to be replicating, but, erm, I think that would be the thing 
that would be easiest, to be able to either, um, break it up into trial related paperwork and 
questions and erm, physio intervention, assessment and treatment, really. Erm, but I don’t 
think there’s a way around it. I think it’ll have to be done in one session. I think it’s going to 
take a long time” [Physiotherapist 202]. 
 
It was also felt that the delivery of this first session improved as physiotherapists became 
more familiar with the trial requirements. 
 
“I think maybe, definitely, the more I did, the slicker I got at it” [Physiotherapist 202]. 
 
One physiotherapist noted that patients were not ‘just trial candidates’ – that the patient’s 
needs still required treatment if they didn’t meet the trial inclusion criteria. 
 
“Erm, there’s also pressure that even if they don’t, you still have to treat the session as 
though it was a normal assessment session, because in case they don’t meet the trial, you’ve 
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still got to do something with them. So, erm, you’re still treating them as a person, not just a 
trial candidate” [Physiotherapist 202]. 
 
Trial Information Booklet 
Patient views 
Patients valued the booklet and each participant used the booklet in a slightly different way. 
For example, some valued the activity diary, others commented positively on the different 
topics in the book. Patients felt the booklet was clear to follow and well laid out, and that it 
could be adapted to suit their individual needs. Others valued having the booklet to refer to as 
and when needed and used it to help explain the nature of JHS to others. Thus, the booklet 
helped to validate patients’ experiences and provided them information that could be shared 
with others. 
 
“It was good. It was very informative. The booklet is really good. Not that anyone else really 
understands, but when I do talk to them about hypermobility if I show them the book, they 
kind of in a way get it a little bit more. Hypermobility is not so well known they do kind of 
understand a little bit more once they read it” [Patient 201]. 
 
Patients felt that the information in the booklet was appropriately pitched. However, 
participants also noted that it did not contain a lot of information that was new to them.   
 
“So whilst we kind of went through it, a lot of the stuff wasn’t new to me, it wasn’t anything I 
had to learn, it wasn’t stuff to read through. But at the same time it just clarified in my mind 
that, ‘Okay, they get it’ … But to me I needed a bit more because I’m obviously doing all 
those things and it’s not making any difference. So whilst all that is great and I appreciate it 
pinpoints what’s wrong, I still need something else” [Patient 103]. 
 
The booklet provided patients with a reminder of strategies to manage their symptoms, and of 
previously held information, and helped them to develop a deeper understanding of JHS.   
 
“I think it was certainly useful, it was more of an affirmation of the things that I knew 
already. But some of it was really useful to connect the dots, if that make sense? So things 
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that I’d thought about quite separately it was quite interesting to see them together in one 
thing. That was really positive actually” [Patient 102]. 
 
Participants were prompted to think about whether any other sort of media might be helpful.  
One participant suggested mobile technology whilst another felt that visual reminders of 
exercises was important. 
 
“Because sometimes it’s all well and good going along to your physio sessions and going, 
‘Oh yes, exercises, oh great.’ But actually if you’ve got nothing to follow it up with it can 
leave you feeling a bit lost. […]I’ve realised what I need to have is like a wall chart, like an 
A4 sheet of paper with my exercises on. Because I find with the booklet I’m flicking and then 
missing a page, so I was finding it quite difficult to work out what I should be doing in order  
[…] Because then I can stick it up on the wall. While she’s having dinner I can go, ‘Oh I’ll do 
20 of those now.’ A visual reminder works much better for me” [Patient 102]. 
 
Physiotherapist views 
Physiotherapists felt that the booklet helped to provide a focus and structure for the 
intervention and that this would be particularly valuable for new members of staff.  
 
“They said it was quite good, coming in, fairly new to the department; it was quite nice to 
follow that structure. It was quite nice for them as therapists to follow something. So, I 
suppose that’s quite a good tool in terms of you wanting continuity with therapy 
interventions” [Physiotherapist 201]. 
 
The requirement to adhere to the structure of booklet may have potentially resulted in 
therapists spending less time addressing specific patient needs. Working through the booklet 
could, for example, have resulted in rushing or truncating the hands-on physiotherapy 
component of the session.  Although physiotherapists conceded that whether or not this was 
problematic depended upon the individual patient, they nonetheless did report occasions 
when providing patient-led care and following the booklet proved to be a difficult dichotomy.  
 
“I’m a little bit undecided. I thought it was very useful in terms of it did provide some 
structure, um, and it gave, in terms of some other stuff to do, and it talked through a lot of the 
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education. Often without that you would, kind of, sometimes miss a little bit here or there. 
Um, on the flip side I kind of ended up, I found that I working through the workbook and I’d, 
‘Opp... I’ll go back.’ And it, kind of, then took me less away from actually assessing the 
patient, looking at the patient and those sorts of things” [Physiotherapist 102]. 
 
Moreover, this participant felt that the booklet could potentially be ‘dangerous’ without 
adequate training, to both patients and physiotherapists. 
 
“As it stands now, as we’re doing it, if we were just to give therapists a booklet, I think it 
could be dangerous in the wrong hands and without the knowledge” [Physiotherapist 102]. 
 
Along the same lines, therapists felt that it was important to demonstrate the correct way of 
doing exercises and one physiotherapist felt that the booklet did not provide comprehensive 
explanations relating to why a particular exercise was required. 
 
“It would give them, yes, the starting blocks, but it doesn’t give them huge amounts of 
reasoning, um, and as I say, more information about the quality. And obviously a lot of our 
work is correcting the compensations and things like that, and they would never get any of 
that in a booklet” [Physiotherapist 101]. 
 
Whilst the information in the booklet was generally considered to be adequate, it was 
remarked upon that the information could be expanded upon in treatment sessions as 
required. 
 
“I think the booklet errs on basic and so is not going into huge amounts of detail for patients. 
I think the idea is that it’s the basic information that then we can expand on in the treatment 
sessions and things like that” [Physiotherapist 101]. 
 
One physiotherapist felt that even if patients did not initially consider the information in the 
booklet was of relevance to them, adhering to its structure allowed topics to be discussed 
which may have otherwise been circumvented, and, as a result, improve outcomes. 
 
“Sometimes you can see them rolling their eyes a little bit, with, ‘Why are we discussing it?’ 
But, actually, it’s really relevant and really important that by the end of discussing it, you’ve 
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had another breakthrough, or, erm, you’ve gained some insight into what’s causing a lot of 
their problems, which you may not have done if you picked up off their verbal clues that they 
didn’t really want to talk about it and you’re thinking, ‘I didn’t really think it’s very high on 
the agenda either,’ and then you’ll just park it, perhaps to go into later, whereas this makes 
you do it” [Physiotherapist 202]. 
 
Some changes to the booklet were recommended, e.g., font size, a slightly larger booklet 
which would allow making notes easier, and making the booklet more like a diary. Patients 
with additional needs were also discussed. 
 
“I mean, for the average person, I think it’s fine. It’s not too complicated. I think the other 
thing I guess you need to take into account is - But then, they’re probably excluded - is often 
you get your ADHD patients or dyslexia. Whether there are alternate formats. We don’t often 
see ethnic minorities here, so that’s probably not an issue in terms of language and stuff. The 
size of the print’s probably - maybe here needs to be a little bit bigger, just for, you know, so 
you take into account people’s eyesight.  It could be slightly bigger, maybe, the booklet, so 
that they’ve got a bit more space. I don’t know what ((colleague’s name)) says, but I guess 
what might be quite nice is you have a slightly bigger one that they can put their own notes to 
it. So it becomes their own proper little diary that they can… Rather than being too small, 
that’s a possibility, maybe” [Physiotherapist 201]. 
 
Physiotherapy sessions 
Patient views 
Patients generally felt that there was scope to adjust the method and pace of the sessions to 
meet their individual needs and felt that physiotherapists were willing to do this. 
 
“They’d tailor exercises to suit where my flexibility and my problems were” [Patient 102]. 
 
One patient valued seeing the same physiotherapist at each appointment. 
 
“…by seeing the physio, the same person, that was really important. Um, because they were 
able to see the, my changes. I think that’s so crucial. Um, and I think, again, emotionally how 
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he saw me through, he could tell from the moment I stood up in the waiting room to walking 
through what had happened, what happened in that week preceding” [Patient 203]. 
 
Whilst another felt that they may benefit from seeing different physiotherapists. 
 
“It’s good having the same one because you don’t have to go through, from start to finish. I 
suppose you lose the knowledge that they have of everything you’ve been through or what 
you’ve done before. So it’s good to have the same person, but it might just be nice... I felt the 
benefit from having someone else come in on the session” [Patient 103]. 
 
The importance of ‘hands on’ physiotherapy was highlighted by both patients and 
physiotherapists, in addition to, or in combination with, the educational aspects of the 
intervention. 
 
“So he would spend the first bit talking and then the second bit doing. Um, and yeah that, that 
worked really well actually” [Patient 203]. 
 
Patients’ expectations and comparisons to previous physiotherapy 
Most patients felt that the intervention met their expectations. One thought the intervention 
would involve more ‘hands on’ physiotherapy. One described wondering if they might not be 
in pain at the end of the intervention sessions, but, like other patients and therapists, accepted 
that this would be a longer term goal. Patients felt that previous experiences of physiotherapy, 
which was not specifically for JHS, tended to be of more limited value. 
 
“I had some prior to this when I originally went into the doctors and was saying about joint 
pain. But the physio there didn’t, kind of, really... He was giving me stuff to do which was 
actually causing me more pain...” [Patient 103]. 
 
Physiotherapist Views  
Because of the individual nature of JHS, physiotherapists felt that there was a need to tailor 
the treatment to meet the patient’s needs. 
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“I think it will give a structure to the basics, like a rehab programme, yes; there will be 
components of it, but within that you still need to have an individual approach. You can’t be 
too generic with these people, because each person’s really different. So I think it helps like 
you would if you did a rehab programme, you’re going to have basic information that will be 
generic throughout the whole, which I guess that does address. In terms of the exercises, 
that’s very individual, so I don’t think you could really, necessarily put people into a generic 
programme like that” [Physiotherapist 201]. 
 
A lack of time to complete all aspects of the physiotherapy sessions was highlighted by some 
therapists.  They recognised the need to balance the information content with the hands on 
physiotherapy to meet the patient’s needs. 
 
“Personally speaking proportions wise I tend to spend a lot of time going through the booklet 
as I’m supposed to do and then kind of rushing through the physio session bit at the end. 
Erm, and, I think that’s, it depends what kind of patient you have, so some of the participants 
are basically nodding their heads, waiting to get the booklet out of the way, to get on to the 
hands on other bit. Whereas some are all about the booklet. So, I think that reflects the 
different types of learners and the different types of patients that you have, really” 
[Physiotherapist 202]. 
 
However, one physiotherapist felt that this would improve with practice. 
 
“I think it’s probably something that would improve with practice and getting to know the 
book better, and those sorts of stuff. Um, but, yeah, sometimes found that I was getting 
through everything in the workbook and, you know, which was great and, again, 
standardised their treatment a little bit more. But then, actually, the individual bits of 
tailoring exercises and stuff to them and sometimes that is at risk of getting lost a little bit” 
[Physiotherapist 102]. 
 
Homework 
Patient views 
All patients described a busy lifestyle; one participant who had previously worked full time 
had recently given up work and felt that otherwise it would have been too difficult to focus 
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on the demands of the intervention and that any benefit from participation may have been 
compromised. Patients were more able to incorporate exercises into their lifestyle that were 
not ‘over and above’ their normal routine, such as correcting posture or movement patterns. 
One patient appeared to be daunted by the prospect of achieving set goals. 
 
“I think I found, like the goals section of the book I was getting a bit stressed about it because 
I was a bit worried about, ‘Well I don’t really know what is achievable, because I want to go 
back to swimming and circuit training, but at the moment I can barely walk for 20 minutes.’  
So actually going into the session and him going, ‘We can just look at you walking to work, 
that can be a goal’, it was like, ‘Oh, okay.’ So it made it much more achievable. […] So the 
thing I’ve had difficulty with is fitting the exercises in my day. I’m not doing very well at 
putting in a routine, and I know that I need to do that. Actually realising that I need to do this 
daily, or at least every other day, and I still haven’t found balance of that yet” [Patient 102]. 
 
Some patients found that even though they were able to correctly do exercises during the 
physiotherapy session, they were less confident to continue these at home, or needed 
encouragement to continue doing the exercises. 
 
“Obviously the physiotherapist is an encouragement to you. At home when you’re doing 
those things you don’t have that person going ‘Go on,’ that encouragement. You’ve kind of 
got your own head saying ‘That hurts, just stop.’ So yes, in a way you do it, it’s kind of bit of 
both really, it just depends on how much you’re willing to push yourself” [Patient 201]. 
 
It was noted that having appointments already booked helped to motivate patients to do their 
homework. 
 
“It was quite motivating in terms of thinking, ‘Oh God I’ve got to see him again on Thursday, 
if I haven’t done it then, I know...’ kind of thing. Um, so yeah, so again I think again that’s 
where the structured thing comes in. If you know you’re going back to somebody they’re 
going to know if you haven’t done something and all the rest of it” [Patient 203]. 
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Physiotherapist views 
Therapists felt that patients’ engagement with homework was mixed. They reported that 
some of their patients had read ahead, engaged, reflected and made notes in the booklet, 
whilst others had not. One therapist reported that whilst the booklet was useful, the amount of 
homework actually done may not be reflected in what patients had written in the booklet.  
Some felt that just having an awareness of the next session was helpful. 
 
“They come with awareness of what we’re going to talk about, the conversation flows really 
freely” [Physiotherapist 202]. 
 
One physiotherapist felt that the outcome of the intervention may be affected by the 
participant’s level of engagement with homework. 
 
“I think we could still advise them and things like that, and give them the information. But 
it’s structured in a way, especially with the, the continuing what they should be filling in and 
things like that. I think you’re going to get a much better outcome if the patients are on board 
and completing it” [Physiotherapist 101]. 
 
Summary 
Patient views of what worked well 
The intervention helped to raise patients’ awareness of posture, core strength and ‘correct’ 
movements. 
 
“I’m aware now. So when, I always set myself, um, because I can’t, literally, sit with my feet 
on the floor like you’re supposed to, I set my goals so that during my breakfast when I sit up 
to the table I sit up straight, I have my feet on the floor, and I eat my breakfast” [Patient 202]. 
 
Patients valued this even if they were not always able to put their knowledge into practice. 
 
“It’s made me think more about my posture, and the way that I’m sitting and standing 
differently. I’m trying to correct that. When I’m picking up ((child’s name)) and playing with 
her, and things like that. But I found it difficult to adapt” [Patient 102]. 
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Patients’ awareness of exacerbating and ameliorating behaviours such as posture, analgesic 
use and pacing, was greatly enhanced. 
 
“Um, it’s been brilliant in that way, it has brought much more awareness of what I’m doing 
with my body, um, and how that is affecting. [...] And so then to be aware of what that’s 
doing to me now, and then to physically feel the change...” [Patient 202]. 
 
Patients were particularly pleased that JHS was being recognised and the topic of research. 
 
“I thought it was really good and really positive. Part of it is simply having it recognised” 
[Patient 102]. 
 
Patients felt that the information they had been given could be used to help others to 
understand their experiences, as they had often met with a lack of understanding regarding 
their symptoms. 
 
“Um, I feel like, by doing it my family is much more aware of it and I get much less hassle 
from them about everything and they’re then being a, really supportive” [Patient 202]. 
 
As described above, patients valued the combination of ‘hands on’ physiotherapy and 
educational components of the intervention. 
 
Physiotherapist views of what worked well 
The intervention was thought to be useful in that it gave structure to the treatment for JHS 
and helped to focus on particular issues; the therapist was required to cover topics that they 
might otherwise have steered away from. 
 
“I think it’s really nice to have a structured intervention that you stick… So you’ve got some, 
so people are saying the same thing and you’re not missing anything. I think that will be 
really nice. People are able to reflect on their intervention and if they find a structured way 
of… If they find this structured way more useful, then maybe that will help to change our 
practise as all” [Physiotherapist 201]. 
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One felt that the treatment intervention could potentially be very helpful for a particular 
group of patients. 
 
“I think this treatment, tailored to the right people at the right time works very well” 
[Physiotherapist 102]. 
 
One physiotherapist felt that the education aspect of the intervention was particularly 
important. 
 
“…this is an interesting part of the intervention because, historically, people with 
musculoskeletal pains and joint pains were treated with exercise or hands-on physio, 
whereas the intervention that’s been chosen for the trial is much more about discursive, 
erm…management, so it’s lots of talking therapy and education, ‘cause without the 
understanding you’ve got no chance of managing your condition” [Physiotherapist 202]. 
 
Patient views on challenges 
Patients described challenges which were specific to their circumstances, such as post-natal 
depression. However, finding time to do exercises at home, and to attend the sessions, was 
the greatest barrier to adherence. 
 
“I think the problems with it were my time and my life, nothing to do with the trial” [Patient 
106]. 
 
Physiotherapist views on challenges 
One physiotherapist felt that patients, in general and prior to the trial pilot, often had negative 
expectations of physiotherapy and did not expect physiotherapy to be beneficial. 
 
“Some of the main challenges we had were that patients had been treated in lots of different 
places and all been told lots of different things. That they couldn’t be helped. There was 
nothing to benefit them. They were preventing their own rehab. All sorts of things like that 
really, more than anything else. So the patients were coming in extremely negative, expecting 
physio not to work” [Physiotherapist 101]. 
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It was suggested that for some patients, completing the delivery of the intervention within a 
four month period may be difficult. Sessions may be scheduled too closely together or 
patients may need more than six sessions. One physiotherapist noted that standard practice at 
one hospital is to offer between two and 20 sessions to suit patients’ needs. 
 
“With some of those that, again, are slower and things like that, with the study we haven’t 
got the timescales to make the timeframes longer, to, to give them that time to adapt and 
progress a little bit more and things with it” [Physiotherapist 101]. 
 
The ability to be flexible and to tailor the intervention to the individual patient was 
considered to be a key issue; on the one hand, a potential challenge, and yet the structure of 
the intervention was also appreciated and valued. 
 
“He was able to use that [the booklet] as a tool, but not, but able to work with it ..... It was 
very much tailored to where I was, to where I was at the moment” [Patient 203]. 
 
“When we’re seeing patients, everything is a little bit more fluid. You might jump backwards 
and forwards a little bit, whereas that probably can help you to be a bit more focused, maybe, 
if you follow through a booklet. I think, from people who are quite new here, so the inpatients 
have tried it out, even though they’re not in the trial. I’ve asked them just to trial the booklet 
with the patients, just to see what, you know, how they’ve found it. They said it was quite 
good, coming in, fairly new to the department; it was quite nice to follow that structure” 
[Physiotherapist 201]. 
 
Suggestions for improvements 
One patient participant felt that the provision of more information before enrolling on to the 
trial may have been beneficial: 
 
“I guess information coming into it. I came in a bit blind. But I don’t know what. Maybe like 
a, a full breakdown of what, you know, like, a, with a letter with the appointment, you know, 
‘you’re seeing ((Physiotherapist’s name)) at 3:15. And this is what we’ll be doing...’ You 
know – so an introduction into what’s wrong with you, or, you know, like what you’re 
symptoms are. ‘Then we’ll do an assessment for such and such. Then we will discuss these 
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topics …’ I don’t know, just to give me a bit more information as to what was happening, the 
structure within that first session” [Patient 202]. 
 
Patients either did not make any suggestions for improvements or recognised that it may be 
difficult to suggest generic improvements, and made suggestions specific to them. For 
example, access to additional information on specific aspects, e.g. medication, was suggested 
by one patient [Patient 201]. Other suggestions relating to the individual’s needs are reported 
below: 
 More detailed advice on exercises: 
“It’s difficult to say because I can only reference it to my situation really. I think that it 
would’ve been useful – I think that comes from me, it would’ve been useful to look into the 
exercises in more precision, for me. But we did in the last session, but I think that’s only 
something I’ve really thought about in retrospect really. […] I think, maybe, my situation 
didn’t really help, going back to work and walking every day has knocked me back a few 
stages. I think if that hadn’t been the case I probably would’ve asked, we would’ve got more 
into the exercises and I would’ve then been able to ask more questions. …. I don’t know 
about other people with hypermobility, but for me specifically the exercises are about the 
finer points. Because sometimes I can do it, but just because I can doesn’t mean I should” 
[Patient 102].  
 The opportunity to see other health professionals: 
“I think having more opportunities within the programme to possibly see different 
specialists” [Patient 103]. 
 More structured or detailed programme of advice: 
“Um... I guess it depends on who, individual, um, how you like things. And I think, for a lot of 
people, that book would work very well. What came out of all of it for me is I am somebody, 
and again I guess whether it’s because I spend my life telling other people what to do, I 
wanted to be told, myself, what to do. Unlike what, what did come out of it was I very much 
like an ordered programme of events, ‘Do this, this, this, this and this’. And whether that can 
be, sort of, developed within that programme a bit more really?” [Patient 203]. 
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Personal changes arising from taking part in the intervention 
Patients reported a greater awareness of the importance of posture and correct movement. 
 
 “The physio’s kind of helped my head home in on what’s causing the pain, more than 
anything. So I’m a bit more aware as to what could, possibly, stop it” [Patient 103].  
 
Patients reported being more aware or more ‘in tune’ with their body and more accepting of 
their limitations. 
 
 “I think I’ve probably been slightly more in tune with my body when it’s knackered and in 
pain. I haven’t beaten myself up for not doing a lot” [Patient 106]. 
 
The long term nature of the condition was recognised.  Neither patients nor physiotherapists 
expected quick results. 
 
“He was quite clear and I was quite clear that this wasn’t going to change overnight and 
that’s why the doing too much and then giving up was an unhelpful strategy. It’s playing the 
long game, really” [Patient 106]. 
 
“I think a lot of it is just giving myself a break and just realising that it is real and that it is 
manageable. Also that it’s long term, this is something that I’m going to be managing for the 
rest of my life and I don’t have to do it all now” [Patient 102]. 
 
“It doesn’t all end here, you’ve got to keep working at it. And you will go up and down, we’re 
on the end of the phone if you go down. But otherwise keep going and finding out what is out 
there that you can...what is out there that you can go and enjoy to continue exercising and 
looking after yourself long term?” [Physiotherapist 101]. 
 
3.4 OVERALL CONCLUSIONS 
The strength of this part of the research lay in determining the acceptability of the 
physiotherapy intervention to patients and therapists and in gathering information related to 
recruitment. Unfortunately all of the patients recruited were women and two were unavailable 
for interview. This might be seen as a limitation, particularly if the experiences of men or 
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those who were not interviewed were at variance with the data collected. Nevertheless the 
study generated very useful information.    
 
The consent rate was relatively low at eight of the 42 referrals screened (19%). A large 
number of referrals (23, 55%) were found to be ineligible based on the inclusion and 
exclusion criteria. Closer analysis of those excluded suggested that slight refinement of the 
inclusion and exclusion criteria might be helpful, for example to not specifically exclude 
those with a concomitant diagnosis of fibromyalgia or those with mild anxiety or depression. 
 
Patients were generally positive about the advice and physiotherapy interventions and pleased 
that JHS treatment was being recognised, researched and ‘taken seriously’ as JHS patients 
often met with a lack of understanding regarding their symptoms by health professionals and 
lay people.   
 
The study patient handbook was rated highly by patients. Having written information 
provided in this format provided validation and something that could be shared with others.  
Some valued the activity diary, others valued just having something to refer to as and when 
needed. 
 
The physiotherapy programme raised patients’ awareness of posture, core strength, pacing of 
exercise and ‘correct’ movements. Patient participants appreciated seeing the same 
physiotherapist and that the therapist was able to tailor the intervention programme to suit 
their personal needs.   
 
3.5 AMENDMENTS 
A number of changes were made to the design of the pilot RCT on the basis of interview 
data, additional observations during the conduct of the pilot, and discussions with the 
research team. Where appropriate, these changes were approved by substantial amendment to 
the ethical approval for the PHyT study (13/SW/0083). 
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3.5.1 Refinement of the physiotherapy intervention 
Following the data collated at the end of Stage 2, a number of minor changes were made to 
the intervention and training package. 
 
• The flexibility of the delivery of the intervention was seen as an important feature by both 
patients and physiotherapists. Minor changes were therefore made to enhance the ability of 
patients and therapists to use the intervention in a flexible manner. Session numbers were 
removed from the patient handbook to enhance the perceived flexibility of the 
intervention. The flexibility of delivery was also re-iterated and encouraged in the 
introduction section of the patient handbook and was further reinforced in the training 
package. 
• The patient handbook was increased in size from A5 to A4 to make it easier to handle and 
to provide more space for making notes. The exercise ‘menu’ was printed in landscape 
format to also provide more space for patients and physiotherapists to add notes. 
• The patient handbook incorporated ideas for videoing movements using patients’ own 
mobile devices, an idea suggested by our patient research partners. 
• Some additional figures about pacing of activity were incorporated to clarify this concept. 
• The training package was revised to include practical training. Detailed ‘speaker notes’ to 
supplement the training slides were developed. The training package was refocused to 
emphasise diagnosis and to incorporate findings from our UK wide survey of 
physiotherapy practice37 and findings from the Stage 2 pilot of the intervention. 
 
3.5.2 Refinement of the pilot trial design 
Some further minor amendments were made to the study procedures for the subsequent pilot 
RCT. These were in an attempt to boost referrals, to prevent unnecessary exclusions from the 
study and to streamline study procedures. Specific changes were as follows: 
 
• The minimum age of participants was reduced from 18 to 16 years. Three potential 
participants had been excluded on the basis of being under 18 years but 16-18 year olds 
are commonly seen within the adult rheumatology services and JHS is common in this age 
group. 
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• The wording of the inclusion and exclusion criteria was refined to ensure that those with a 
concomitant diagnosis of fibromyalgia and those with mild anxiety or depression were not 
unnecessarily excluded from taking part. The revised wording is detailed in the following 
chapter. 
• A local clinical service agreement was reached with another local NHS Trust (University 
Hospitals Bristol NHS Foundation Trust) so that referrals of people with JHS were 
forwarded to North Bristol NHS Trust so that they could be considered for the study. 
Patients were given a choice as to which service they accessed. 
• The reply slip was amended to encourage potential participants to respond both positively 
(‘I am interested in taking part’) and negatively (‘I am NOT interested in taking part’). If a 
reply slip was not received after two weeks, one further recruitment pack would be sent. 
• The questionnaire burden on participants was reduced. The MYMOP was removed as this 
was incomplete in many cases. Therapists reported that it was extremely difficult to 
complete the MYMOP effectively in the time available for the baseline assessment. The 
second page of the EQ-5D-5L (the vertical VAS) was removed on the advice of our health 
economists as it would not be used later for the health economics evaluation. The final 
shortened version of the BIoH questionnaire was used. 
• Questionnaire return would be closely monitored, with written and telephone reminders at 
two weeks and four weeks in the event of non-return. 
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CHAPTER 4  STAGE 3: PHYSIOTHERAPY FOR HYPERMOBILITY TRIAL (PHyT): QUANTITATIVE & ECONOMIC EVALUATION 
 
4.1 AIMS & OBJECTIVES 
The overall aim of this stage of the research was to conduct a pilot randomised controlled 
trial (RCT) of a comprehensive physiotherapy intervention to determine if it was feasible to 
conduct a future definitive RCT.71  
 
A number of objectives related to determining the acceptability of the research design and the 
physiotherapy intervention to patients and physiotherapists and these are addressed in the 
following chapter (Chapter 5). The current chapter will therefore concentrate on reporting 
quantitative aspects of the pilot RCT. Specific objectives reported in this chapter were to 
determine the number of potentially eligible patients with JHS; assess the rates of patient 
recruitment and retention; explore the practicalities of collecting the proposed cost and 
outcome measures; and explore of the value of information (VOI) of a subsequent, larger 
RCT. 
 
4.2 METHODS 
4.2.1 Overview of the pilot RCT  
The pilot study was conducted within the same two NHS Trusts that took part in the pilot of 
the intervention (Stage 2, reported in Chapter 3). The study was designed as a parallel two-
arm randomised controlled trial, comparing an advice control against advice plus 
physiotherapy. Figure 6 summarises the study design.  
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Following an assessment and advice session, participants were randomly allocated to receive 
the physiotherapy intervention or to continue with usual GP care. Further details of the 
interventions and other study procedures are given in subsequent sections. 
 
Figure 6. Flow diagram illustrating the design of the pilot randomised controlled trial. 
(The shaded area represents the initial physiotherapy assessment and advice session). 
 
 
4.2.2 Physiotherapist recruitment 
The same physiotherapists who took part in Stage 2 were invited and agreed to take part in 
the pilot RCT. All four physiotherapists were retrained in the assessment of JHS, the revised 
intervention package, and the study processes (see Appendix 7 for training materials). 
Training was conducted at the University of the West of England, Bristol by the chief 
investigator (SP) and one of the principal investigators (RL). To determine the feasibility of 
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conducting in-service training of the intervention package, the trained physiotherapists were 
asked to train at least one other physiotherapist within their NHS Trust. This meant that a 
minimum of 3 physiotherapists with a variety of experience were available within each Trust 
to implement the intervention. 
 
4.2.3 Patient recruitment 
The process of identifying and approaching people with JHS was similar to that described in 
Stage 2. The principal investigator within each NHS Trust screened all referrals to their 
rheumatology physiotherapy service and sent a participant information sheet (see Appendix 
8) and reply slip to all potentially eligible patients. Those responding positively were then 
scheduled for an initial assessment to confirm eligibility, to provide an opportunity for further 
discussion and explanation and, should they agree to take part, to provide signed informed 
consent. A formal patient screening proforma was completed for all patients (see Appendix 
9). A full baseline study assessment was then conducted with those consenting to the study 
(please see the section entitled ‘Baseline physiotherapy assessment’). 
 
Some minor changes were made to the inclusion and exclusion criteria between Stage 2 
(feasibility of the intervention) and Stage 3 (pilot RCT) due to unintended exclusions and in 
an attempt to boost recruitment. This included reducing the minimum age from 18 to 16 
years; clarifying that fibromyalgia and Ehlers Danlos Syndrome (hypermobility type) were 
not exclusion criteria; and clarification of wording regarding multiple joint osteoarthritis and 
psychological treatment. A local service agreement was also made with another local NHS 
Trust (University Hospitals Bristol NHS Foundation Trust) to forward JHS referrals to North 
Bristol NHS Trust so that those patients could be offered the opportunity to take part in the 
study. The final inclusion and exclusion criteria were as follows: 
 
Inclusion criteria: Referred for physiotherapy for suspected JHS; more than 16 years old; 
able to give informed consent; able to understand and communicate in English (with the 
assistance of an interpreter as necessary); fulfil the Brighton criteria for JHS (see Table 1, 
Chapter 1).11 
 
Exclusion criteria: Other known musculoskeletal pathology causing pain, particularly 
multiple joint osteoarthritis and inflammatory musculoskeletal disease such as rheumatoid 
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arthritis (fibromyalgia and Ehlers Danlos Syndrome (hypermobility type) are not exclusion 
criteria); other serious pathology including malignancy; conditions affecting ability to 
exercise e.g. uncontrolled cardiovascular disease; recent physiotherapy for JHS (within the 
last year); pre-existing significant psychological distress or psychiatric conditions; referred 
for or currently undergoing psychological treatment, such as Cognitive Behavioural Therapy. 
 
4.2.4 Baseline physiotherapy assessment 
Following eligibility screening, a full physiotherapy clinical assessment was carried out for 
all patients consenting to take part in the study. This included taking a subjective medical 
history and history of their present complaints, followed by an objective examination of 
elements such as posture, joint range, strength, gait and movement, focussing on 
identification of relevant signs and symptoms associated with the patient’s condition. The 
format of the assessment was not prescribed and followed each individual physiotherapist’s 
usual practice. Baseline study questionnaires were completed either in advance of the initial 
physiotherapy assessment or immediately following consent and these were posted back to 
the chief investigator using pre-paid envelopes. 
 
4.2.5 Advice intervention 
At the end of the baseline physiotherapy assessment all participants received advice booklets 
produced by the Hypermobility Syndromes Association54 and Arthritis Research UK55. These 
contain information and advice on a range factors such as physical activity and joint 
protection. The physiotherapist discussed in particular the following sections from the 
Arthritis Research UK55 booklet: ‘What is joint hypermobility?’ (page 5), ‘How is joint 
hypermobility diagnosed?’ (page 10), ‘Drugs’ (page11-13 with advice to discuss further with 
their GP) and ‘Self-help and daily living’ (page 14). All patients were also given an 
opportunity to ask the physiotherapist for additional advice specific to their own 
circumstances. Physiotherapists were instructed to provide any additional advice to patients 
according to information contained within the advice booklets.  
 
Usual practice within the rheumatology services at the two NHS Trusts was for a one hour 
initial appointment. As part of this research, an additional 20 minutes was allocated for 
consent and delivering the advice intervention. 
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4.2.6 Randomisation 
Following the baseline physiotherapy assessment and delivery of the advice intervention, and 
after the patient had left the department, all patients were randomised using an automated 
randomisation service devised specifically for the study. This was developed and 
administered by the Bristol Randomised Trials Collaboration and could be accessed by 
telephone or computer, ensuring that treatment allocation was concealed from the clinician 
and participant. The principal investigator on each site contacted the randomisation service to 
determine treatment allocation. The system asked for the principal investigator’s unique 
identification code, a study centre code, and the date of birth and gender of the study 
participant. The system then randomly generated a treatment allocation of ‘Advice’ or 
‘Advice and physiotherapy’ and a unique study identification number for the participant. 
Automatic notification was also e-mailed to the principal investigator. Allocation to the study 
arms was in the ratio 1:1, with a block size of 4. There was no stratification by study site or 
other factors. 
 
Due to the nature of the interventions, it was not possible to blind clinicians or participants to 
the treatment allocation. All patients were contacted by the principal investigator on each site 
by telephone to advise them of their treatment allocation. Those randomised to the advice 
control were asked to follow the advice given during the baseline physiotherapy appointment 
and advice intervention, supported by the HMSA and Arthritis Research-UK booklets. No 
additional physiotherapy sessions were scheduled for these patients. Those randomised to 
receive advice and physiotherapy were given an initial appointment to attend for 
physiotherapy.  
 
4.2.7 Physiotherapy intervention 
A comprehensive 'whole body' physiotherapy intervention was developed by the research 
team as described in Chapter 2. This was subsequently amended slightly as described in 
Chapter 3. The accompanying training materials for physiotherapists and the patient 
handbook are available in Appendix 7 and 10. The physiotherapy intervention built on 
information already delivered to patients as part of the advice intervention, supplemented by 
the HMSA54 and Arthritis Research UK55 advice booklets. As already described, the 
intervention aimed to enhance the ability of people with JHS to manage their condition and to 
be physically active. It included advice on a range of topics, tools to aid reflection and 
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planning, and a ‘menu’ of exercises that could be selected as appropriate. The intervention is 
described fully in Chapter 3 and the associated Patient Handbook is included as Appendix 10. 
The intervention was delivered over a maximum of six 30 minute sessions across a four 
month period. A 30 minute follow-up appointment reflected usual practice within the two 
Trusts and is also typical of that delivered across the UK.37 The spacing of the sessions was 
agreed with each patient on an individual basis, allowing some flexibility in delivery. 
 
4.2.8 Primary outcomes 
As this was a pilot trial, the primary outcomes were to determine:   
• The number of potentially eligible patients with JHS referred to the two NHS Trusts. 
• The rate of patient recruitment and retention. 
• An estimate of the value of information (VOI) of a subsequent, larger, RCT. 
 
4.2.9 Secondary outcomes  
One purpose of the pilot trial was to pilot the potential primary and secondary outcome 
measures for a definitive trial, examine the completeness of data, estimate the variability of 
potential outcome measures and obtain an idea of feasible effect sizes.  
 
All patients completed questionnaires at the start of the study prior to randomisation, at four 
months and again at seven months post-randomisation. All questionnaires were administered 
by post, with pre-paid return envelopes. Baseline questionnaires were posted to all patients 
who indicated a potential interest in taking part in the study in advance of their baseline 
assessment. The consenting therapist checked verbally with the patient whether the baseline 
questionnaire had been completed and, if not, these were completed following consent. A 
participant database was used to monitor questionnaire return and to schedule the posting of 
four month and seven month questionnaires. Participants who failed to return questionnaires 
within two weeks of the relevant due date were sent a reminder pack and were also contacted 
by telephone. A second reminder pack was sent after a further two weeks and further 
telephone contact made. No further attempts were made following this point. As this was a 
pilot study, all available questionnaires were included in analysis, regardless of when they 
were returned. The process of questionnaire administration is commented upon later.  The 
seven month follow-up was considered satisfactory for the pilot study to assess participant 
retention post-treatment but also ensure timely completion of the study.  
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A copy of the month 4 questionnaires is included in Appendix 11. These were identical to the 
baseline and month 7 questionnaires except that resource use and adverse events were not 
assessed at baseline. Also, in the month 7 questionnaire the resource use and adverse events 
sections asked about the previous 3 months rather than 4 months. The biographical 
questionnaire administered at baseline was identical to that used in Stage 2 (Appendix 4A). 
 
Outcomes considered candidates as primary outcomes for a definitive trial were: 
• Rheumatology Assessment Patient Index Data (RAPID3)61 – a score between 0 and 30 (30 
most severe) obtained from the Multidimensional Health Assessment Questionnaire 
(MDHAQ). 
• A new condition-specific physical function questionnaire developed by the research team 
(the Bristol Impact of Hypermobility (‘BIoH’) Questionnaire)64 (Appendix 11) – a score 
between 0 and 360 (360 most severe). 
 
Outcomes considered as secondary outcomes for a definitive trial were: 
• Physical function, pain, global status, fatigue, and self-reported joint count (MDHAQ).61 
• Pain at rest and on movement (visual analogue scales, Appendix 11). 
• Health-related quality of life preference score (EQ-5D-5L).72 
• Exercise self-efficacy (the Exercise Self-efficacy Scale).67 
• Resource use questionnaires to measure healthcare use and costs (Appendix 11). 
• Adverse events (e.g. dislocations or other injury, Appendix 11). 
 
4.2.10 Sample size 
A formal sample size calculation was not carried out for this pilot study.  We aimed to 
randomise a total of 60 patients in the pilot RCT over a 12 month recruitment period in the 
expectation that this would provide sufficient data on likely recruitment and retention rates. 
We also estimated this sample size would yield sufficiently precise estimates of outcome 
variability and between group differences to inform sample size calculations for a future 
RCT. Due to delays in study approval prior to Stage 1 a reduced 8 month recruitment period 
was used in this pilot RCT.  
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4.2.11 Data Analysis 
It was not the intention of this pilot study to formally test hypotheses related to group 
differences. All analyses are therefore descriptive and exploratory in nature. Analyses are 
performed on an intention to treat basis and point estimates and confidence intervals reported.  
 
Economic analyses  
We tracked the use of NHS staff time and expenses in developing the training materials and 
in delivering the training sessions prior to the pilot trial to provide context about the fixed set 
up costs of the intervention. NHS resource use (including medications, community, primary 
and secondary care) was collected using patient-completed resource use questionnaires 
administered at 4 and 7 months.   
 
Resource use was valued using national unit costs.  Physiotherapist and other primary care 
visits (e.g. GP, podiatrist) were valued using estimates from the Unit Costs of Health and 
Social Care 2014.73  Hospital care, including admissions, accident and emergency, urgent 
care and outpatient visits were costed based on most relevant healthcare resource group 
code(s) in NHS reference costs 2013 to 2014.74 Medication costs, based on the drug name 
and dose reported by the patient, were estimated using the net price recorded in the British 
National Formulary (BNF).75 Based on this information we estimated the NHS cost of 
physiotherapy, other primary care, hospital care and medications at four and seven months, 
summarised using descriptive statistics.  
 
We estimated utilities (a single index summary of health-related quality of life) and Quality 
Adjusted Life Years (QALYs) based on the EQ-5D-5L76 administered before randomisation 
and at four and seven months.  EQ-5D-5L responses were weighted and aggregated to a 
summary score using the value set for England.77 EQ-5D-5L results are summarised using 
descriptive statistics. 
 
Value of Information Analysis 
We use value of information methods78 to explore the potential value of a future larger RCT 
with the same interventions as included in the pilot RCT. Value of information requires a 
decision model that captures the health benefits and resources use costs arising from adoption 
of the interventions being compared into clinical practice. This model should be based on all 
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currently available information, however sparse (in our case results from the feasibility 
study). The important point is that all uncertainty in the available evidence is reflected, so 
small samples will have correspondingly wide confidence intervals that are propagated 
through the decision model. The key idea is that further evidence will reduce uncertainty in 
the inputs to the decision model (i.e. the confidence intervals will be narrower), which in turn 
may change the optimal decision. If the optimal decision changes then we can work out the 
gain in net monetary benefit (health care benefits minus costs) resulting from using the “new” 
rather than the “current” optimal intervention. Value of information measures what on 
average we would expect this net monetary benefit gain from collection of new evidence to 
be. The expected value of perfect information (EVPI) measures the expected gain in net 
monetary benefit resulting from elimination of uncertainty in all model parameters. The 
expected value of partial perfect information (EVPPI) measures the expected gain in net 
monetary benefit resulting from elimination of uncertainty in a subset of model parameters 
(e.g. utility, cost, or natural history parameters). The expected value of sample information 
(EVSI) measures the expected gain in net monetary benefit from reducing uncertainty in a set 
of model parameters through the collection of new evidence using a specific study design. 
EVSI can be compared between different types of research to establish priorities. We report 
here EVPI and EVPPI for a variety of model parameters, but note that these give an upper 
bound on the expected returns from a new RCT, the actual value will be less than this 
depending on sample size and other design factors.  
 
Our pilot trial provides evidence on QALYs and intervention costs and resource use costs 
over a 7-month time period from a small number of patients. We fit statistical models for 
total costs and EQ-5D-5L, adjusting for baseline EQ-5D-5L score,79 to obtain estimates of 
mean total costs and mean EQ-5D-5L for the two interventions. EQ-5D-5L was assumed to 
have a Normal distribution, and costs assumed to have a log-Normal distribution (model 
details in Appendix 13). We considered a bivariate model that accounts for correlation 
between costs and EQ-5D-5L, however scatter plots of EQ-5D-5L scores versus costs 
indicated no evidence of such correlations. Results are therefore presented from the model 
without correlation. We estimated QALYs using the “area under the EQ-5D-5L curve” 
approach, where a piecewise linear trend is assumed for the two time-periods (0-4 months 
and 4-7 months). We report the mean total costs, mean EQ-5D-5L at 4 and 7 months. We also 
report mean total costs and mean QALYs over the 7month time period, and the expected net 
benefit for a range of willingness-to-pay per QALY thresholds. The expected net benefit is 
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equal to the mean QALYs multiplied by willingness-to-pay per QALY minus mean total 
costs. A Bayesian approach is taken to estimate the statistical models, evaluated using 
WinBUG1.4.380 (code available in Appendix 13). To identify all the available relevant 
evidence to inform the decision, we used a recently published systematic review31 to identify 
other relevant intervention studies on JHS patients.  We conducted a rapid review of journal 
articles listed in PubMed estimating utility scores or healthcare costs in patients with JHS 
(Table 9). We consulted with the project team to identify long term natural progression 
studies and information on annual incidence of new JHS patient referrals. The results of these 
searches are given in Section 4.3.9.  
 
Table 9. Search terms for the rapid review of utility scores or healthcare costs in JHS.  
Group PubMed search terms 
Synonyms for cost cost OR resource use 
OR synonyms for utility scores quality of life OR utility OR EQ-5D OR 
EQ5D OR SF36 OR SF-36 
AND synonyms for JHS ehlers danlos OR hypermobility 
 
The net monetary benefit depends on the monetary value (“willingness-to-pay”) that we give 
to changes in health outcomes (in QALYs). We plot EVPI, and EVPPI for a range of 
willingness-to-pay per QALY thresholds.  We also present population level EVPI and EVPPI 
given the annual incidence of new JHS referral, assuming a life-time of the intervention of T 
= 1, 5, and 10 years, and discounting at 3.5%.81  
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The life-time of the intervention represents the time until the intervention becomes obsolete 
for example by being superseded by a new intervention. 
 
The decision model is evaluated using Markov chain Monte Carlo simulation in 
WinBUGS1.4.3, so that all uncertainty in the model parameters is propagated directly into the 
model, and allows a probabilistic model to be evaluated.82 EVPI is computed in WinBUGS 
directly83 for a range of willingness-to-pay thresholds. EVPPI for subsets of parameters 
(costs, efficacy and baseline utilities) were computed using a Generalised Additive Model 
approach84 evaluated using the Sheffield Accelerated Value of Information web-application.85 
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4.3 RESULTS 
4.3.1 Recruitment and retention 
Figure 7 provides the CONSORT flow chart detailing recruitment and retention of patients 
for the primary clinical and economic outcomes. The intention was to recruit patients with 
hypermobility over a 12 month period, however due to delays reported previously (Chapter 2) 
this recruitment period was reduced to eight months. In total 121 patients were referred to the 
two physiotherapy units between January and August 2014. An initial assessment of 
eligibility was carried out and 107 patients were found to be potentially eligible and were 
contacted about the study. Of these 55 (51%) attended for baseline assessment and of these, 
29 (53%) gave consent and were randomised. The proportions of men referred and recruited 
were 7.6% and 10.3% respectively. Figure 5 illustrates recruitment during the eight months. 
Within the first two months recruitment was slow, followed by nearly a third of the final 
sample being recruited in month 3. Recruitment in months 4 to 8 was reasonably consistent 
with four patients recruited in each month with the exception of month 5 (only one was 
recruited in month 5). Of the 29 randomised, 14 (48%) and 15 (52%) were allocated to the 
Advice only and the Advice & Physiotherapy arms respectively.  
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Figure 7. CONSORT diagram. 
 
 
  
Enrollment Referrals screened (n=121) Not meeting inclusion criteria (n=14) 
- Other musculoskeletal conditions (n=5) 
- Too young (n=4) 
- Physiotherapy within last 12 months (n=4) 
- Pregnant (n=1) 
 
Patients contacted (n=107) 
Attended advice session (n=29) 
No response (n=25) 
Declined to participate (n=18) 
- Want active treatment (n=1)  
- Other musculoskeletal conditions (n=5) 
- Too busy (n=2) 
- Too far to travel (n=1) 
- No reason (n=8)  
- Too young (n=1) 
Did not attend clinic (n=9) 
 
Advice (n=14) 
- Received no physiotherapy (n=10) 
- Received additional physiotherapy  (n=2) 
- Withdrew & received physiotherapy (n=2) 
Month 7 questionnaire completed (n=11) 
Lost to follow-up (n=3)  
Primary outcome data available: 
RAPID3 (n=10) 
BIoH (n=11) 
 
Advice & Physiotherapy (n=15) 
- Received at least 1 physiotherapy session (n=14) 
- Withdrew & received no physiotherapy (n=1) 
Month 7 questionnaire completed (n=8) 
Lost to follow-up (n=4)  
Primary outcome data available: 
RAPID3 (n=7) 
BIoH (n=8) 
Follow-Up (Month 7) 
Randomisation 
Excluded (n=15) 
- Not JHS (n=10) 
- Awaiting surgery (n=3) 
- Undergoing psychological treatment (n=2) 
Declined to participate (n=11) 
- Want active treatment (n=9) 
- Too busy (n=1) 
- No reason (n=1)  
 
Assessed (n=55) 
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Figure 8. Cumulative frequency of recruitment during the 8-month period. 
 
 
All baseline and outcome data were collected using a single patient-reported questionnaire at 
each time point. Two patients completed none of the questionnaires (one Advice, one Advice 
& Physiotherapy). At baseline the questionnaire was completed by 24 of the 29 (83%) 
participants. Before month 4 follow-up, two patients allocated to the Advice arm withdrew 
from the study (both requesting active physiotherapy treatment) and one patient in the 
Physiotherapy arm (unable to fit appointments around work) also withdrew. Of the remaining 
26 patients 17 (65%) completed the month 4 questionnaire and 19 (73%) the month 7 
questionnaire. Completion rates were consistently higher amongst those randomised to the 
Advice & Physiotherapy arm than the Advice arm for each of the three time points (Table 
10). 
 
Table 10. Number (and %) of questionnaires completed at each time point. 
 Advice (N=14)a Advice & 
Physiotherapy 
(N=15)b 
Overall (N=29)a,b 
Baseline 10 (71%) 14 (93%) 24 (83%) 
Month 4 7 (58%) 10 (71%) 17 (65%) 
Month 7 8 (67%) 11 (79%) 19 (73%) 
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a2 patients withdrew after baseline from the Advice arm. 
b1 patient withdrew after baseline from the Advice & Physiotherapy arm. 
 
4.3.2 Adherence to randomised treatment 
All patients in both treatment arms attended their advice session at which consent was taken. 
Amongst those allocated to Physiotherapy, the patient who withdrew from the study after 
randomisation did not receive any physiotherapy sessions. For one patient the number of 
sessions attended was not recorded. The remaining thirteen patients randomised to Advice & 
Physiotherapy attended a total of 63 sessions equating to 80.7% compliance overall (mean 
number of sessions was 4.8; range 1 to 6). These patients completed a mean of 14.1 (range 3 
to 18) of the topics covered in the intervention package.   
 
Two patients in the Advice arm reported visiting a physiotherapist at either four or seven 
month follow-up. 
 
4.3.3 Baseline characteristics 
With the exception of age and gender, which was collected for all patients, baseline 
demographic and symptom data were only available for those patients that completed a 
baseline questionnaire. The Advice and Advice & Physiotherapy arms were comparable at 
baseline in terms of their socio-demographic details (Table 11) and their baseline symptoms 
and problems (Table 12). The only exceptions to this were in relation to gender, age, marital 
status and current joint pain (RADAI). Patients allocated to the Advice & Physiotherapy arm 
were more likely to be older, single females experiencing more joint pain than the Advice 
arm. Given the small sample size these differences at baseline are likely to have occurred by 
chance despite randomisation. There is a lack of good epidemiological evidence for 
prognostic indicators in JHS but it is generally understood that joint hypermobility is more 
prevalent in women and declines with age.2 Joint pain is predictive of functional outcome in 
other conditions such as rheumatoid arthritis86 and osteoarthritis87 so it seems reasonable to 
assume that it might also be predictive in JHS. There is no evidence to suggest that marital 
status is prognostic. Given the sparsity of data, marital status was not adjusted for in the 
initial analyses but was considered in auxiliary analyses. 
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Table 11. Socio-demographic details. 
 Advice 
(N=14) 
Advice & 
Physiotherapy 
(N=15) 
Gender (No. (%) female) 11 (78.6%) 15 (100%) 
Age (mean (SD)) 33.3 (9.71) 37.2 (14.13) 
Ethnic group (No. (%) white)a 10 (100%) 13 (92.9%) 
Marital status (No. (%))a 
Single 
Married/partner 
Divorced/separated 
Widowed 
Other 
 
3 (30.0%) 
7 (70.0%) 
0 
0 
0 
 
5 (35.7%) 
7 (50.0%) 
2 (14.3%) 
0 
0 
Years of education (median (IQR))a,b 13 (12 to 13) 13 (12 to 13) 
Further education (No. with (%))a,b 9 (90%) 11 (84.6%) 
Paid employment (No. (%))a 9 (90%) 14 (100%)a 
a Baseline questionnaire completed by 14 in Physiotherapy arm and 10 in Advice arm 
b Item not completed by 1 patient in Physiotherapy arm 
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Table 12. Baseline symptoms. 
Measure Advice 
(N=10) 
Advice & 
Physiotherapy 
(N=14) 
Beighton score (mean (SD)) 5.7 (2.3) 5.8 (1.8) 
MDHA Questionnaire   
Functiona (mean (SD)) 2.21 (1.81) 1.69 (1.35) 
Pain (mean (SD)) 5.85 (1.72) 5.93 (2.01) 
Global (mean (SD)) 4.45 (3.00) 4.89 (1.68) 
RAPID3a (mean (SD)) 12.52 (5.77) 12.49 (4.67) 
RADAI (mean (SD)) 9.70 (5.25) 16.43 (9.28) 
Other symptoms (mean (SD)) 13.64 (11.28) 17.13 (10.84) 
Fatigueb (mean (SD)) 5.67 (3.29) 5.89 (3.31) 
BIoH Questionnaire (mean (SD)) 200.77 (49.19) 199.05 (58.34) 
BRAF Questionnaire   
Average fatigue (mean (SD)) 5.5 (2.55) 5.14 (2.80) 
Effect of fatigue (mean (SD)) 4.9 (2.88) 5.36 (3.15) 
Coping with fatigue (mean (SD)) 4.1 (1.91) 3.64 (2.50) 
Pain in…   
most affected joint at rest (mean (SD)) 47.10 (26.28) 49.43 (22.34) 
most affected joint on movement (mean 
(SD)) 
53.70 (29.99) 61.07 (25.42) 
all joints in general at rest (mean (SD)) 33.40 (20.92) 41.93 (22.62) 
all joints in general on movement (mean 
(SD)) 
45.20 (28.17) 52.29 (24.14) 
Exercise Self-Efficacy Questionnairec 
(mean (SD)) 
43.17 (13.86) 48.99 (17.51) 
EQ5D (mean (SD)) 0.65 (0.30) 0.72 (0.12) 
a2 missing in Physiotherapy arm, 2 missing in Advice arm 
b1 missing in Advice arm 
c3 missing in Physiotherapy arm  
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4.3.4 Completers and non-completers 
Baseline data was also compared between those for whom month 7 outcome data was 
available and those who withdrew or were lost to-follow-up (Table 13). Baseline values were 
compared for age, gender and RADAI score (potential prognostic factors), the primary 
outcomes RAPID3 and BIoH scores and EQ-5D-5L. Of the 24 with a completed baseline 
questionnaire seven withdrew or were lost to follow-up and gave no month 7 outcome data. 
Age and gender was known for the remaining five patients who returned no baseline 
questionnaire; of these two completed the month 7 questionnaire, one withdrew and two were 
lost to follow-up. 
 
Table 13. Comparison of baseline characteristics between those who completed month 7 
follow-up and those who did not. 
Measure Completers 
(N=19) 
Non-completers 
(N=10) 
Gender (No. (%) female) 18 (94.74%) 8 (80.00%) 
Age (mean (SD)) 37.79 (12.93) 30.60 (9.32) 
RADAIa (mean (SD)) 13.76 (8.41) 13.29 (9.12) 
RAPID3a,b  (mean (SD)) 12.95 (5.11) 11.44 (3.90) 
BIoHa (mean (SD)) 197.48 (57.34) 205.32 (46.79) 
EQ-5D-5La,c (mean (SD)) 0.70 (0.24) 0.68 (0.16) 
aData only available for the 24 patients returning a baseline questionnaire 
b2 missing in Physiotherapy arm, 2 missing in Advice arm  
c17 completers and 7 non-completers on EQ5D form 
 
4.3.5 Primary and secondary patient-reported outcomes 
As described previously the analyses of patient-reported outcomes are exploratory only; it 
was not the intention of this pilot study to estimate the effect of physiotherapy, only to pilot 
the potential primary and secondary outcome measures for a full trial, examine the 
completeness of data, estimate the variability of potential outcome measures and obtain an 
idea of feasible effect sizes. The Rheumatology Assessment Patient Index Data (RAPID3) 
score (calculated from items relating to difficulties, pain and global measure of how the 
patient is, within the Multi-Dimensional Health Assessment Questionnaire) and the BIoH 
score were measured as potential primary outcomes for a definitive trial. 
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Degree of missing data 
The RAPID3 score is an amalgamation of 12 items within the MDHA Questionnaire; if one 
or more items are missing for an individual then the overall RAPID3 score cannot be 
calculated (although missing data can be imputed – see ancillary analyses). Of those 
completing questionnaires, missing data was present for 4 (17%) participants at baseline, 1 
(6%) at month 4 and 2 (10%) at month 7. The BIoH score is an amalgamation of 55 items and 
the scoring system automatically incorporates imputation (using the patient’s average value 
in that section) for missing values. Before imputation, of those completing questionnaires, the 
numbers with missing data were: 4 (17%) at baseline; 3 (18%) at month 4; and 1 (5%) at 
month 7. With the exception of one patient at baseline who had 10 missing values, patients 
had between 1 and 3 items missing, so imputation is unlikely to have had major impact on the 
final score. For all secondary outcomes missing data was very low; less than 5% for all and in 
the majority of cases 0%. 
 
Change between baseline and follow-up 
Whilst a future definite RCT would compare RAPID3 and BIoH at follow-up adjusting for 
baseline, change scores from baseline to follow-up are also reported here for completeness. 
Table 14 presents the mean change in participant RAPID3 and BIoH scores from baseline to 
4 month and 7 month follow-up. Caution is needed in any interpretation since the number of 
patients included is very small due to different patients having missing data at different time 
points. 
 
Table 14. Changes in RAPID3 and BIoH scores between baseline and follow-up. 
 Advice Advice & 
Physiotherapy 
RAPID3 N=4 N=8 
Mean change: baseline to month 4 (SD) 2.79 (5.11) -4.79 (3.38) 
Mean change: baseline to month 7 (SD) -2.21 (0.71) -4.88 (2.77) 
BIoH N=6 N=10, 11a 
Mean change: baseline to month 4 (SD) 14.51 (27.80) -31.72 (36.75) 
Mean change: baseline to month 7 (SD) 1.70 (14.44) -34.26 (36.57) 
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a In the Advice & Physiotherapy group there were 10 patients for whom a change score could 
be calculated from baseline to 4 months and 11 patients from baseline to 7 months. 
 
Table 14 suggests that whilst reductions were seen in RAPID 3 and BIoH at 4 and 7 months 
in the Advice & Physiotherapy group, amongst the few with sufficient data receiving Advice 
only, there was on average an initial increase in symptoms by month 4 followed by a 
reduction in RAPID3 to just below that at baseline and just above the baseline score for 
BIoH. 
 
Between group comparisons 
Figure 9 displays the mean RAPID3 and BIoH scores at baseline, month 4 and month 7 
amongst the two treatment arms. Looking at mean scores across patients at each time point, a 
different picture is seen to that in Table X above. Both groups demonstrated an improvement 
from baseline to month 4 in terms of RAPID3 and BIoH scores. Values in the Advice group 
returned back to towards baseline between month 4 and month 7 and this was more marked 
for the BIoH scores. Values in the Physiotherapy group continued to improve between month 
4 and month 7. These different interpretations based on change scores or actual scores at 
months 4 and 7 are a result of the fact that different individuals are included in the two 
analyses. Additional patients are included in the latter analysis.   
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Figure 9. Mean (95% CI) RAPID3 and BIoH scores at baseline month 4 and month 7 
follow-up. 
 
(a) RAPID3 
 
 
  
 
 
 
 
 
 
 
 
 
(b) BIoH 
 
 
Linear regression models 
Linear regression models reported in this section firstly considered the unadjusted association 
between treatment group and outcome at month 7, and secondly the association adjusted for 
baseline measure, age, gender and RADAI score. Participants are analysed in the arms to 
which they were randomised with missing data ignored, with the exception of the Bristol 
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Impact of Hypermobility (BIoH) score for which missing data was imputed as part of the 
scoring system (Appendix 12). 
 
Table 15 presents the difference in mean scores at month 7 between the two treatment arms. 
Both the unadjusted and adjusted analyses for RAPID3 and BIoH are consistent with a 
potential beneficial effect of the Advice & Physiotherapy arm. If the addition of 
physiotherapy is beneficial then the results in Table 14 also suggest that the new outcome 
measure BIoH may be more sensitive to change than the RAPID3 score. In terms of RAPID3 
the observed difference in means is in the region of 0.3SDs compared to 0.5SDs for BIoH. Of 
course given the small sample size and exploratory nature of these analyses, whilst the 
confidence intervals are consistent with large beneficial effects of the Physiotherapy 
intervention, they are also consistent with no difference between the groups, or indeed a 
moderate detrimental effect. 
 
Table 15. Pilot trial results for primary outcomes (all values mean (SD) except where 
indicated). 
Outcome 
measure 
Advice (N=7) Advice & 
Physiotherapy 
(N=11) 
Unadjusted difference 
in means (95% CI) 
Adjustedb difference in 
means (95% CI) 
RAPID3a 11.00 (6.82) 10.27 (6.05) -0.73 (-7.42 to 5.95) -1.26 (-5.60 to 3.08) 
BIoH 195.83 
(61.79) 
163.99 
(67.39) 
-31.85 (-95.71 to 
32.01) 
-28.57 (-75.97 to 
18.84) 
aData missing for 1 patient in Advice arm and 1 patient in Physiotherapy arm  
bModels adjusted for baseline measure of outcome, age, gender, RADAI score 
 
The results of linear regression models examining differences between the groups in terms of 
secondary outcomes are presented in Table 16.  For the majority of outcomes the 95% 
confidence intervals demonstrate that a moderate benefit of advice plus physiotherapy is 
plausible and that a beneficial effect of advice only of the same magnitude is less likely. 
Exceptions relate to the RADAI score relating to pain in all joints and the visual analogue 
questions relating to pain in the most affected joint at rest and on movement. The confidence 
intervals for these three outcomes suggest that it is also plausible that the addition of 
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physiotherapy may cause more pain; of course all confidence intervals are also consistent 
with no real difference between the groups, as we would expect in this small pilot trial.  
 
In summary, the exploratory results of this pilot trial provide evidence of promise for the 
Physiotherapy intervention which needs to be evaluated in a definitive trial. 
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Table 16. Pilot trial results for secondary outcomes (all values mean (SD) except where indicated). 
Outcome measure Advice (N=7) Advice & Physiotherapy 
(N=11) 
Unadjusted difference  
in means (95% CI) 
Adjusteda difference  
in means (95% CI) 
MDHA Questionnaire     
Function 2.14 (2.54) 2.17 (1.64) 0.02 (-2.13 to 2.18) 0.52 (-0.69 to 1.74) 
Pain 5.07 (2.05) 4.36 (2.68) -0.71 (-3.23 to 1.82) -0.81 (-4.47 to 2.85) 
Global 3.79 (2.60) 3.55 (2.78) -0.24 (-3.02 to 2.54) -0.78 (-4.54 to 2.97) 
RADAI 8.71 (10.39) 12.60 (8.53) 3.89 (-5.90 to 13.67) 3.01 (-3.83 to 9.84) 
Fatigue 4.71 (3.99) 3.77 (3.08) -0.94 (-4.47 to 2.59) -0.04 (-4.15 to 4.07) 
BRAF Questionnaire     
Average fatigue 5.13 (3.14) 3.73 (2.87) -1.40 (-4.32 to 1.52) -0.65 (-4.31 to 3.01) 
Effect of fatigue 4.88 (3.48) 3.36 (3.53) -1.51 (-4.95 to 1.93) -1.68 (-6.61 to 3.26) 
Coping with fatigue 3.63 (2.97) 2.36 (2.34) -1.26 (-3.83 to 1.30) -2.49 (-5.84 to 0.86) 
Pain in…     
most affected joint at rest 38.50 (30.02) 51.45 (29.26) 12.95 (-16.04 to 41.95) 5.90 (-30.88 to 42.68) 
most affected joint on movement 45.13 (26.46) 61.82 (31.94) 16.69 (-12.53 to 45.92) 6.64 (-29.98 to 43.26) 
all joints in general at rest 35.29 (26.74) 26.64 (20.60) -8.65 (-32.32 to 15.02) -18.37 (-51.57 to 14.84) 
all joints in general on movement 42.57 (25.71) 38.64 (26.89) -3.94 (-31.05 to 23.18) -14.34 (-49.21 to 20.52) 
Exercise Self-Efficacy  47.04 (30.02) 60.28 (21.69) 13.24 (-8.81 to 35.29) 7.03 (-18.59 to 32.65) 
aModels adjusted for baseline measure of outcome, age, gender, RADAI score 
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4.3.6 Ancillary analyses 
Missing items within the BIoH were imputed for the primary analysis described above 
following the user scoring guidelines (Appendix 12). Consideration was subsequently given 
to single imputation of missing items within specific sections of the questionnaire which 
contributed to an overall score – this included the 10-item function score (used also to 
generate RAPID3 score) in the MDHA Questionnaire; and the 18-item Exercise Self-efficacy 
questionnaire. Multiple imputation and cases with complete missing data were not considered 
in the analysis of this pilot trial. Table 17 presents the findings for the outcomes with imputed 
data and demonstrates little impact on the findings. 
 
Table 17. Models incorporating single imputation. 
 
Outcome 
measure 
Mean (SD) Difference in means (95% CI) 
Advice 
(N=7) 
Advice & 
Physiotherapy 
(N=11) 
Unadjusted  Adjusteda  
Function 2.14 (2.54) 2.05 (1.61) -0.10 (-2.16 to 
1.96) 
0.19 (-0.96 to 
1.20) 
RAPID3 11.00 (6.82) 9.95 (5.83) -1.05 (-7.42 to 
5.33) 
-1.46 (-8.63 to 
5.71) 
Exercise 
Self-
Efficacy 
41.45 
(17.72) 
61.86 (21.23) 20.41 (0.93 to 
39.88) 
10.55 (-15.00 
to 36.09) 
aModels adjusted for baseline measure of outcome, age, gender, RADAI score 
 
Models were also repeated adjusting additionally for marital status but little impact was seen.  
 
4.3.7 Adverse events 
The baseline, month 4 and month 7 questionnaires contained an open text question asking 
participants to tell the research team about any ‘untoward event, particularly if you feel it has 
been related to taking part in the research or which was unexpected’. Table 18 presents events 
that were reported at months 4 and 7.  
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Table 18. Verbatim adverse events reported by participants in their study questionnaires. ‘Nil reported’ = questionnaire returned but 
section on adverse events left blank. ‘Questionnaire not returned’ = this participant did not return a questionnaire at this time point. *These 
‘events’ were not included in analysis of adverse events. 
Participant Allocation Month 4 Month 7 
112 Advice “I was diagnosed with depression (again) soon after 
filling out the first questionnaire and put on sertraline. 
While on this my pain has improved in my legs 
somewhat, but as at the same time I changed my 
contraceptive pill I cannot be sure which (if either) 
effected [sic] this. Following reading the material on 
hypermobility I was given, I asked my Doctor to change 
my contraceptive pill from oestrogen based yasmin to 
oestrogen free mini-pill” 
“Fractured my wrist in September by falling over. 
Appears that I hyperextended my wrist” 
113 Advice WITHDRAWN (requested treatment) WITHDRAWN (requested treatment) 
114 Advice “Have to undergo physio due to hip pain” Questionnaire not returned 
117 Advice WITHDRAWN (requested treatment) WITHDRAWN (requested treatment) 
121 Advice Questionnaire not returned Questionnaire not returned 
122 Advice Questionnaire not returned Questionnaire not returned 
126 Advice Questionnaire not returned “Still breastfeeding and carry around 12kg child a lot 
usually in a sling”  
*[Not included in analysis of adverse events] 
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212 Advice “I have had a painful Achilles tendon in my left ankle 
for several weeks. Worse after swimming and cycling 
and aches at night. Seen podiatrist for insoles – said 
left Achilles tendon appears swollen compared to right. 
Have been doing stretches and ice pack application but 
not really helping” 
“Have had pain in mid back for past 2 weeks – feels 
like pulled muscles around vertebrae. Have been 
managing with pain relief, massager and trying to keep 
mobile – swimming and gentle stretching and walking. 
Used ice packs and rest for 1 day. Have not yet sought 
help as seems to be getting better slowly” 
213 Advice “I badly sprained my left ankle about 6½ weeks ago. 
It’s a high ankle sprain, above the ankle bone. Has 
been very slow to heal and I’m still in pain. There was 
no specific twist/trip/fall, just came on after a running 
session”  
“Experiencing severe migraines last 6 weeks, probably 
stress related” 
215 Advice Nil reported Nil reported 
216 Advice Questionnaire not returned “Problems with nerve root in my lumber [sic] spine, I 
had bad muscle spasm’s and pains in leg and groin. 
Pains in leg and groin have gone but muscles spasm’s 
remain very bad” 
218 Advice Nil reported Questionnaire not returned 
219 Advice Nil reported Questionnaire not returned 
220 Advice Questionnaire not returned “My shoulder blade had been feeling like it was 
coming away from my chest for a few days causing 
pain and then out of nowhere (at rest) my whole chest 
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went into spasm (intercostal muscles, I guess) and it 
was a 9/10 pain and it felt like someone was sitting on 
my chest and it was agony to breathe. Paramedic came 
and gave me IV paracetamol on top of all the morphine 
(oral) and diazepam I had taken. Nothing was helping 
so I went to A&E to get IV morphine (what usually 
works) and have chest x-ray and heart monitoring. My 
heart was fine. This happened before when they 
thought I was having a heart attack but it turned out to 
be a really high up gut spasm. It’s very hard to find the 
actual problem because the hypermobility can 
masquerade as something else or cover the real 
problem”  
111 Advice & 
Physiotherapy 
“Doctors halved my pain medication so was unable to 
do as many exercises given, physio phoned and left 
messages to my doctor saying to keep me on the same 
dose until physio finished, Doctor got back to physio 
and they agreed to half my dose! Miscommunication” 
Questionnaire not returned 
115 Advice & 
Physiotherapy 
Questionnaire not returned Questionnaire not returned 
116 Advice & Nil reported Nil reported 
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Physiotherapy 
118 Advice & 
Physiotherapy 
Questionnaire not returned Nil reported 
119 Advice & 
Physiotherapy 
Nil reported Nil reported 
120 Advice & 
Physiotherapy 
Nil reported Questionnaire not returned 
123 Advice & 
Physiotherapy 
“Seen by: [name removed] (orthopaedic surgeon) 
29/9/14 Diagnosis bilateral patellofemoral joint 
arthritis; Dr [name removed] (clinical psychologist) 
4/8/14 Self management; Dr [name removed] 7/11/14 
Pain management” 
Nil reported 
124 Advice & 
Physiotherapy 
Questionnaire not returned Nil reported 
125 Advice & 
Physiotherapy 
Questionnaire not returned Nil reported 
127 Advice & 
Physiotherapy 
Nil reported Nil reported 
128 Advice & 
Physiotherapy 
Nil reported Nil reported 
211 Advice & “Dislocated knee half way through trial during Aqua Nil reported 
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Physiotherapy  Aerobics. Knee has been in brace and taken a while to 
heal. Physio has been helpful and has improved quicker 
this time than previous incidents” 
214 Advice & 
Physiotherapy 
WITHDRAWN (too busy) WITHDRAWN (too busy) 
217 Advice & 
Physiotherapy 
Nil reported “I am about to move house again which I seem to be 
doing every 18 months/2 yrs – each time it gets more 
and more painful physically and after each move there 
appears to be a considerable deterioration which does 
not come back to the level it was before pre the move” 
*[Not included in analysis of adverse events] 
221 Advice & 
Physiotherapy 
“Have recently had a sickness bug and a cough making 
back pain and spasms worse” 
Nil reported 
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Adverse events were discussed on an ongoing basis with the study Data Monitoring & Ethics 
Committee (DMEC) who produced the analysis presented in Table 19 below at the end of the 
study. Events classified by two members of the DMEC as possibly being a result of the 
treatment or lack of treatment, including withdrawing from the study to seek additional 
treatment, were included in the analysis. Events were examined using Chi-squared and 
Fisher’s exact tests as appropriate.  
 
Table 19. Analyses of adverse events. 
Type of comparison Advice Advice & 
Physiotherapy 
P value 
4 month questionnaire results: 
No event 
Event (including withdrawn) 
Questionnaire not returned 
 
28.6% (4/14) 
35.7% (5/14) 
35.7% (5/14) 
 
60.0% (9/15) 
20.0% (3/15) 
20.0% (3/15) 
0.236 
Percentage with event (excluding incomplete) 55.6% (5/9) 25.0% (3/12) 0.203 
7 month questionnaire results: 
No event 
Event (including withdrawn) 
Questionnaire not returned 
 
14.3% (2/14) 
50.0% (7/14) 
35.7% (5/14) 
 
80.0% (12/15) 
6.7% (1/15) 
13.3% (2/15) 
0.002 
Percentage with event (excluding incomplete) 77.9% (7/9) 7.7% (1/12) 0.001 
4+7 month questionnaire results 
combined: 
Event (including withdrawn) 
 
76.7% (8/12) 
 
20.0% (3/15) 
0.022 
 
Table 20 presents odds ratios and 95% confidence intervals for an event in the Advice arm 
compared with the Advice & Physiotherapy arm. Having an event appears far more likely in 
the Advice arm. Despite the small numbers this finding is unlikely to have occurred by 
chance alone. It should be noted however, that this analysis includes all events potentially 
related to treatment; in reality the number due to treatment may be far lower. 
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Table 20. Odds ratio of having an event while in the Advice arm. 
 Odds ratio 95% confidence interval 
4 months event 3.74 (0.59 to 23.8) 
7 months event 41.7 (3.19 to 500) 
Event at any time 8.00 (5.72 to 45.5) 
 
4.3.8 Sample size calculation 
Given the nature of the intervention it is envisaged that randomisation in a definitive trial 
would be at the level of the patient not the physiotherapy unit. At the time of conducting this 
pilot RCT the anticipated outcomes that would be primary outcome measures in a definitive 
trial are RAPID3 (calculated from the MDHAQ) and the BIoH score from the newly 
developed Bristol Impact of Hypermobility questionnaire. 
 
RAPID3 score 
As discussed in Chapter 3, although the MDHAQ and its RAPID3 subscale has not been used 
before in JHS, it has been successfully employed with a very wide range of other 
rheumatological conditions and was attractive due to its multi-joint approach to assessment.  
Response criteria for the RAPID3 score have been proposed as a decrease in score of 3.6 
units or more for a ‘good’ response, and 1.8 units or more for a ‘moderate’ response.62 In 
terms of high, moderate, and low severity, and near remission for RAPID3, >12, 6 to 12, 3 to 
6, and ≤3 are proposed respectively.62 Within the pilot trial the mean baseline RAPID3 score 
was just over 12 units (50% classified as high severity), with an SD around 5 units. At 7 
months the SDs were approximately 6 units within the Physiotherapy group and 6.8 within 
the Advice only group. There is currently no published literature reporting variability in 
RAPID3 score amongst JHS patients following an intervention. Table 20 below illustrates the 
required sample size for 80%, 85% and 90% power; a two-sided 1% and 5% alpha level; for a 
difference in means analogous to a ‘moderate’ and ‘good’ response. Since the primary 
outcome for a definitive trial is likely to be 12 months (for which we do not have data), a 
conservative estimate for SD of 7 units has been used to inform sample size in Table 21 
below. 
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Table 21. Sample size required to detect an important difference in RAPID3 score. 
Minimally important difference 
(unit difference in means) 
2-sided 
alpha 
Sample size (per arm) 
80% power 85% power 90% power 
1.8 0.01 354 395 451 
0.05 238 272 318 
3.6 0.01 89 99 113 
0.05 60 68 80 
 
Attrition rate 
Overall attrition within the pilot trial was approximately 35% (higher in the advice only 
group than the physiotherapy group); hence to allow for this degree of attrition the above 
sample sizes would need to be inflated by a factor of 1.54 (1/0.65). Strategies to improve the 
attrition rate are discussed later in Chapter 6. 
 
Recruitment time 
As an example, if a definitive trial was powered to detect a difference in mean RAPID3 
scores of 3.6 units, with 90% power and a two-sided 5% alpha, 80 patients would be required 
for each arm of the trial. Incorporating a factor of 1.54 for a potential loss to follow-up rate of 
35% this would require 122 patients to be allocated to each treatment group. Within the pilot 
trial, on average two patients were recruited and randomised each month from each of the 
two units. If, in a definitive trial, patients could be recruited from six units and it is assumed 
that all have similar referral rates to those within the pilot trial, it would take approximately 
20 months to recruit sufficient patients to the trial. 
 
Making the same assumptions, a five-year recruitment period would be required to detect a 
difference of 1.8 (more within the region of the difference observed within the pilot trial), to 
ensure 80% power, 5% alpha, and an attrition rate of 35%. Unless, the eligibility criteria for a 
definitive trial are dramatically widened, the rate of consent improved or the attrition rate 
diminished, a definitive trial to detect this magnitude of difference appears unlikely.  
 
BIoH score 
Full validation of the BIoH is ongoing and will be completed before any definitive trial takes 
place. It is anticipated that part of this validation will include discussion and consensus as to 
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the minimally clinically important difference to be detected in any future trial. Table 21 
below illustrates the required sample size for a range of minimally important differences; for 
80%, 85% and 90% power and; a two-sided 1% and 5% alpha level. As this is a new measure 
there is no previously published data in terms of the variability in BIoH score. At 7 month 
follow-up the SDs were approximately 62 and 67 units in the advice only and advice plus 
physiotherapy groups respectively. Since the primary outcome for a definitive trial is likely to 
be 12 months (for which we do not have data), a conservative estimate for SD of 70 units has 
been used to inform sample size in Table 21 below. 
 
The highlighted section of Table 22 illustrates the sample sizes required to detect a difference 
of the same magnitude as that observed within the pilot trial – a plausible real size of effect. 
Since the BIoH score can take a value between 0 and 360 a difference in means between two 
interventions of anything less than 30 (a jump of 8.3% on the total scale) is unlikely to be 
significant clinically.  
 
Table 22. Sample size required to detect an important difference in BIoH score. 
Minimally important difference 
(unit difference in means) 
2-sided 
alpha 
Sample size (per arm) 
80% power 85% power 90% power 
10 0.01 1145 1279 1459 
 0.05 770 880 1030 
20 0.01 287 320 365 
 0.05 193 220 258 
30 0.01 163 143 128 
 0.05 74 85 99 
40 0.01 72 80 92 
 0.05 42 48 56 
 
Recruitment time 
As an example, if a definitive trial was powered to detect a difference in mean BIoH scores of 
30 units, with 90% power and a two-sided 5% alpha, 99 patients would be required for each 
arm of the trial. Incorporating a factor of 1.53 for a potential loss to follow-up rate of 35% 
this would require 152 patients to be allocated to each treatment group. Within the pilot trial, 
on average two patients were recruited and randomised each month from each of the two 
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units. If, in a definitive trial, patients could be recruited from six units and it is assumed that 
all have similar referral rates of those within the pilot trial, it would take approximately 25 
months to recruit sufficient patients to the trial. 
 
In terms of RAPID3, recruiting 152 per arm would provide 85% power to detect a difference 
of 3.6 units with a two-sided alpha of 1%, or a difference of 3.0 units with a two-sided alpha 
of 5%. 
 
4.3.9 Economic analysis 
Results: descriptive statistics 
The set up and training resource use and costs in preparation for the pilot RCT included: five 
days of chief investigator (SP) time to develop and refine the training materials; one day for 
the chief investigator (SP) to train four physiotherapists (one band 7, three band 6) in 
intervention delivery; and two five hour sessions for three of these physiotherapists to train 
four additional colleagues (three band 6, one band 7 and one student) in ‘train the trainer’ 
events. Additional expenses included staff travel to training events. Graphic design, printing 
and purchase cost of HMSA booklets (used by patients in both arms of the RCT) totalled 
£520.  
 
The absolute EQ-5D-5L scores in the Advice and Advice & Physiotherapy groups were 
similar at both 4 months and 7 months (Table 23). However, the Physiotherapy group had 
higher mean EQ-5D-5L at baseline and lower variability than the Advice group, and this 
remains the case throughout follow-up.  The changes in EQ-5D-5L scores from baseline were 
also very similar (Table 24). Although the mean change was higher in the Physiotherapy 
group at 4 months and lower at 7 months. There is a high degree of uncertainty in these 
estimates, due to low numbers.  One patient (ID 216) had a large negative EQ-5D-5L score at 
baseline, which lead to unusually high increases in EQ-5D-5L at 7 months on the Advice 
arm. Omitting this patient, the absolute EQ-5D-5L scores are similar across the arms, 
including at baseline, and the variability on the Advice arm is reduced (Table 25). Change 
from baseline at 7months becomes similar between the two arms when the outlier is omitted 
(Table 26). 
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We compared the baseline EQ-5D-5L scores in patients who dropped out of the study and 
those who did not in the Advice and Advice & Physiotherapy arms (Table 27). In the Advice 
arm baseline mean EQ-5D-5L was higher in the drop-outs than in those that continued in the 
trial, whereas in the Advice & Physiotherapy group baseline mean EQ-5D-5L was lower in 
the drop-outs. However, omitting the outlier patient 216, both arms show comparable 
baseline mean EQ-5D-5L that are lower in those that drop-out than in those that continue 
with the trial, as expected (Table 27). 
 
Total costs had a skewed distribution. We provide the observed mean total costs in Table 28 
with confidence intervals obtained from assuming log-costs are normally distributed. We also 
give the median and inter-quartile range. The point estimates indicated higher total costs in 
the Advice & Physiotherapy arm than the Advice arm at 4 months and lower costs at 7 
months. As to be expected given the sample sizes and skewed distributions, there is a high 
degree of uncertainty around these estimates. The largest contributor to the costs was primary 
care visits, followed by community costs. The pattern also persisted when an outlier (patient 
216, who visited their GP 26 times in the second time period, and reported a negative EQ-5D-
5L result at baseline) was removed from the advice group, although total costs for the advice 
group were substantially lower at 7 months when this outlier was removed  (Table 29).  
 
Table 23. Absolute EQ-5D scores. Means and 95% confidence intervals. 
 Advice Advice & Physiotherapy  
 N Mean (95% CI) SD N Mean (95% CI) SD 
Baseline 10 0.65 (0.44, 0.87) 0.30 14 0.72 (0.65, 0.79) 0.12 
4 months 7 0.72 (0.50, 0.94) 0.24 10 0.76 (0.69, 0.83) 0.10 
7 months 8 0.69 (0.47, 0.90) 0.26 11 0.74 (0.64, 0.85) 0.15 
 
Table 24. EQ-5D-5L change from baseline. Means and 95% confidence intervals. 
 Advice  Advice & Physiotherapy  
 N Mean (95% CI) SD N Mean (95% CI) SD 
4 months 6 -0.12 (-0.42, 0.18) 0.29 10 0.07 (-0.04, 0.17) 0.15 
7 months 6 0.06 (-0.13, 0.25) 0.18 11 0.01 (-0.11, 0.12) 0.17 
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Table 25. Absolute EQ-5D scores, omitting outlying patient 216 in advice group. Means 
and 95% confidence intervals. 
 Advice Advice & Physiotherapy  
 N Mean (95% CI) SD N Mean (95% CI) SD 
Baseline 9 0.74 (0.64, 0.84) 0.14 14 0.72 (0.65, 0.79) 0.12 
4 months 7 0.72 (0.50, 0.94) 0.24 10 0.76 (0.69, 0.83) 0.10 
7 months 7 0.75 (0.55, 0.94) 0.21 11 0.74 (0.64, 0.85) 0.15 
 
Table 26. EQ-5D-5L change from baseline, omitting outlying patient 216 in advice 
group. Means and 95% confidence intervals. 
 Advice Advice & Physiotherapy 
 N Mean (95% CI) SD N Mean (95% CI) SD 
4 months 6 -0.12 (-0.42, 0.18) 0.29 10 0.07 (-0.04, 0.17) 0.15 
7 months 5 -0.01 (-0.10, 0.08) 0.07 11 0.01 (-0.11, 0.12) 0.17 
 
Table 27. Comparison of baseline EQ-5D-5L in dropout and non-dropout patients. 
Results are also given for the Advice group non-drop-out patients, omitting outlying patient 
216. Means and 95% confidence intervals are presented with standard deviations. 
 Advice  Advice & Physiotherapy  
 N Mean (95% CI) SD N Mean (95% CI) SD 
Drop-Out 4 0.69 (0.38, 0.99) 0.19 3 0.67 (0.29, 1.05) 0.15 
Non Drop-
Out 6 0.63 (0.24, 1.02) 0.38 11 0.74 (0.66, 0.82) 0.12 
Non Drop-
Out, 
omitting 
patient 216 5 0.78 (0.70, 0.87) 0.07 11 0.74 (0.66, 0.82) 0.12 
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Table 28. Total costs. Observed mean costs are reported with 95% confidence interval 
estimated by assuming Normality on the log-scale and transforming back to the natural cost 
scale. Median and Inter-Quartile Range are also reported. 
 Advice Advice & Physiotherapy 
 N Mean  
(95% CI) 
Median (IQR) N Mean  
(95% CI) 
 
Median (IQR) 
4 months 7 192.0 
(4.0, 875.8) 
128 
(78.75, 248.61) 
10 342.8 
(141.9,462.5) 
279 
(129.78, 470.76) 
7 months 8 556.1 
(1.4,1082.5) 
162 
(13.88, 701.66) 
11 122.6 
(2.1, 118.7) 
32 
(3.525, 131.66) 
 
 
Table 29. Total costs omitting outlying patient 216 in advice group. Observed mean costs 
are reported with 95% confidence interval estimated by assuming Normality on the log-scale 
and transforming back to the natural cost scale. Median and Inter-Quartile Range are also 
reported. 
 Advice Advice & Physiotherapy 
 N Mean  
(95% CI) 
Median (IQR) N Mean  
(95% CI) 
 
Median (IQR) 
4 months 7 192.0 
(4.0, 875.8) 
128 
(78.75, 248.61) 
10 342.8 
(141.9,462.5) 
279 
(129.78, 470.76) 
7 months 7 289.2 
(0.6, 794.6) 
71 
(9.25, 407.875) 
11 122.6 
(2.1, 118.7) 
32 
(3.525, 131.66) 
 
 
Value of Information Analysis 
Pilot Trial Results: Statistical model, adjusting for baseline EQ-5D-5L 
We use statistical models to estimate the mean costs and QALYs under the two interventions. 
EQ-5D-5L scores are assumed normally distributed, and a piecewise linear model is assumed 
on the intervals 0-4 months and 4-7 months, adjusted for baseline EQ-5D-5L score. Costs are 
assumed to be log-normally distributed, adjusted for baseline EQ-5D-5L score. Because the 
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model predicts total costs and QALYs for a given baseline EQ-5D-5L score, we integrate 
over the estimated distribution of baseline EQ-5D-5L scores to obtain a population average 
for total costs and total QALYs (see Appendix 13 for details).  
 
As previously noted, patient 216 on the Advice arm was identified as having an unusually 
high cost at 7 months (26 GP visits), and also a negative EQ-5D-5L score at baseline leading 
to an unusually high improvement in EQ-5D-5L at 7 months. Model fit improved by omitting 
this outlier, and although the estimates changed, none of the conclusions changed. We 
therefore omit this outlier in the results presented below. 
 
The effect of adjusting for baseline utility scores is that for those with lower EQ-5D-5L 
scores, utilities increase over time, whereas for those with higher EQ-5D-5L scores, utilities 
decrease over time. However, for all baseline EQ-5D-5L scores, Advice has higher EQ-5D-
5L than Advice plus Physiotherapy. 
 
Table 30 presents the cost-effectiveness analysis results from the statistical modelling.  
Compared with Advice only, Advice & Physiotherapy has lower expected costs (242.9 
compared with 399.0) but lower expected QALYs (0.41 compared with 0.45).  At both 
£20,000 and £30,000 willingness-to-pay per QALY thresholds Advice only is the most cost-
effective intervention, as seen by the negative expected incremental net benefit. There is a 
high degree of uncertainty in these results, so that it is plausible that Advice & Physiotherapy 
is the most cost-effective intervention. 
 
Table 30. Estimates of expected costs, expected QALYs, and expected incremental net 
benefit (INB), averaged over the distribution of baseline EQ-5D-5L scores [omitting 
outlier patient  216]. Results based on WinBUGS simulation with 50,000 samples following 
a burn-in period of 50,000. 
Posterior mean (95% CrI) Advice Advice & Physiotherapy 
Expected Costs (£) 399.0 (33.6, 1797.0) 242.9 (32.8, 947.2) 
Expected QALYs 0.45 (0.40, 0.50) 0.41 (0.36, 0.45) 
Expected Incremental Net 
Benefit (£) Advice+Physio vs 
Advice only 
 £20,000 threshold: 
-675.7 (-2309.0, 1189.0) 
£30,000 threshold: 
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-1092.0 (-3318.0, 1315.0) 
 
Previous relevant literature to inform the VOI analysis 
Our rapid review of studies reporting utilities or costs identified 149 potentially relevant 
articles on PubMed. Based on a review of titles and abstracts we found 6 papers reporting 
generic health-related quality of life in patients with JHS (Table 31). These studies typically 
were cross-sectional surveys with small numbers of patients with JHS (range 20 to 115). All 
of the studies used quality of life measures (e.g. SF-36 or PedsQL) which were not designed 
to calculate utility scores. We did not find any articles describing the costs of treating JHS. 
We did not identify any economic models for JHS patients.  
 
The systematic review of interventional studies for JHS31 identified only 4 studies despite no 
restrictions on study design. Of these Kemp et al35 included only children; Sahin et al24 
focussed on knee exercises, rather than a whole body approach; Ferrell et al33 was a cohort 
study that measured quality of life with the SF-36 (also identified in our rapid review Table 
30); and Barton and Bird34 was a cohort study that did not report enough detail to know the 
age of participants nor to calculate an effect size. None of the studies had follow-up longer 
than 5 months, therefore the 7 month follow-up from our pilot trial represents the most 
mature evidence of efficacy of therapeutic exercise interventions in JHS patients, and it is 
therefore this evidence that is used to define our uncertainty in intervention efficacy (the 
range of potential benefits/harms) for use in the decision model. 
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Table 31. Summary of studies identified in the rapid review of economic evidence. 
Study name Design Condition Setting Participant 
characteristics 
Sample size Outcomes 
Pacey et al36 Survey Joint 
Hypermobility 
Syndrome 
Children age 6-16 with JHS from 
specialized clinic in Sydney, 
Australia. Private paediatricians 
and paediatric rheumatologists 
recruited additional patients. 
Mean age 11.55 
(SD=2.95) 
years, 39 
female, 50 male 
89 PedsQL 
reported by 
children and 
parents 
Albayrak et 
al88 
Survey 
with 
controls 
Benign Joint 
Hypermobility 
Syndrome 
Konya Research and Educational 
Hospital, Turkey. Patients aged 
18-50 with BJHS and severe pain. 
Not clear if these were patients at 
the Konya hospital. Control group 
were age matched healthy 
volunteers. 
In BJHS group, 
mean age 30.17 
(SD=7.47), 13 
male, 102 
female 
115 with BJHS 
and 114 healthy 
controls 
SF-36 and 
VAS for pain 
De Wandele 
et al89 
Survey 
with 
controls 
Ehlers-Danlos 
Syndrome 
Hypermobility 
Type 
Patients with EDS recruited by 
Centre for Medical Genetics at 
Ghent University Hospital, 
Belgium. 
In EDS-HT 
group, mean age 
40.7 
(SD=12.17), 5 
male, 75 female 
80 with EDS-
HT, 43 health 
controls. 11, 7, 
and 38 with 
other EDS 
subtypes. 
SF-36 and 
other 
questionnaires 
related to 
autonomic 
symptoms 
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Ferrell et al33 Cohort 
study 
Joint 
Hypermobility 
Syndrome 
JHS patients recruited from 
hypermobility clinic at Glasgow 
Royal Infirmary, Scotland. 
27.3 years (16 
to 49), 2 male, 
16 female 
N=20 baseline, 
18 completed 
intervention 
SF-36, knee 
pain VAS 
Rombaut et 
al90 
Survey 
with 
controls 
Ehlers-Danlos 
Syndrome 
Hypermobility 
Type 
Women with EDS-HT recruited 
by Centre of Medical Genetics at 
Ghent University Hospital, 
Belgium. 
In EDS-HT 
group, median 
age 38 (range 
25-67), all 
women 
32 with EDS-
HT, 32 healthy 
controls 
RAND-36 for 
QoL 
Berglund et 
al91 
Survey 
with 
controls 
All Ehlers-
Danlos 
syndrome 
Postal survey of members, 
aged>18, of the Swedish National 
EDS Association. Swedish 
population study used as control. 
Mean age 46.1 
(CI 44.5-47.7) 
250 any EDS, 76 
(30%) 
hypermobility 
type. 250 
matched healthy 
controls 
SF-36 and 
HADS (for 
mental health) 
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In the absence of any existing models, and no evidence on intervention efficacy or natural 
history of JHS patients beyond the 7-month follow-up of our pilot trial, we restrict our model 
to a 7-month time horizon. This assumes that all differential costs and benefits between 
Advice only and Advise & Physiotherapy will have been accrued by 7-months. The model is 
identical to that presented in the previous section (see Appendix 13 for details), estimated 
using the data collected in the pilot trial (omitting the outlier patient 216).  
 
Population measures of value of information require an estimate of the incidence of new 
patients that will be eligible for the intervention. We estimate the population of England and 
Wales aged 16 and above to be 46,161,703.92 Based on a recent survey of physiotherapy 
services93 we estimate the average annual rate of new physiotherapy referrals as 0.033. 
Connelly et al14 estimated that 30% of referrals to a musculoskeletal triage service receive a 
diagnosis of JHS. Under these assumptions then we estimate the annual incidence of new 
hypermobility patients referred to physiotherapy services to be:  
46161703*0.033*0.3 = 457,000 
 
The 30% of referrals receiving a diagnosis of JHS reported by Connelly et al14 is likely to be 
an overestimate because the authors specifically applied the diagnostic criteria to all patients 
referred to the triage clinic where they were, and many of those patients might not otherwise 
have been diagnosed with JHS and problems associated with JHS may not have been the 
primary reason for referral. We therefore also present results for an incidence estimate based 
on a much more conservative estimate of 10% of referrals receiving a diagnosis of JHS: 
46161703*0.033*0.1 = 152,334 
 
Value of Information Results 
The Population Expected Value of Perfect Information is plotted against willingness-to-pay 
per QALY for 3 different life-times of the intervention (1 year, 5 years, and 10 years) and for 
the two different estimates of incidence (Figure 10). These figures represent the potential 
health gains (in net monetary units) from knowing the best intervention to use (based on the 
range of plausible values predicted from our pilot study), multiplied by the population 
eligible to benefit over different time horizons. As expected the value of new research 
increases with the life-time of the intervention and with estimates incidence. The curves have 
a peak around the threshold where the optimal decision changes (from Physio for low 
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willingness to pay to Advice for high willingness to pay). There appears to potentially be a 
high value of new research if it were to eliminate all uncertainty in the model, reflecting in 
part the number of individuals likely to benefit and also the plausible health benefits/harms 
that are consistent with the results from our small pilot study (i.e. the range of values given 
by the confidence limits).  
 
Table 32 shows for a willingness-to-pay of £20,000 per QALY the population EVPPI for 
eliminating uncertainty in all inputs to the decision model (EVPI) and for three different 
subsets of parameters: cost parameters alone, efficacy parameters alone, and baseline EQ-5D-
5L distribution parameters alone. This is helpful to identify which model inputs the decision 
is most sensitive to, and identify where future research efforts may be most worthwhile. It 
can be seen that the decision is most sensitive to uncertainty in the cost parameters, and 
further research to understand the differences in costs between the interventions is likely to be 
of value. This is the case even if incidence of JHS referrals is only 152,334 per year and the 
life-time of the intervention is only a year. There is also value in reducing uncertainty in the 
efficacy (EQ-5D-5L) parameters, especially if the life-time for the intervention is likely to be 
long and incidence of JHS referrals is large.  
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Figure 10. Population Expected Value of Perfect Information is plotted against 
willingness-to-pay per QALY for 3 different life-times of the intervention (1 year, 5 
years, and 10 years) and for the two different estimates of incidence. 
 
 
 
Table 32. 1-year and 5-year population EVPI and EVPPIs for various subsets of 
parameters for willingness-to-pay per QALY threshold of £20,000 and for the two 
different assumptions on incidence.  
Population EVPPI Incidence = 457,000 Incidence = 152,334 
Parameters 1-year  5-year 1-year 5-year 
All (EVPI) £58.0m £271.2m 19.3m 90.4m 
Cost parameters £49.4m £231.0m £16.5m £77.0m 
Efficacy parameters £19.0m £88.9m £6.3m £29.6m 
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Baseline EQ-5D-5L 
distribution 
£1.4m £6.4m £0.5m £2.1m 
 
4.4 DISCUSSION 
In conclusion, the results of the pilot RCT seem to support the feasibility of conducting a 
definitive RCT of physiotherapy for JHS. The pilot raised a number of important issues 
which will be briefly identified here. Many of these are discussed in more detail in the 
Discussion chapter (Chapter 6). 
 
Firstly, recruitment was challenging throughout the recruitment period, despite strategies 
being implemented to clarify the inclusion and exclusion criteria and to enhance referrals. 
The rate of recruitment was <4 recruits per month across two sites. In a future RCT close 
attention needs to be made to the number of patients in exclusion categories such as ‘no 
response’, ‘want active treatment’ and ‘did not attend clinic’ in the CONSORT diagram 
(Figure 4). Specific strategies to deal with these are discussed later in Chapter 6.  
 
Another consideration is whether identifying patients at the point of referral for 
physiotherapy is the right point at which to try to recruit. There may be more patients in 
primary care that could be identified and offered treatment earlier in the referral pathway. 
However there are likely to be major problems in trying to effectively identify such patients, 
given the reported lack of recognition of the condition by many health professionals. 
 
The retention rate was also an issue in the pilot RCT. Whilst only three participants officially 
withdrew from the study (two from the Advice arm and one from the Advice & 
Physiotherapy arm), questionnaire return was incomplete at all time points. Both of the 
withdrawals from the Advice arm cited that the reason was to access active treatment, 
suggesting a lack of satisfaction with the Advice intervention. Questionnaire return was also 
consistently lower for the Advice arm, again suggesting dissatisfaction with this intervention. 
Face to face completion might be much better, coupled with a redesign of the Advice 
intervention to make it more credible. Analysis of the drop-outs is potentially informative, 
indicating that patients with low baseline utilities were more likely to drop out on the Advice 
arm. This might indicate that this format of control intervention is not acceptable to patients 
137 
 
with low quality of life. Additional information related to these issues has been gained from 
the qualitative research findings to be reported in the following chapter (Chapter 5). 
 
Adherence to physiotherapy was generally very good. The one withdrawal from this 
treatment arm cited lack of time as being a reason, suggesting that for some attending six 
sessions could be a large commitment. On the whole, however, attendance was very good and 
there seems to have been a strong effect of the Physiotherapy intervention on improving 
exercise self-efficacy when compared with the Advice intervention. This would seem to 
indicate some support for self-efficacy being an important mediator in realising positive 
effects on clinical outcomes. 
 
There is a lack of evidence on any long-term outcomes, meaning that there is uncertainty as 
to what the long-term effects of the Physiotherapy arm may be. Follow up in this study was 
only to seven months (three months post treatment). Any future definitive trial should include 
longer term follow-up, such as to 12 months. 
 
For a future definitive RCT we have assumed that the control arm will be the same (or has the 
same costs and benefits) as the control in the pilot RCT. If not, then the results might not 
extend and this would be a limitation of the analysis presented in this chapter).  
 
Training costs of the intervention might be considered part of Continuing Professional 
Development (CPD) and would obviously diminish if spread out among more patients. The 
economic results suggest that the Advice arm is most likely to be cost-effective if willing to 
pay over £3000 per QALY. This is because it has higher quality of life, but also higher costs. 
This suggests that the Physiotherapy intervention may have cost-saving benefits, rather than 
improvements in quality of life. This seems conflicting with the results seen on the majority 
of the clinical measures and it may be that the EQ-5D-5L may fail to reflect the benefits that 
the clinical measures do. It might also be that the higher joint pain scores reported in the 
Physiotherapy arm had a disproportionate effects on the EQ-5D-5L scores. Johnsen et al91 
compared the EQ-5D-5L with the SF6D (derived from the SF-36) in a population with 
chronic low back pain. The authors found that the EQ-5D had less similarity to a condition-
specific outcome measure (the Oswestry Disability Index) in terms of sensitivity, specificity 
and responsiveness The SF6D performed better on these indices. So it is possible to see 
divergence in outcome between the EQ-5D-5L and different clinical scores. 
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CHAPTER 5  STAGE 3: PHYSIOTHERAPY FOR HYPERMOBILITY TRIAL (PHyT): PATIENTS’ AND PHYSIOTHERAPISTS’ EVALUATION 
 
5.1 AIMS  
This chapter reports the qualitative evaluation of the pilot RCT. The broad aims of this part of 
the research were to determine the: 
• Acceptability of the research design and physiotherapy intervention to patients in terms of 
quality of life. 
• Acceptability and feasibility of the physiotherapy intervention to physiotherapists in terms 
of training and implementation. 
 
5.2 INTRODUCTION  
The overall design of the pilot RCT has already been described in detail in Chapter 4. This 
chapter will therefore focus specifically on aspects related to the qualitative evaluation of 
patients’ and physiotherapists’ experiences of this complex intervention. Complex 
interventions are often difficult to assess quantitatively, and qualitative assessment can 
provide nuanced and comprehensive information about the value, acceptability and 
effectiveness of the treatment in question. The qualitative component of this pilot trial has 
allowed the researchers to explore the processes and the context within which the 
intervention was evaluated, as well as expectations of the intervention and outcomes which 
have meaning to those with JHS.  It has also allowed a deeper understanding of how the 
physiotherapy intervention can be incorporated into the life of someone living with JHS. As 
discussed previously, qualitative methods are valuable and well established in the pre-trial 
development phase of research to both help develop and refine the trial and to improve our 
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understanding of the experiences of patients receiving, and staff delivering, an intervention.40-
46 Such methods are recommended in the development and evaluation of complex 
interventions.95 
 
This chapter will firstly report the methodology and findings related to patients’ experiences, 
followed by physiotherapists’ experiences. 
 
5.3 PATIENTS’ EXPERIENCES 
5.3.1 Objectives 
Specific objectives related to exploring patients’ experiences were as follows: 
1. To explore participants’ experiences of living with JHS, events leading to diagnosis and 
subsequent referral for physiotherapy (in order to contextualise their experience of the 
trial). Also to explore their experiences of, and attitudes towards, the use of physiotherapy 
to manage JHS.  
2. To ascertain the acceptability of the trial design for participants, including treatment aims 
and randomisation, and their preferences for treatment. 
3. To develop an understanding of the participants’ experiences of the Advice and 
Physiotherapy treatment interventions.  More specifically, to ascertain participants’ 
perception of the value, acceptability and effectiveness of both trial arms and to develop 
an understanding of any barriers and facilitators to participant compliance.  Also to 
understand the acceptabity of data collection. 
4. For each of the trial arms, to ascertain whether participants perceived any changes had 
been made or experienced in terms of their health, behaviour and wellbeing. Also to 
develop a deeper understanding of which outcomes or changes are considered to be 
meaningful by the patients. 
5. To explore participants’ suggestions for improvements to the trial design and to each of 
the interventions (Advice & Physiotherapy).  
6. To explore the views and experiences of participants who did not complete the 
intervention and patients who did not wish (or were unable) to take part. 
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5.3.2 Methods 
Eighteen of the 29 participants recruited to the trial were interviewed between July 2014 and 
March 2015, either in person or via the telephone. Interviews took place at the end of the 
Physiotherapy intervention and at a corresponding time point for those randomised to receive 
the Advice intervention (i.e. at 4 months following randomisation for both arms). The 
participant information sheet and consent form for the pilot RCT included information 
regarding the interviews. This information was reiterated verbally to interviewees and verbal 
consent sought before each interview, supplementing the informed written consent given 
earlier in the study. Nine of the 18 participants recruited at Site One and nine of the 11 
participants recruited at Site Two agreed to take part in an interview. Interviews lasted 
between 18 and 90 minutes and were conducted by an experienced qualitative researcher 
(RT) employed on the project. Topic guides were used to facilitate the interviews and, in line 
with an inductive approach, were revised in light of emerging findings (Appendix 14). The 
interviews focussed on trial recruitment, acceptability of the trail, the acceptability of the 
physiotherapy and advice intervention (including content and delivery), changes experienced 
or made following participation, and suggestions for improvements. Six of the 23 decliners 
also agreed to be contacted by a researcher to describe their reasons for being unable or 
unwilling to participate. 
 
All interviews were audio-recorded, fully transcribed, anonymized, checked for accuracy and 
then imported into a qualitative software package (NVivo 10) to aid data analysis. Thematic 
analysis,50 using the constant comparison technique51 was used to scrutinise the data to 
identify and analyse patterns across the dataset. Transcripts were examined on a line-by-line 
basis with codes being assigned to segments of the data and an initial coding frame 
developed. An inductive approach was used to identify participants’ perceptions of their 
experiences. To enhance analysis and enable team discussion and interpretation, team 
members (RT and JH) independently coded 10% of the transcripts; any discrepancies were 
discussed to achieve a coding consensus and maximise rigour. Scrutiny of the data showed 
that data saturation had been reached at the end of analysis, such that no new themes were 
arising from the data.52 
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5.3.3 Results 
Demographic details for the patient participants who were interviewed are reported in Table 
33. 
 
Table 33. Participant demographics and treatment allocation. 
Participant Age  
(Years) 
Sex  
 
Treatment Allocation Site 
111 36 Female Advice & Physiotherapy 1 
112 30 Female Advice 1 
113 22 Male Advice [withdrawn following advice – wanted 
active treatment] 
1 
114 25 Female Advice 1 
119 33 Female Advice & Physiotherapy 1 
121 35 Female Advice 1 
123 23 Female Advice & Physiotherapy 1 
127 66 Female Advice & Physiotherapy 1 
128 56 Female Advice & Physiotherapy 1 
211 27 Female Advice & Physiotherapy 2 
212 46 Female Advice 2 
215 38 Female Advice 2 
216 38 Male Advice 2 
217 52 Female Advice & Physiotherapy [withdrawn following 
advice– too busy] 
2 
218 18 Male Advice 2 
219 42 Female Advice 2 
220 24 Female Advice 2 
221 47 Female Advice & Physiotherapy 2 
 
Living with JHS (Objective 1) 
Symptoms 
Participants suffered from a wide range of joint pain, including in the hips, knees, shoulders, 
wrists, ankles, hands and toes. Alongside joint problems, participants described other diverse, 
long term symptoms which they attributed to JHS, including fatigue, problems with the 
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effectiveness of local anaesthetics, sleep disruption, Irritable Bowel Syndrome, depression 
and anxiety. Participants described days when: 
 
“You wake up and just ‘oh please not today, I really can’t face it’ but you haven’t got a 
choice you’ve just gotta get going, especially when you’ve got kids and things, it’s – you’ve 
just got to keep going” [Advice 121]. 
 
They also described how these symptoms often limited their lifestyle and behaviour choices. 
 
“Otherwise I would say that I’m fit and healthy, apart from these annoying discomforts, and I 
feel that it limits me in the exercise that I want to do because I’ve always been a very sporty 
person” [Advice 215]. 
 
Diagnosis trajectory 
Although many participants were newly diagnosed with JHS, participants usually described 
experiencing symptoms of joint hypermobility for many years. Although not always 
problematic, most noted the onset of symptoms much earlier, often in childhood. 
  
“At first they called it like ‘clumsy child syndrome’” [Advice 216]. 
 
“When I was younger, it always used to be like ‘oh it’s just growing pains’” [Physiotherapy 
123]. 
 
Some participants had been previously told that they were hypermobile but were not given 
further information about how or what symptoms may develop. 
 
“When I went and had my knee operation, they just said ‘oh, you’re hypermobile’, that’s it. 
This is why we’re putting you in a brace. That’s it” [Advice 121]. 
 
Factors prompting diagnosis and referral for physiotherapy 
A specific injury or symptom that had become increasingly problematic was what usually 
prompted participants to seek healthcare. For example, participants often found they had 
become unable to participate in activities that they had previously engaged in. Usually, 
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however, diagnosis was slow and often difficult. 
 
“I’ve always been busy, what’s changed? And they just ran full bloods and said, ‘Oh they’ve 
come back fine’ and I said ‘but that’s not giving me the answers to why I’m feeling like this’” 
[Advice 121]. 
 
“I had all sorts of misdiagnoses” [Advice 216]. 
 
The meaning of diagnosis 
As in Stage One and Two of this research, participants in Stage Three reported that a 
diagnosis was extremely important in helping participants to ‘make sense’ of their symptoms. 
 
“I literally when [the physiotherapist] told me I said, I burst into tears […] especially when I 
read through that leaflet, it was just literally my entire life, and I was just like ‘all this time 
I’ve been going to the doctors and being told that it’s all in my mind ’” [Advice 121]. 
 
“All the things, like when you’re a kid, being clumsy, and things like that, not being able to 
do PE, and these little things, it’s, it all adds up” [Physiotherapy 111]. 
 
Pre-trial symptom management 
Participants described a number of ways in which they managed their symptoms prior to 
taking part in the trial, typically through the use of pain-killers and avoiding exacerbating 
behaviours. Prior to the trial, many participants were unclear about how best to manage the 
condition and which behaviours might exacerbate or ameliorate their symptoms. 
 
“I just avoided, avoided exercise I suppose, and avoided, sort of, exacerbating it” 
[Physiotherapy 119].  
 
“I had been going to the gym for a while, you know, under the probably mistaken belief that 
[…] lots of heavy lifting would sort of, you know, strengthen the muscles and therefore the 
tendons and then it would improve the situation, although actually it had been making I 
worse, I think” [Advice 113,  withdrawn following advice  – wanted active treatment]. 
 
144 
 
Prior experiences of physiotherapy 
Most participants had received physiotherapy for specific joint injuries in the past.  
Experiences and attitudes to physiotherapy were mixed; some had received physiotherapy for 
an injury or specific problem and found it to be helpful: 
 
“When it’s like, specific joints that I know will flare up […] it helps it massively physio I 
find” [Advice 218]. 
 
However others’ attitudes to physio were “pretty negative” [Advice 219]. Participants felt 
that their bodies did not behave or respond in the same ways as those without JHS and that 
physiotherapy that did not take JHS into account was not appropriate.   
 
“I’m not a normal person, I don’t have the joints of a normal person, so that isn’t actually 
relevant to me” [Advice 220]. 
 
Thus, even where physiotherapy had been helpful in the resolution of a specific joint 
problem, its effectiveness was limited if JHS was not recognised as an underlying factor 
contributing to their joint problems. 
 
“I had a fantastic knee physio specialist, who, erm, really helped me, erm, and I had a really 
great shoulder specialist […].  I think she got to the point where she said ‘you know, I can 
only give you so many exercises. I can’t change your physiology’” [Advice 220]. 
 
Many felt that the physiotherapists who had treated them in the past had eventually ‘given 
up’. 
 
“I felt a little disappointed that she, this physio had kind of given up in a sense saying, you 
know ‘I, there’s only so much I can do’ and, erm, that kind of thing” [Advice 220].    
 
Attitude to the use of physiotherapy to treat JHS 
In spite of the ambivalent views regarding the value of previous physiotherapy, and 
sometimes negative experience of physiotherapy, many felt that physiotherapy had the 
potential to treat their symptoms and participants were open to the possibility that there may 
be a form of physiotherapy which they would find helpful to manage their symptoms. 
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“If somebody said to me the question ‘do you think it would help’ I would say ‘yes’. I don’t 
have any knowledge, you know, any evidence to base that on” [Advice 219].  
 
“I was hoping there may be some exercises that I wasn’t doing, I thought actually it might 
make things - improve things a little bit” [Physiotherapy 127]. 
 
Acceptability of the trial for patients (Objective 2) 
Recruitment and attitudes to participation 
Participants were usually referred for physiotherapy (and subsequently informed about the 
trial) for ongoing, progressively worsening or recurring joint problems and pain. Participants 
had a clear understanding of the aim of the research and what would be involved when taking 
part and none felt the need to discuss the study with anybody else to help them decide 
whether or not to participate. Most participants who took part in the trial were keen to be 
involved in research investigating JHS, to help augment the evidence base and develop an 
understanding of JHS. Participants were also keen that JHS should be better understood 
within wider society. Quotes relating to participants’ attitudes to participation in the trial are 
show in Table 34 below.   
 
Table 34. Summary of participants’ attitudes to taking part in the trial. 
Participant Treatment 
Allocation 
Attitude to participating 
111 Advice & 
Physiotherapy 
“Glad really, I think. So people can sort of realise […] people 
think it’s all in the mind and things like that” 
112 Advice “Excited actually.  I thought it sounded really interesting. I 
always quite liked the idea of being involved in a study[…] I 
thought ‘oh, how wonderful. It would be really interesting to 
be involved in more of an understanding about what it is that 
has caused me so much pain for so many years’” 
113 Advice (then 
treatment) 
“Wanted to be a part of it” 
114 Advice “Happy to [take part]  […] if I can help anyone or, help out, 
as much as I can, knowing how it feels […] so we could help 
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other people with the same situation” 
119 Advice & 
Physiotherapy 
“I think it’s important that people do these things, you know, 
and I was in the, the right place at the right time […] I just 
think it’s important to do” 
121 Advice “kind of way forward for people in the future that have been 
diagnosed with it, which is why I agreed to do it, because I 
spent years with nothing” 
123 Advice & 
Physiotherapy 
“I was more than happy to take part cause I just see it as if, 
erm, because I’ve struggled so much with like understanding 
what’s wrong with me and stuff, I just think I was all for to, 
you know, see if anything could be done or to help others or 
anything” 
127 Advice & 
Physiotherapy 
“I’m always quite happy to do these things, if they’re going to 
be of benefit to the, to other [other] people” 
128 Advice & 
Physiotherapy 
“Well, I thought it would be quite interesting cause I feel as 
though there hasn’t been anything  […] really. So, erm, and I 
thought it, you know, it would be a good thing to do” 
211 Advice & 
Physiotherapy 
“I was quite pleased to be asked really, yes, quite happy to 
take part in things that help other people” 
212 Advice “I was in a bit of a dilemma I suppose that the time, because 
at that time I was still working. I was trying to get my head 
around whether I should be having more input, physiotherapy-
wise or whether this was going to be enough for me, with 
advice and being left to get on with it, so to speak” 
215 Advice “I wanted to see whether I was going to, erm, answer positive 
for some of them […] so part of me I think was a way of 
finding out was I or wasn’t I [suffering from JHS]” 
216 Advice “It was useful [… ] I mean I’ve done medical studies before 
[…] I was taking part in other medical studies, […]. I’m erm, 
studied human biology. I’m interested in that, I’m doing 
everything I - it’s interesting” 
217 Advice & 
Physiotherapy 
“If there’s any way that I can erm, do something that will 
assist people to, to have a better quality of life -  And 
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particularly in view of my daughter, erm, and understand 
what’s going on, then I’d be very happy to take part” 
218 Advice “Well, I find it’s quite interesting […] and I thought, well, it’d 
be a great opportunity for me, er, not only help myself, but you 
know, see how it works […] I thought it was an amazing idea” 
219 Advice “I thought it was really important like that. Because, erm, you 
need to know whether physiotherapy actually does help 
people, but I don’t know that from evidence, […] research into 
anything is important so that you can understand things 
more[... ] Even if it doesn’t help me it might help somebody 
else” 
220 Advice “I was very interested to. I think it’s you know, any, any 
research into something that’s you know, not well understood 
is, is good” 
221 Advice & 
Physiotherapy 
“Oh I was really thrilled to take part because, erm, I’m very 
interested in finding out more about my own body. […] I’m a 
movement teacher myself. So, erm, I try and help others with 
their pain a little bit. So, erm, I’m very interested in, in what 
pain can do to your body. Don’t know enough about it, so it, it 
was ideal for me to find out about my body. To try and sort of 
pass it onto others and try and help others a little bit” 
 
Study information and treatment equipoise 
Participants understood the principles of equipoise. 
 
“The thing is, the study didn’t know whether or not physiotherapy helped. And I can 
understand why, okay, because of the nature of the disorder.  Er, it made sense” [Advice 
216]. 
 
Moreover, most participants also recognised that physiotherapy had not necessarily been 
helpful in the past, and potentially may exacerbate their symptoms.  
 
“The pain levels, and the, the constant sort of stiffness of everything […] And that’s what I 
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thought it would sort of help with. Erm, but again, I’m not entirely sure ‘cause, you know, 
what I’ve received is basically a five-minute appointment with a physiotherapist before, 
where they’ve given me a list of ‘do these exercise and come back in a month’, that’s all I’ve 
had before” [Advice 218]. 
 
Treatment preference 
Regardless of their prior experiences and understanding of equipoise, many participants still 
hoped to be randomised into the Advice & Physiotherapy arm, hoping that ‘something’ rather 
than ‘nothing’ would be more beneficial. The preference to access physiotherapy was 
particularly strong amongst those participants who were experiencing pain. 
 
“I think when you’re in that situation and you’re, you’re in pain you want something to 
help[…] I think I was very keen to be in the physiotherapy group” [Physiotherapy 119]. 
 
A preference for physiotherapy was also expressed when they felt that they needed ongoing 
health guidance and support. 
 
“I would have preferred to have the physiotherapy, but I didn’t have it […] like so when I do 
have a flare up, I’m not sure if I am actually doing the correct thing by taking my weight of it, 
or if I should be keeping it moving and things like that […] it would have been nice to, er, 
find out, erm actually more into […] what the correct kind of thing to do is” [Advice 114]. 
 
On the other hand, others felt that, although they would have preferred physiotherapy, they 
also felt that taking part in the trial was important and thought that: 
 
“Well, I’ve lasted this long, I might as well just carry on the way I am” [Advice 121]. 
 
Some had no preference for ether treatment arm and were “just happy to go with whatever 
really” [Advice 215], or willing to participate knowing that it would be possible to withdraw 
from the study and access physiotherapy if necessary. 
 
“I'd have preferred to go in [i.e. have physiotherapy], for being so long without anything, to 
the point where I'd kind of just rip my hair out, and then finding out I was in the control 
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group, I was like, ‘Well, I've lasted this long, I might as well just carry on the way I am’ but I 
also said to him, ‘So what happens if I do have an issue or a flare-up or something like that?’ 
He said, ‘If, at any point, it becomes too much, we can take you out of the study and we can 
help you, you know, you're on our radar and we can’” [Advice 121]. 
 
… or to access physiotherapy once the trial was over. 
 
“when I first saw the physio, he said, ‘Well, when the trial is over, I will see you anyway’,  so 
it wasn’t going to make that much difference” [Physiotherapy 127]. 
 
Those quotes might also suggest an issue with equipoise on behalf of the physiotherapists 
involved with the trial. Others were willing to take part because the evidence to suggest that 
physiotherapy is effective in treating JHS is lacking. 
 
“I can understand how it could do more harm than good, if you don’t really know, then I’m 
probably, probably best off not trying it, I’d say” [Advice 216]. 
 
Nonetheless, when randomised to the control arm, some reported feeling “a bit 
disappointed” [Advice 219], whilst others felt: 
 
“I guess I was slightly, well, not disappointed, cause as I said, I now it’s not, you know, the 
be all and end all, and you know it h - it has its purpose for the study, erm but I thought ‘Ah, 
it’s not going to work. This is erm, er kind of frustrating. That puts me back’” [Advice 220]. 
 
Others, although disappointed, took a longer term few and were more circumspect: 
 
“I was quite disappointed actually […] but I thought ‘I don’t care if I’m not’. It was 
disappointing because I was quite looking forward to getting the physiotherapy especially if 
it helped reduce my pain. On the other hand, I sat there and thought at the end of the day I 
can have physiotherapy afterwards” [Advice 112]. 
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Participants’ experiences of the trial (Objective 3) 
Pace, format, content and delivery of the Advice session 
Interviews with patient participants were carried out four months after their advice session.  
Some participants therefore reported difficulties in recalling details of this session. For some, 
the Advice session was recalled as an opportunity to discuss in more depth more generic 
information they had previously accessed from different sources, such as the internet, and 
provided an opportunity to ask questions about JHS relevant to their personal circumstances.  
Generally, patients found the Advice session helpful and informative. Some felt that, due to 
time restrictions, particular aspects of JHS were not discussed in enough depth. 
 
“It was helpful but it just really touched, just touched upon the subject […]  I mean some 
things weren’t even, you know, gone into ‘cause there just was not enough time, I mean, for 
somebody else it might have been enough, but not me” [Advice 219]. 
 
Athough some participants would have liked more information, most felt that the Advice 
session was pitched at about the right level, and could be tailored to meet the needs of the 
individual patient. 
 
One participant randomised to the Advice & Physiotherapy arm felt that Advice alone would 
have been an inferior treatment. 
 
“I don’t think I’d have been that – um, it wouldn’t, well, it wouldn’t have been that good 
really, if that was all I was going to get, then I wouldn’t have been that impressed with it, 
really” [Physiotherapy 127]. 
 
Written literature: HMSA and Arthritis Research UK booklets 
The participants’ evaluation of the HMSA54 and Arthritis Research UK55 booklets was 
mixed. Some could not recall being given booklets. Others felt that the booklets were very 
useful and could be used as a starting point for finding out more about JHS and one 
participant passed the booklet on to their GP. 
 
“I think the one I found particularly, personally, I found particularly helpful and very 
informative […] this is the one I actually gave to my GP who, as I say, has a particular 
interest in this” [Treatment 217]. 
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What worked well: ‘Active Ingredients’ of the Advice intervention 
Face to face discussion about JHS: 
Most participants valued the opportunity of discussing JHS with somebody who was an 
expert in the field. 
 
“Basically, talking to someone about it and understanding it more made me even feel a little 
better” [Advice 114]. 
 
One participant described the physiotherapist’s explanation of JHS and the use of a model 
skeleton to demonstrate movement as being “amazingly invaluable” and that the 
physiotherapist  “explained properly […] like no other person has before, how it actually 
affects me, and the reason why I get the pain and the best way to avoid it” [Advice 218]. 
 
Provision of information about JHS: 
The information provided was another important aspect of the Advice session.  
 
“From that, you know, couple of hour session; receiving all that advice I found more 
invaluable than anything else” [Advice 220]. 
 
Many felt that the information booklets given during the advice session were helpful to 
support the information given verbally by the physiotherapist. 
 
“He delivered it really well, and it was really helpful having the leaflet […] it is quite a lot to 
take in, especially ‘cause I was in a bit of a state” [Advice 121]. 
 
Understanding about JHS provided a lot of reassurance, and in turn allowed participants to 
understand and therefore mange their symptoms. 
 
“The fact that I just didn't feel like I was going mad anymore, which, it was a huge, huge 
thing that I'm not going insane [Laughter], that I'm not imagining things. […] the relief in 
not knowing I'm going mad was a huge thing […] whereas now I just think, ‘Well that's what 
the matter is, this is what helps’” [Advice 121]. 
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Making sure exercises are done correctly: 
Many participants valued the contact with the physiotherapist in order to ensure exercises are 
carried out properly. 
 
“I needed, before I even started the exercises I needed to be in, I needed my body to be in the 
correct position. And I think that’s something that other physios haven’t, er, picked up on. A 
lot of them are just like, ‘Do a load of exercise’ […] but you’re not, you know, dealing with 
the underlying physiological, erm, you know, where your bones are supposed to be and 
where your joints are supposed to be [... ] So it was, erm, it, the advice was really great for 
me because I needed to not really do any exercises at that point I just needed to change the 
way I stood, the way I sat, the way I, you know” [Advice 220]. 
 
A combination of information and physiotherapy and lifestyle advice: 
Participants described the holistic approach to the advice session, taking into account 
personal circumstances and lifestyle, as being a valuable aspect of the advice session. 
 
“The 50% of talking about your lifestyle, your sleeping, erm, was something that really made 
me sit back and think, ‘Oh hang on a minute. I really need to get my life in order a bit more, 
and I need my sleeping pattern to be better so that it doesn’t make the pain worse’. I hadn’t 
even thought about that” [Advice 221]. 
 
Were expectations of the Advice intervention met?  
Many participants reported that they did not know what to expect, or went ‘with an open 
mind’ or did not have any expectations. Some had low expectations. One participant felt that 
they would have expected physiotherapy to help, but did ‘not really’ have any expectations of 
the advice treatment arm. 
 
“If I’d had the physiotherapy then maybe I would have expected it to help me” [Advice 219]. 
 
“I did not really have any expectations. Just hope I suppose […] I do not think you can really 
say if anything met your expectations until it’s all over and done with and you have the 
findings” [Advice 112]. 
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For others, their expectations were met or exceeded, because of their prior experience of 
physiotherapy. 
 
“Because my expectations were it was just going to be another physio and it would probably 
help a bit […] but I wasn’t, er, expecting to get the results that I got, at all” [Advice 220]. 
 
One participant felt that the study did not meet their expectations because they were hoping 
for physiotherapy, but had been randomised to the advice intervention arm. 
 
Global evaluation of the Advice intervention 
Information related to individuals’ global evaluation of treatment is shown later in Table 35. 
For those who went on to have the physiotherapy, they still felt that the advice session was of 
value.  
 
“It was very, you know, very, it made, I definitely felt very positve afterwards” [Treatment 
119]. 
 
Others were less positive and did not feel that the advice arm was helpful. 
 
“I didn’t really feel that I got much out of it” [Advice 219]. 
 
However some were very happy with the advice provided and felt that it empowered them to 
self manage their JHS. 
 
“I think he was really thorough. And so no, I don’t think anything could have improved it. I 
think he did what he had to” [Advice 215]. 
 
Participants’ experiences of the Physiotherapy intervention  
Participants generally felt that the physiotherapy sessions were flexibile enough to be tailored 
to meet their specific needs. 
 
154 
 
“I found that there was some things where some of it wasn't so relevant and so we just moved 
on and then the other bits that were we could focus on it in more detail” [Physiotherapy 211]. 
 
“She'd often sort of change an exercise slightly, because she knew that I was struggling to do 
it. So she'd change it slightly to adapt it for me” [Physiotherapy 111]. 
 
 
“I think, I think we talked about changing them and then we ended up doing them more or 
less in the order they were in the book. They actually, kind of, they flowed nicely” 
[Physiotherapy 119]. 
 
The Physiotherapy patient handbook 
Generally the patient handbook was very well received: 
 
“The information, the booklet, look at your lifestyle plus the physio, er, I think it was 
fantastic” [Physiotherapy 221]. 
 
“Erm, I found it nice and easy to read. …I’ve kept it because it was such a good booklet. I 
want to revisit it at some point. I don’t think there’s anything I’d particularly change about it. 
It was very easy to understand. Erm, and I think most people would understand it” 
[Physiotherapy 221]. 
 
The booklet reinforced the work done in the physiotherapy sessions. 
 
“I think the tendency is, as I said, you go in, you do your exercise, you have a discussion, you 
walk away, you leave it. […] and I think it [the booklet] almost stimulates you to make sure 
that you do try and do some of the things you’ve discussed in there because you think, ‘Ooh 
yeah, no we did talk about that, maybe I ought to try doing that then’. […] Whereas, I think 
sometimes if you haven’t got something like that, then erm you, then, then you don’t bother in 
quite the same way. You, you think you’re going to, and you mentally, you know ‘Oh yeah I’ll 
do that, I will do that’. But you just don’t do it – in the same way. And I think actually having 
a booklet makes you do it more. You know you think, at the start, you think, ‘Why have I got a 
booklet, why am I being, you know, why am I doing this?’.  And that’s why I said it’s part of a 
155 
 
process. It doesn’t become clear until you’re actually in the process of doing it and you’re 
actually in the process of using the book and then it starts to become a point to it, if that 
makes sense?” [Physiotherapy 217]. 
 
“Well it's good really, ‘cause sometimes you forget what exercises you've done, and she’d 
tick the boxes, so then you could sort of come home and have a look through it. And then at 
your own pace, you can sort of do the exercises at home. And then you’re not forgetting 
which one’s which, and so it’s good. It’s showing the actual pictures as well, so just in case 
you forgot what it was” [Physiotherapy 111]. 
 
Although the book was considered by many to be important, some felt that there was not 
enough time in the session to work through the booklet and then ‘hands on’ exercises and 
physiotherapy. 
 
“I think we both felt that it would have been nicer to have a longer period of time to not just 
go through the booklet but to actually go through the actual exercises in, you know – in more 
detail” [Physiotherapy 217]. 
 
A minority did not feel that the booklet was of value. 
 
“I felt the booklet was useless really. And even if I had written in it, it wasn’t even looked at 
anyway” [Physiotherapy 217]. 
 
What worked well: ‘Active Ingredients’ of the Physiotherapy intervention  
The flexibility of the physiotherapy sessions allowed the intervention to be tailored to meet 
the individual needs of the participant. In effect then, the intervention was slightly different 
for each patient. For example, participants felt that taking their individual circumstances into 
account, physiotherapists could appropriately tailor their treatment. 
 
“It was actually focussing on what was going to do best for me. It was what was different 
with this session to anything else I’ve done” [Physiotherapy 127]. 
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Other aspects of the advice with physiotherapy intervention were also highlighted as working 
particularly well, as illustrated in the following examples. 
 A whole person approach:   
As with the advice session, participants valued the holistic approach to the physiotherapy. 
 
“It was very nice to actually be seen as a whole person, rather than individual bits and 
pieces” [Physiotherapy 127]. 
 
Ongoing support:   
“I think maybe one of the reasons that doing the actual physio helps is that, you know, it’s, 
it’s a hell of a lot easier to remember all the advice when you kind of, you know that you’re 
going to go back to a physio in a couple of weeks and have to prove that you’ve actually been 
following the advice” [Advice 113, withdrawn to Physiotherapy]. 
 
Combination of treatment components:  
“I can’t think of anything specific, other than, you know, the accumulation of, of the different 
sessions all worked to improve it” [Physiotherapy 128]. 
 
Being shown how to exercise correctly:   
“Showing you how to do it and then watching you saying ‘oh no, you need to put your arm 
there, or your leg there’. That helps massively […] ‘cause a lot of exercises I was doing and I 
was doing it completely wrong and I was like ‘well this is easy’” [Physiotherapy 111]. 
 
Were expectations of the Physiotherapy intervention met? 
“I had very low expectations, and, and they certainly exceeded my expectations because I 
didn’t really have any. I, I, I didn’t really expect much.[…]  I thought, ‘Oh here we go. I’m 
going to find some physio that doesn’t really understand me, doesn’t know much about it’ 
and I, I, I didn’t have any expectations and I was pleasantly surprised” [Physiotherapy 221]. 
 
Trial questionnaires 
Views regarding the questionnaires were mixed. 
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“If I'm being honest, they were very repetitive questions. And I understand why they're 
repetitive. But I just felt a bit annoyed” [Advice 218]. 
 
“Looking forward to writing down in it. I think it’s going to be quite therapeutic” [Advice 
112]. 
 
Changes following participation in the trial (Objective 4) 
Most participants felt that participation in the trial, in both arms, led to some changes being 
made or experienced. A summary of these changes are shown in Table 35. A notable change 
reported by both treatment arms was the increased feeling of being able to cope with and 
understand the symptoms of JHS. Similarly, many felt that changes arose from developing a 
deeper understanding of the condition and therefore being able to implement behavioural 
changes to deal with their symptoms. 
 
Changes following the Advice Session 
One participant reported it was like “weights dropping off” [Advice 112] as the 
physiotherapist explained the symptoms of JHS. Like others, this participant found that 
during the advice session “everything just fell into place”.  However, physically, few changes 
could be identified. 
 
“Mobility  [...] that has not changed  [...] Fatigue, that has not changed as a result of the 
advice session because all is has done is made me understand it more. I do not feel like a 
waste of space, is probably the best way of putting it, I have a bit more understanding for why 
I am always tired so therefore, it has become more acceptable and I have lived with it better 
rather than always worrying that there is something wrong with me […] At the end of the 
day, I am not going to magically stop being tired all the time from a bit of advice” [Advice 
112]. 
 
Rather, the advice allowed the participant to self-manage the condition. 
 
“Really, just through all the information, I made myself a bullet point list of all the things that 
I could do to make a start on making myself feel better” [Advice 112]. 
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“I felt more positive about things that I, because I – it was allowing me to, to look at things 
more and research it myself, it, it, it was making it, it was giving me a much better 
understanding of the whole thing” [Physiotherapy 221]. 
 
“It was very nice to actually be seen as a whole person rather than bits and pieces” 
[Physiotherapy 127]. 
 
Participants in the Advice intervention arm reported making number of changes following the 
Advice session. Behavioural changes included modifiying exersice regimes (for example 
stopping weightlifting and running or increasing exercise levels). Others felt less able to 
make informed changes. 
 
“I didn’t really, erm, know what to do, or anything like that, erm, so I just, erm, I did start 
swimming more so – I thought that would be quite good”  [Advice 114]. 
 
In spite of making behavioural change and being more aware of activities which could 
ameliorate or exacerbate JHS symptoms, many participants still experienced considerable 
amounts of pain. 
 
“You know, I’m still feeling the pain […] and still feeling the same as I have before. It’s just 
now I understand why I’m feeling it […] it’s not like – there isn’t any magical way to get rid 
of all the pain – it’s just the understanding of why I think that’s the reason why it’s changed.  
I think, yeah, massively” [Advice 218]. 
 
For others, even though their knowledge and understanding of the condition had improved, 
making changes was difficult. 
 
“It’s very difficult to make the changes that I needed to make just like that. Erm, It’s without 
really going back and asking somebody ‘what – am I doing this right’ and things like that” 
[Advice 219]. 
 
Changes following the Physiotherapy intervention 
As shown in Table 35 most of the participants reported positive changes following the 
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physiotherapy sessions. Behaviour changes included changes to their exercise regime and 
changes to posture, pacing and sleep. In addition, participants reported making changes to 
their work patterns or environments. As a result, participants noticed changes to pain levels, 
ability to cope with pain, along with changes to sleep and fatigue. 
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Table 35. Summary of participants’ attitude to intervention arm, overall evaluation and changes made or experienced after treatment. 
Participant  When diagnosed and 
reason for referral  
Attitude to intervention 
arm 
Overall evaluation or 
experience of treatment  
Changes made or experienced 
Advice Participants 
Advice 112 <3 months. Pain after 
10 years of problems. 
No specific current 
joint injury. 
Preference for 
physiotherapy. 
Disappointed, wanted 
physiotherapy, but 
participated as knew 
physiotherapy was a later 
option. Recognised that 
physiotherapy may not 
help. 
Positive:  Like a massive weight 
had been lifted. “Someone saying 
‘This is what the problem is’ 
changed my life really”. 
Has a greater understanding of 
the condition, now more 
acceptable to live with. Very 
positive psychological changes, 
“just knowing I’m not crazy” 
Helps validate to others. 
No behaviour changes from 
literature, but from seeing a 
podiatrist. 
Advice 114 Approx 10 years, aged 
16. Hip problems. 
Preference for 
physiotherapy. 
Would have preferred 
physiotherapy as is 
unsure whether she is 
“doing the correct 
thing” (e.g. restricting 
movement). But happy 
Positive: Just given a better 
understanding. “Talking to 
someone about it and 
understanding it more, made me 
even feel a little better”. 
None specific. Did not really 
know what to do. No difference 
to health (e.g. pain, fatigue). 
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to take part to help 
others. 
Advice 121 “Recently” (now mid 
30s). Following knee 
surgery and joint 
problems. 
Preference for 
physiotherapy. 
 
Positive: “I was a blethering 
wreck by the end of it, just a 
relief really, that I wasn’t going 
mad, you know, there is 
something that all these things 
relate to”. 
Hard to make any changes but 
has taken painkillers more 
frequently, taken more regular 
rest breaks and say “no” when 
necessary. No changes to sleep. 
Pain has been better. “I am in 
control of how I can help myself 
[…] I feel a lot happier now in, 
that I’m not going mad and there 
are things that I can do to help 
[…] You know, it’s really really 
made a difference”. 
Advice 212 <1 year ago. Ambivalent: “It looks 
like it might not work 
anyway  [... ] so perhaps 
it’s just enough to have 
the information and do it 
myself”.   
Positive: “To speak to someone 
who does understand it does 
help. From that point of view, it 
was a really good thing”. 
Tried pacing exercises 
differently, greater awareness of 
posture. Improved sleep if 
exercise is better. More accepting 
of JHS symptoms due to having 
a greater understanding of the 
condition. Psychological 
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improvements. 
Advice 215 < 1 year. Recent onset 
of hip and knee pains. 
History of a lot of 
sport. Childhood 
dislocations. 
No preference: Happy 
with either treatment 
arm, as “didn’t really 
think the diagnosis of 
hypermobility was 
correct”. 
Positive: “Great to have 
information to read around a 
subject when you’re a bit unsure 
of whether you have that 
condition or not”. Therapist 
“was really thorough”. 
Some postural changes and 
changes to exercise regime. Has 
not noticed any physiological 
changes or improvements. 
Advice 216 < 1 year. Lower back 
pain after car stopped 
working. Pain started 
age 20, diagnosis at 37 
(now 38). 
No preference: “can 
understand how it 
[physiotherapy] can do 
more harm than good.” 
Positive: “Really really 
interesting”. 
No behaviour changes. Was an 
informative session, nice to talk 
to someone about it. The 
diagnosis made a lot of 
difference. 
Advice 218 3 years ago. Preference for 
physiotherapy. 
Positive:   Positive: “the 
advice that I received you know, 
was more invaluable than I can 
ever imagine. From that, you 
know, couple-of-hour session; 
receiving all that advice, I found 
that more invaluable than 
anything else”.  
Changes to posture, walking and 
moving. Purchased knee brace.  
No changes to pain. 
Advice 219 6 months ago. Preference for Negative: “I felt disappointed, Yes, but due to other, unrelated, 
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physiotherapy. and to be fair I felt like it was a 
bit of a waste of a, waste of time 
[…] there wasn’t enough time as 
I was newly diagnosed and I was 
wanting to know this, you know, 
lots of different things. There was 
just not enough time to give as 
much advice as I feel I would 
really have liked”. 
lifestyle changes. Has tried to 
make changes but difficult 
without really going back and 
asking somebody “What – am I 
doing this right?” 
 
  
Advice 220 14 years ago. 
Diagnosed following 
hip pain age 11 (now 
25). 
 
Preference for 
physiotherapy initially. 
Very interested realising 
the JHS is not well 
understood. Initially 
wanted physiotherapy, 
but realised it is not the 
be all and end all.  
Intrigued but worried it 
might cause a set back. 
Positive: “But, [erm], it worked 
out very well for me having the 
one off session […] it genuinely 
has made a dramatic difference 
[…] I think, [erm], to sum it up 
[…] the physio looked at me and 
how my body behaved. Erm, and 
looked at, yeah, instead of, erm, 
talking about how the human 
body should behave or the 
average human body should 
behave. […] And he took the time 
Postural and other behavioural 
changes, resulted in physical 
improvements. Less tired, lifted 
mood, more “alive”. 
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to, erm, you know, research into 
my lifestyle […] of what it’s 
really like day to day to live with 
those kinds of joints”. 
Advice & Physiotherapy Participants 
Physiotherapy 111 < 1 year. Hip 
pain/diagnosis of 
fibromyalgia. 
Hoped to have 
physiotherapy.  
Positive:  “Erm, I'm glad it 
happened. ‘Cause it has 
definitely made a difference”. 
“[…] exercise seemed to help.  If 
I was doing the right exercises, 
strengthening exercises. So I 
joined the gym. So yeah, it's sort 
of given me a better attitude 
towards exercise […] I'm still 
going to the gym. And I think that 
does help, definitely. And the 
slowing down, I'm still trying 
that … make the kids do more 
[…]. Still tired […] Not aching 
as much when I'm waking up in 
the morning”. 
Physiotherapy 119 < 1 year. Knee 
problems following 
symptom flare up. 
Preference for 
physiotherapy. 
Positive: “You know, I, I feel 
pretty much better. It’s a good 
feeling […]I think a lot of people 
More aware of pacing, setting 
time aside to do exercises, 
increased awareness of 
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find it difficult to appreciate 
actually you being in pain all the 
time, it’s really, really hard to 
deal with it emotionally and 
psychologically. […]I think 
having, having had the 
physiotherapy helped me get 
over that. But also knowing that 
if the pain comes back I have the 
coping mechanisms to deal with 
it.” “Erm, more generally it’s 
just all improved, it’s you know, 
I’ve, it’s, it’s now, for me, a 
managed condition [... ] I don’t 
even think about it every day, you 
know, I, I think about it when I 
get the odd twinge or when, you 
know, when my joints click or 
whatever. It’s, it’s, it’s just 
become part of my life rather 
than ruling my life”. 
movement, posture. Has had 
workplace assessment. Changes 
to sleep position, resulting in 
improved sleep. “The 
improvement to my health is, is, 
has been fairly remarkable, I 
mean I’ve gone from being in 
pain, pretty much, all the time to 
some degree to, I mean like right 
now I’m not in pain and I haven’t 
been, I haven’t been regularly in 
pain for a few months now. […] 
the fatigue has, has pretty much 
vanished”. 
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Physiotherapy 123 < 1 year. Knee surgery 
after a long history of 
symptoms since about 
the age of 4. 
Did not understand the 
choice available. 
Negative:  Pointless, felt not 
listened to. But information 
session good in one way as an 
“answer to all my pains and 
problems”. 
First session helped with lots of 
symptoms like sleeping. Feels a 
bit more energetic.  Learned to 
pace. 
Physiotherapy 127 Start of trial. Very 
loose joints, frequent 
sprains. Rheumatology 
visit for osteoarthritis. 
Preference for 
physiotherapy. 
Two therapists seen; Positive 
with one physiotherapist, 
negative with the other.  
“It was very nice to actually be 
seen as a whole person rather 
than bits and pieces”. 
Subtle changes to exercise 
regime, which made a big 
difference, particularly core 
stability. 
Physiotherapy 128 Approx 10 years ago. 
Hip problem. 
Preference for 
physiotherapy, but 
would have accepted 
either. 
Positive: “Generally when I’ve 
had physio before, amongst other 
things, it has helped to a degree, 
so I was hoping it would have the 
same effect. And I’ve got to be 
honest, it has, it has improved” 
Pain reduction, less joint 
dislocation. 
Physiotherapy 211 Approx 6 years ago.  
Huge flare up of 
symptoms and pain. 
Preference for 
physiotherapy, but 
interesting to see if 
advice only would be 
Positive: “The most useful thing 
I’ve taken part in since being 
diagnosed”. 
“Completely changed from 
where I was before the trial … 
life changing really”. 
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beneficial. 
Physiotherapy 217 >1 year. Ongoing 
symptoms. 
“Sort of hoped” for 
physiotherapy, but also 
would have accepted 
advice. 
Advice session: “Very positive” 
that somebody else actually 
could explain symptoms and that 
there was an explanation for 
them. Sessions not long enough 
to ensure exercises were done 
properly. 
Pacing or resting rather than 
“push on”, saying “no” to other 
people, not to “go 100 miles an 
hour all the time.” Changes to 
medication use, taking 
painkillers before pain becomes 
too severe, using different shoes.  
Quality of life “slightly better”, 
less “boom and bust”. “A lot 
more sustainable and on the 
whole, not hitting those walls of 
extreme, extreme pain”. 
Physio 221 Recently diagnosed. 
Hip instability. 
No preference. Positive: “I’ve seen lots of 
people in the past about things 
and injuries. And you just think 
sometimes, ‘Do people really 
understand me? Maybe not’. You 
know? [Laughter] And then, then 
you, when I went there, I, I found 
people that were just brilliant”. 
Has made practical changes for 
example buying a new mattress 
which has improved sleep.  “So 
totally made me think about 
things …” Learned to “slow it 
down and think about me a bit 
more and calm down a bit”. 
“Totally” changed quality of life. 
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Advice 113 
(withdrawn, 
received 
physiotherapy). 
<1 year Very strong preference 
for physiotherapy . 
Advice session was not enough 
to help with specific symptoms.  
But if not experiencing 
symptoms: “I think I wouldn’t 
have dropped out. […] I just 
couldn’t, you know, I just 
couldn’t do nothing about it, you 
know”. 
Advice only was “Probably, you 
know, it’s probably better than 
nothing […] the advice is 
definitely a good thing to give 
people, but then you know, 
depending on the severity of the 
problems [...] that was the main 
reason that I wanted to drop out, 
in that I could actually get some 
help, ‘cause it was – I, I don’t 
think it was going to go away on, 
you know, just with the advice”. 
169 
 
Suggested improvements (Objective 5) 
Participants described a number of ways in which their experiences of the trial may have 
been improved. 
 
Suggested improvements to trial design 
Although participants understood the notion of equipoise and that there was no evidence that 
physiotherapy was more beneficial than advice, participants still, by and large, felt that 
Advice was ‘less’ of an intervention than Advice & Physiotherapy. Participants described the 
Advice arm as being in the ‘wrong’ arm or as ‘not being part of it’. 
 
“I suppose, as I said, I was a bit dissapointed that I wasn’t gonna get any physiotherapy or 
any further advice […] the control group or however you like to put it that I was in.  [Erm] 
felt like you were sort of not really part of it anyway.  Because you’d have that session at the 
beginning and then that was it” [Advice 219]. 
 
Suggested improvements to the Advice intervention 
A number of suggestsions were put forward to augment the Advice intervention arm, 
including additional information sessions, pain management advice, and alternative or 
complementary therapies. However, there was no general consensus as to what would 
augment the Advice treatment arm. For example, some participants felt that two advice 
sessions would be beneficial, whilst others felt that the single advice session worked well, 
minimising travel time and expenses. The suggestions for improvements to the Advice 
intervention are summarised in Table 36. 
 
Table 36. Summary of suggested improvements to the Advice intervention. 
Suggested 
improvement  
Illustrative quote 
Additional pain 
management 
course 
“He did explain to me the best way to avoid pain and when I do get pain how 
to hold my knee and all that. So that was addressed […] I think the, the only 
thing for me was, erm, obviously sort of pain management” [Advice 118]. 
Gym 
membership, 
alternative 
“Erm, the likes of that gym membership idea, that's a fantastic idea, because 
not only does it give that, that person access to that gym, I think, yeah, it 
probably, you know, give them more chance to go” [Advice 218]. 
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treatments and 
heat therapy 
“what I found invaluable for me, is a lot of alternative treatments, which are 
like reflexology [erm] going for a massage on my back, that really does 
help” [Advice 218]. 
Ongoing 
telephone support 
“Not necessarily face to face advice but perhaps when others received their 
physiotherapy and then more advice then that would come hand in hand.  
But the people in the other group should have had advice by phone” [Advice 
219]. 
On-going check 
ups 
“I reckon kind of a rolling check-up every now and again would be a good 
idea” [Advice 113, withdrawn - received Physiotherapy]. 
 
“It's literally, it's all there. Yeah, so, yeah, maybe, just so you could have a, 
even if it was like a phone call conversation that you could have with 
somebody, so that you know, erm, that it would be a, you know, that if you 
needed somebody, or they're saying, ‘How are you getting on?’ or whatever, 
or if you'd had a fall, or something like that, then they'd kind of be aware of 
that ongoing thing” [Advice 121]. 
Group 
interventions 
“I don’t know whether they do it, but anything like erm, any groups or 
anything, like not only like information sessions or something, like something 
you can go to and erm, have more – proper, a proper talk to you, if you get 
me? Something like that would have been a lot more helpful as well. […] 
meeting other people, or someone just like fully explaining, ‘cause I never 
really got fully explained by someone, it’s only from what I’ve read from like 
a few of the booklets and online, like about hypermobility, so I’ve never 
actually got personally told what it is and what it’s about and the symptoms 
or anything” [Physiotherapy 123]. 
 
“It would nice to erm, speak to other people, erm, with the, the condition, 
just to know that you’re not by yourself and that there are other people, and 
have a common thing” [Advice 114]. 
Advice session 
split into two 
sessions  
“I think it was done well, but I think it would be better spread out over 
maybe two. I know you can't do the full thing, but maybe two, because for 
half of it my head was spinning with all the, you know, you know, ‘I'm not 
going mad I'm not’, but then I'm trying to focus on the information side of 
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things, umm, or maybe you do one and we get shown the exercises and 
everything then, perhaps a month later, you went back and then you could 
check that, you know, it's right or you're doing it right or, you know, 'cause it 
is quite a lot of things to try and remember, I'm rubbish at trying to 
remember things, ermm, just so that you know you've, you're doing it all 
properly” [Advice 121].  
 
“I think maybe just presented in smaller sections, yes, more bit sized sections 
so that you can just do a bit and think about it a do a bit and think about it” 
[Physiotherapy 121]. 
More 
comprensive  
advice regarding 
JHS 
from 
physiotherapist  
to support reading  
material. 
“Perhaps the session could have involved a bit more of sitting down and 
going through what normally happens with somebody who has this. Perhaps 
not everybody would have been like me and gobbled up every bit of reading 
material because I am an avid reader so I am, I suppose, probably quite 
different to other people in that way. Not everyone obviously. So perhaps 
that could have been some way of improving it because there are people who 
would not read it all” [Advice 112]. 
 
Suggested improvements for the Physiotherapy sessions 
Most of the participants who were randomised to the Advice & Physiotherapy arm evaluated 
the intervention positively. These participants offered a range of suggestions for 
improvements which were usually very specific and related to the individual participants’ 
circumstances and interaction with the physiotherapist. It was apparent that the sessions were 
flexible enough to be tailored to meet the needs of the individual participant and it was 
therefore unsurprising that the issues raised by some participants as being problematic were 
not experienced as such by others. For example, several participants felt that on-going contact 
with physiotherapists or ‘maintenance’ physiotherapy would be desirable. 
 
“I reckon kind of a rolling check up every now and again would be a good idea […] like 
every six months or so, just to make sure you’re still keeping up with stuff” [Advice 113, 
withdrawn - received physiotherapy]. 
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However others felt that ongoing contact with a physiotherapist may not be required. 
 
“I think that’s debatable.  I think if you carry on and, and do what you’re supposed to be 
doing, then possibly not […] if you have a relapse then maybe you might” [Physiotherapy 
128]. 
 
Similarly, some participants felt that group physiotherapy sessions might be valuable. 
 
“I think a group session would’ve been helpful, erm, also because I’ve never met anyone else 
who has hypermobility syndrome […] it would’ve been good to sort of get to know other 
people and you know, have a bit more of a – a sort of feeling of how other people are, are 
dealing with it, and you know, what, what’s going on for them” [Physiotherapy 119]. 
 
But others preferred one-to-one physiotherapy. 
 
“I don’t mind group information but group physiotherapy I wouldn’t want, no. I think it’s 
quite a personal thing” [Physiotherapy 128]. 
 
Two participants specifically noted the complexity of the intervention, and in particular, the 
potential for differences between physiotherapists. 
 
“You’re doing a, a trial, you know, with lots of different people, with lots of different 
physiotherapists, but the outcome could be so different, depending on which physiotherapist 
you have” [Physiotherapy 127]. 
 
“Sometimes there’s some very good ones and sometimes there’s some not quite so good 
[laughter] but that’s the only, I can only base it on what I’ve seen on that side of things” 
[Advice 121]. 
 
Other, more practical issues were raised.  For example one participant felt that getting to the 
hospital for the physiotherapy sessions was “a bit of a pain” [Physiotherapy 111] and others 
suggested physiotherapy sessions could be held in easier to access locations. 
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“Somewhere with better, easier access and easier parking, so that I could have actually done 
it on my own without actually having to have somebody drive me and be responsible for the 
parking, because it’s very, very difficult now to actually know that you’re going to be able to 
get parked and get to your appointment on time. And, the distances involved are too far for 
me to walk now” [Physiotherapy 217]. 
 
The use of social media was suggested by one participant as a means of contacting others 
with JHS. 
 
“I've only recently gone online through Facebook I found people with the same conditions 
and it's been really interesting, I just talk to them. Sometimes it's difficult to find people, or 
you don't know where to start, so the possibility of people getting together or a group of 
people that can talk together I found that really helpful” [Physiotherapy 211]. 
 
Non-completers and decliners (Objective 6) 
Three participants withdrew from the study. One was randomised to Advice & Physiotherapy 
and withdrew to having a lack of time to be involved in the trial. The other two participants to 
withdraw had been randomised to Advice and withdrew from the study in order to access 
specific treatment. One of these participants was interviewed. This participant (Advice 113, 
withdrawn - received physiotherapy) felt that they were given too much information about 
the physiotherapy intervention and felt disadvantaged by not being allocated to that treatment 
arm, but did not cite this as a reason for withdrawing. Table 37 summarises data related to 
decliner interviews.  
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Table 37. Summary of short telephone ‘interviews’ with individuals who did not or could not participate in the trial. 
 D1 D2 D3 D4 D5 D8 
When diagnosed <1 year. When aged about 
11.   
< 1year. Not interviewed; 
brief telephone 
conversation. D4 
felt they would  
”rather not risk 
it”. 
Within the last two 
years. 
8-9 years ago for 
EDS. 
Reason for 
physiotherapy 
referral 
For JHS which 
was causing 
chronic 
problems.  Felt 
physio was 
now needed. 
Part of ongoing 
treatment, 
including a pain 
management 
course. 
For JHS. Hip problems, 
referred for JHS, by 
chance. 
Only just seen a 
specialist. Has been 
pushing for physio 
following own 
research. 
Prior physiotherapy No (not 
specifically 
asked but 
inferred from 
other 
responses). 
Yes, for years.   Yes, for other 
things – acute,  
one off things. 
Not for JHS per 
se. 
Since the age of 
about 14. 
Physiotherapists 
“didn’t know what 
to do”.  
Extensive 
physiotherapy, also 
knee surgery. Not at 
all useful. 
Reason for 
declining  
Did not want to 
risk being in 
the non-
physiotherapy 
arm. Had 
Thought it was a 
good idea. 
Already on a 
pain 
management 
Was not in a 
position to 
participate due to 
other life events.   
Wanted to 
participate but 
could not due to 
lack of time. Too 
busy:  “The busiest 
Distance to 
physiotherapist in 
Bath.  Not practical. 
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already waited 
a long time.   
course 
preventing 
participation. 
year of my life”. 
Understanding of 
study aim 
All understood 
clearly. 
To help manage 
JHS.  
To understand 
about EDS side 
of things and the 
hypermobility 
and finding out 
about what 
physiotherapy 
could help or not 
help with. 
To understand 
whether 
physiotherapy itself 
makes more of a 
difference than just 
the knowledge, or 
whether the 
knowledge itself is 
powerful enough. 
How to treat 
JHS/EDS better. 
Understanding of 
aim and what would 
be involved was not 
clear. D8 felt that it 
would be extra trips 
to hospital if 
involved in the trial. 
Under-standing of 
what would be 
involved 
A “risk” of 
“just receiving 
stuff to read 
about or self-
manage, cos I 
thought I’d 
already tried 
all that”. 
To an extent, but 
further 
explanation was 
not given as she 
was currently on 
a pain 
management 
course.  
Therefore  “Not 
Probably going 
to physiotherapy 
sessions and 
doing either 
exercises to help 
with JHS or not 
having anything 
done, whether or 
not you have any 
“I think at the time 
I didn’t know what 
it involved as such, 
so I just said, ‘Yes 
I’m up for it and 
I’ll read about it’”. 
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entirely sure” 
what would be 
involved. 
extra problems. 
Understanding of 
treatment allocation 
Yes, but had 
“already 
selected out of 
it”.  
The two arms 
were explained.   
No explanation 
of how allocation 
would work. 
That it would 
“just be 
random”. 
Believes details 
were in the letter 
but could not recall 
details. 
Unclear. 
Treatment 
preference 
Physiotherapy, 
as above. 
Rather have the 
physiotherapy. 
“No, not if I 
could have done 
them, no.” 
Physiotherapy if 
not so busy. 
Advice & 
Physiotherapy.  
Would have been 
“devastated” not to 
have physiotherapy. 
Anything that 
would encourage 
participation 
Different 
approach to 
having “advice 
only” arm. 
No, but did not 
have a clear idea 
of what the study 
entails. 
No, personal  
situation 
prevented 
participation.  
No. No, felt it would be 
far to travel. 
Further 
information 
required? 
No, very clear 
that she did not 
want to 
participate and 
Don’t know, as 
was not going 
ahead with the 
study.   
No, think it was 
very very 
informative. 
No, felt it was well 
written and very 
self-explanatory. 
More information 
about medication. 
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risk not getting 
physiotherapy. 
Other comments Cannot 
understand 
rationale for 
not having any 
physiotherapy. 
Cannot 
envisage 
anyone would 
participate in 
something 
preventing 
access to 
treatment. 
Thinks it is quite 
a good idea.  
Lack of research 
in JHS, limited 
mobility 
research.  Wishes 
a study of this 
kind had been 
running when 
she was a 
teenager.    
Would like to 
take part after 
pain 
management 
course. 
Would be 
interested in 
receiving a 
summary of 
research 
findings.  
“Just want to say 
thank you, I’m very 
happy that there is 
someone doing a 
study with joint 
hypermobility, I 
know it’s very 
difficult to get 
people to do that, 
so thank you”. 
Focus group, group 
intervention would 
be valuable. There 
is a lack of 
understanding about 
the condition. 
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5.3.4 Discussion: patient participants’ experiences of the trial  
The interviews with patient participants during Stage Three of the study allowed for a 
detailed exploration of patients’ experiences of being involved in the trial. As in Stage 1 and 
2, participants described diverse symptoms of JHS, often experiencing many years of 
individual joint problems, often during childhood. Although historically these symptoms 
were ‘not necessarily problematic’, for some, symptoms were often severe. Diagnosis was 
slow, and participants were often mis-diagnosed with eventual diagnosis usually following 
repeated injury or pain in a particular joint (most frequently hip, knee or ankle). Most 
participants had previously experienced physiotherapy, but this had focussed on a single joint 
rather than the holistic approach employed in the trial, and the outcome of physiotherapy was 
mixed. Most participants had been keen to try a form of physiotherapy that they thought may 
be different to their previous experiences. 
 
Participants were told about the trial after referral to secondary care to either a rheumatologist 
or physiotherapist. All participants who subsequently participated in the trial reported being 
keen to do so and fully understood the aims of the trial. Although some conceded that if 
physiotherapy was of no value their time would potentially be wasted in having 
physiotherapy, and they understood the notion of equipoise, for many ‘something rather than 
nothing’ was preferable. Most participants felt that the advice intervention was ‘less’ of an 
intervention than physiotherapy. A number of those who declined to participate did so 
because they wanted to ensure they received physiotherapy. Recruiting participants earlier in 
the referral trajectory may have resulted in participants having a different attitude to 
participation, although given the lengthy delays in securing a diagnosis expressed by many 
patients, adequately identifying JHS patients in primary care might prove extremely difficult. 
Having waited for a referral for what they believed would be physiotherapy, it is 
understandable that a patient may not want to accept the alternative advice intervention. In 
terms of the acceptability of the treatment arms, the perceived lack of equipoise between 
‘Advice’ and ‘Advice & Physiotherapy’ may have had wide reaching implications.   
 
Only one person having physiotherapy reported that it was a generally negative experience 
and that the treatment was a “waste of time”. Most benefited from the physiotherapy in some 
way.   
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5.3.5 Key findings in relation to study objectives 
The strength of this part of the research lay in strong recruitment of participants. The majority 
of patient participants in the pilot RCT were interviewed, as were six patients who declined to 
take part in the trial. Participants were broadly representative of those recruited to the pilot 
RCT in terms of sex, trial arm and clinical site. This helped to generate extensive data. A 
potential limitation lies in the possibility that those who declined to take part in interviews 
varied in their experiences and that these experiences were therefore not captured. The key 
findings in relation to the study objectives are summarised below. Objective 1: In order to contextualise participants’ experience of the trial, to explore their experiences of living with JHS, events leading diagnosis and subsequent referral for physiotherapy.  Also to explore participants’ experiences of, and attitudes to, the use of physiotherapy to manage JHS 
Numerous and diverse symptoms experienced by the participants had a varying effect on 
their quality of life.  Prior to diagnosis, many had experienced problems for many years, often 
in childhood, and an important finding was the need for greater recognition amongst health 
professionals that JHS can cause problems. One of the most important outcomes of obtaining 
a diagnosis for the participant was the validation of their symptoms, the reassurance that their 
experiences were ‘real’ and they were ‘not going mad’.   
 Objective 2: To ascertain the acceptability of the trial design for participants, including treatment aims and randomisation, and their preferences for treatment 
Participants all felt that the trial was important and valued the recognition of JHS as a 
condition with diverse, complex and often problematic symptoms.  Participants found it to be 
a valuable opportunity to learn about JHS. Although participants understood the notion of 
equipoise and that the evidence suggesting the effectiveness of physiotherapy to treat JHS 
was lacking, many felt that the two arms were unequal, and that those in the Advice & 
Physiotherapy arm obtained ‘more’ treatment that those ‘only’ receiving Advice. This may 
have impacted on the participants’ retrospective evaluation and attitude to participating in the 
trial and the outcomes. 
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Objective 3: To develop an understanding of the participants’ experiences of the Advice intervention and the Advice with Physiotherapy intervention.  More specifically, to ascertain participants’ perception of the value, acceptability and effectiveness of the treatments and develop an understanding of any barriers and facilitators to participant compliance.  Also to understand the acceptabity of data collection 
The provision of information and guidance about managing JHS in the Advice session 
(including the two information booklets provided at the advice session) was highly beneficial 
for many participants, regardless of whether or not they were subsequently randomised to 
receive the Physiotherapy intervention. Equally, many felt that the Advice intervention would 
be of limited benefit if they were suffering from an acute problem related to JHS which 
required physiotherapy input. Many felt that physiotherapy, or at least contact with a 
physiotherapist, was required for on-going support, reassurance and for the treatment of an 
acute or specific injury or problem. The patient handbook used to support the six 
physiotherapy sessions was generally rated postiviely, as a useful resource, which was user 
friendly and could be referred back to at a later date and used to reinforce what had been 
learned during the physiotherapy sessions. 
 Objective 4: For both intervention arms, to ascertain whether participants perceived any changes had been made or experienced, to participants’ health, behaviour and wellbeing.  Also to develop a deeper understanding of which outcomes or changes are considered to be meaningful by the patients 
The majority of participants reported making or experiencing some changes following the 
Advice intervention and the Physiotherapy intervention. Some found the information ‘life-
changing’, whilst for others, the information was a reiteration of information they had already 
accessed independently. For the participants who did feel the intervention had been 
beneficial, it was psychological benefits stemming from an enhancing feeling of being able to 
cope with the symptoms of JHS, to know how best to manage symptoms. Some participants 
also reported physiological changes including improvements in pain, sleep, and mobility. 
 Objective 5: To explore participants’ suggestions for improvements to the trial design and to each of the interventions (advice and physiotherapy components) 
There is no ‘one size fits all’ physiotherapy or advice intervention. This was reflected in the 
design of the trial which allowed for considerable flexibility within the treatment and advice 
sessions. Suggestions for improvements reflected the individual’s personal experience of the 
trial and individual circumstances and none of the suggestions could be considered 
unanimous.  
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 Objective 6: To explore the views and experiences of participants who did not complete the intervention and patients who did not wish (or were unable) to take part 
Wanting to access physiotherapy and lack of time were the primary reasons for not 
participating in the trial. 
 
5.4 PHYSIOTHERAPISTS’ EXPERIENCES 
5.4.1 Introduction 
Physiotherapists were interviewed at the beginning and at the end of Stage 3 (the pilot RCT) 
to explore their views relating to the practicalities and effectiveness of the intervention as 
well as their experiences of participating in the pilot RCT. 
 
5.4.2 Aims & objectives 
Interviews were carried out in order to develop a deeper understanding of physiotherapists’ 
views and experiences of being involved in the pilot trial. Specifically, the topic guides 
(Appendix 6 and 14) were designed to address the following objectives: 
 
1. To evaluate the format and delivery of the training for the pilot RCT.  To ascertain trainer 
and trainee physiotherapists’ training needs and requirements and obtain trainees’ views 
on their ability to carry out the trial post-training. 
2. To understand the experiences of the physiotherapists delivering the trial interventions. 
3. To evaluate the format, content, design and usability of the patient handbook. 
4. To explore physiotherapists’ views regarding the trial design, recruitment, randomisation 
and equipoise. 
5. To ascertain physiotherapists’ views on how the trial intervention arms could be improved 
in future trials or as part of standard care, and what improvements could be made and how 
physiotherapists can be supported in their role when delivering the physiotherapy 
intervention. 
 
The initial study protocol indicated an intention to also interview physiotherapists who had 
not been directly involved with the trial to determine the feasibility of rolling out the 
physiotherapy package. In hindsight the research team felt that this would only generate 
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hypothetical data as the physiotherapists would lack the context of familiarity with the 
intervention. It was therefore decided to concentrate on interviewing those who had 
experienced training and those who had delivered the intervention as part of the trial. 
       
5.4.3 Methods 
In-depth semi structured face to face or telephone interviews were carried out with JHS 
trained physiotherapists who were already involved in the trial and with therapists (‘trainees’) 
who had received the JHS training delivered by the trained therapists (‘trainers’). All 
participants received a participant information sheet and gave signed informed consent. 
Interviews were carried out immediately after training (within 4 weeks of being trained, see 
Appendix 6) and at the end of the trial (within 4 weeks of the last trial participant being seen, 
see Appendix 15). Interviews lasted between 23 and 76 minutes, and were digitally recorded 
and professionally transcribed. Transcripts were analysed using a thematic approach. Broad 
themes were assigned to the data which reflected both the main research questions and key 
issues which emerged in the interviews. The process of data analysis was similar to that 
already described for the patient interviews. 
 
In total, seven physiotherapists (3 trained, 4 trainees) participated in the interviews prior to 
trial commencement. Four physiotherapists (Band 6) were trained to deliver the 
hypermobility training to therapists who had not previously been involved in the study. At 
Site One, one trainee was a Band 5, with little previous experience in treating JHS, one was a 
Band 6 with limited experience of JHS and one was a student physiotherapist (second year 
undergraduate). At Site Two, one JHS specialist (Band 6) trained one other Band 6 therapist, 
who had prior experience of treating inpatient JHS patients. 
 
5.4.4 Results 
Table 38 summarises the physiotherapists who were interviewed at each site. 
 
Table 38. Number of physiotherapists interviewed at each site. 
Physiotherapist Site 1 Site 2 Total 
Trainer  (‘Post Training’ interview) 2 1 3 
Trainee (‘Post Training’ interview) 3 1 3 
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Trainer (‘End of Study’ interview) 2 1 3 
Trainee (‘End of Study’ interview) 1 0 1 
 
Training for the PHyt trial (Objective 1)  
Training was delivered by the trial chief investigator (SP) and one of the principal 
investigators (RL) to the physiotherapists already involved in the trial. Approximately two 
months later, the same training package was delivered at Site One by the trained 
physiotherapists to three additional therapists. The study chief investigator (SP) observed this 
training day. At Site Two one physiotherapist was trained over two sessions, separated by a 
number of weeks. 
 
General evaluation of training package format and delivery 
Overall, all participants viewed the JHS training positively and felt that the level of training 
was appropriate. Experienced trainees valued it as a ‘refresher’, as well as identifying 
information that was new to them. Less experienced trainees, including a physiotherapist 
undergraduate student, also found the information to be pitched at the right level, and 
reported that “all the information was really good” [Trainee D, Post Training]. 
 
Trainers, who were delivering the training for the first time, expected that the delivery of the 
training may evolve and improve over time. 
 
“I think, again, because we weren’t 100% okay with each bit, probably I didn’t deliver it as 
best as I could do, to my own standards” [Trainer C, Post Training]. 
 
One trainer felt that the training was limited from a general lack of empirical knowledge 
about JHS. 
 
“The difficulty is that we don’t really know exact answers on the theoretical approach. There 
is no evidence based on it, we haven’t got it there, that’s why we’re doing the study” [Trainer 
B, Post Training]. 
 
Whilst the benefits of allowing some flexibility in the training content to suit the trainee 
needs was recognised, it was also recognised that the training package was able to 
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demonstrate a standardised approach to assessing and treating JHS. However, one therapist 
cautioned against making the package of training too inflexible. 
 
“We thought it was a good way of standardising information; however, there's also the 
recognition that these are very complex patients who you can't always be quite so – not rigid, 
but you can't be quite so prescriptive in what you're going to say to them because of how 
you're going to manage them, because each one’s going to be a bit individual; there are 
going to be other aspects” [Trainer F, Post Training]. 
 
The training was delivered using a mixture of hands-on, interactive sessions and more formal 
lecture style presentations. Some felt that the training session was quite lengthy. 
 
“I think it got a bit long and drawn out at the end” [Trainer C, Post Training]. 
 
Trainees also reported that a lot of information was provided during the course and that this 
could be overwhelming. 
 
“It was good. Um, it, it explained everything that needed to be done. Um, so it, it was all in 
depth. But I just came out of it thinking, ‘There’s a lot that I need to remember’” [Trainee A, 
Post Training]. 
 
However, trainees generally did not feel that the training day was rushed and generally 
reported that the course was delivered well. At Site Two, training was delivered over two 
sessions, although the trainer felt that it would have been better to deliver the training in one 
session. 
 
“It's probably better to try and do it all in one, while it's all familiar, really, rather than 
having a big gap and then it's trying to recall what you've already gone through. Yes, I think 
it's probably better, because you're going through the information, then you can go and say, 
‘Let's go and have a look at the practical side of it a little bit’” [Trainer F, Post Training]. 
 
Some trainees felt that it may be a good idea to have two training sessions “because I think 
that helps with your learning; then you’ve got a chance to consolidate in between” [Trainee 
G, Post Training]. Some physiotherapists highlighted the need to re-read, refer back or 
185 
 
refresh their memory of what they had learned on the course, for example, to re-read the 
booklets they had been given. 
 
Training for the Advice session 
Trainer physiotherapists recognised that the delivery of the advice session may be difficult 
for newly trained physiotherapists and were careful not to ‘overload’ the trainees. They noted 
that the trainees appeared to be anxious about this session, even though a lot of the content of 
this session would be considered to be ‘normal care’. 
 
“None of it was completely alien or different, and I was happy with delivering all of it. It was 
just an awful lot to do and a lot of it, and the questions around it, were, ‘What do I do in 
assessments?’ I think that a lot of their concern was that there was so much to do, but 
actually a lot of it they do in their normal assessment, they would’ve already covered it. I 
think it’s a lot to do […] when you’re not necessarily quite so au fait with the paperwork […] 
that can take a bit of time. That was really their main concern, how much there was to fit in” 
[Trainer B, Post Training].   
 
One trainer reported that the trainees initially lacked confidence in their knowledge and 
ability to treat patients with JHS but that trainees subsequently gained the confidence in their 
clinical skills. 
 
“I think we were going through in quite a lot of detail and I think they thought, ‘Oh my God, 
this is quite a lot to take on board’, but when you reassure them that actually, you have all 
these clinical skills and you would do this anyway, they were like, ‘Oh, yes, we do actually, 
don’t we’” [Trainer C, Post Training]. 
 
Training for the Physiotherapy sessions 
The standardisation of the training relating to the physiotherapy sessions was highlighted. 
One participant felt that different physiotherapists could potentially deliver the training quite 
differently and therefore that it was important to ensure the theoretical aspects of the training 
were standardised. 
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Respondent:  “I think the difference comes in, it’s not saying treating differently, but I 
suppose it’s the theoretical thinking about, ‘Why am I doing this particular exercise or 
those?’ […] As I say, a lot of physios do work in different ways, and therefore, I don’t know, 
my one thing, now thinking about it is, in terms of thinking about that exercise and how it’s 
being delivered. Some people may take a more general exercise route, some people are more 
specific. A lot of it would depend in their training, what they’ve done previously and how they 
view it. […] actually within terms of exercise and those specific exercises they do, it’s just 
being aware of that really and making sure that it gets delivered the same” 
Interviewer: “Just to make sure that’s standardised”? 
Respondent: “Well yes, the theoretical approach at least” [Trainer B, Post Training]. 
 
One trainee reported feeling daunted by the prospect of the physiotherapy sessions following 
the training. 
 
“that was the one that kind of freaked me out a little bit. Because we basically, the way that 
we done it, is we done the, kind of, what is hypermobility and the criteria, in the morning. 
And then they basically said, they gave us this handbook kind of just before lunchtime and 
said, ‘This is the handbook that they get, but we’re going to cover this, um, in the afternoon.’ 
And that booklet just looks very detailed. And, then when it came to that part, and talking 
about what you need to get done in your half an hour follow ups, seems quite a lot to do. And 
even, and even [physiotherapist’s name] was saying, ‘You’ll, you’ll literally just be talking 
and talking and talking.’ So I’m thinking, ‘If, if she, as a manager and a specialist in 
hypermobility is saying it’s, you’re going at quite a speed, someone like me, who has a 
limited experience. Seems, seems a bit frightening’” [Trainee A, Post Training]. 
 
Training relating to the Physiotherapy patient handbook 
One therapist felt that delivering the training on the workbook was ‘boring’ and that it was 
necessary to make it more interesting for the trainees. 
 
“From a workbook perspective, I found it a bit dull and boring, actually. I was working from 
the text that we got given and it was quite repetitive. I was trying to go through and jazz it up 
and the idea was to keep it quite bland, so that you’re not bringing in a lot of patient 
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information and different things as well, or patient history, I suppose” [Trainer C, Post 
Training]. 
 
The patient handbook was generally rated positively, although the exercises included in the 
booklet met with a more a mixed response from trainers and trainees. 
 
“I think the booklet’s really good and I think that covers what we normally do in terms of the 
different sessions, like taking control  […] I think that’s really good. I just think it’s the 
exercises at the back that probably aren’t quite what I would normally do. But I understand, 
we’ve been told we can add our own in, anyway” [Trainee G, Post Training]. 
 
One therapist felt that the rationale for including specific exercises required further 
explanation. 
 
“Maybe a little bit more on some of the reasoning behind some of the exercises we give, a 
little bit” [Trainer C, Post Training]. 
 
One participant was unclear how to use the booklet in each of the physiotherapy sessions. 
 
“They obviously said this is the booklet the patient’s going to have, but I was a bit confused 
as to how we were supposed to use the booklet with our treatment, if you see what I mean?  I 
had to ask [colleague name] and when I had my follow up and came back in, I was a bit like, 
‘Am I supposed to actually go through everything in this book with her?’ She was like, ‘No, 
they’re supposed to go away and read that and they’re supposed to just come in and ask you 
questions about it and then your treatment is what I would normally do, so you’d just assess 
someone and you treat them how I would normally treat a patient.’ Obviously, I was a bit 
confused as to how these six things in the booklet were going to feed into my treatment and 
assessment. I was a bit confused about that; I’m still a bit confused about that. I think I need 
to go away and actually read the booklet back to back” [Trainee D, Post Training]. 
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Additional training requirements 
Trainee and trainer physiotherapists described possible additional training requirements 
(Table 39). A number of suggestions for changes may have reflected individual preferences 
rather than a general consensus.   
 
Table 39. Suggested changes to the training package. 
Area of training Suggested change Illustrative excerpt 
Information session  Allow more time for 
training  
“Cause in that part particularly, the advice 
part and the handbook, there’s a lot of 
information and also it’s a case of the logi- you 
know, just gave us these leaflets and said, ‘You 
have to refer to page eight’, or whatever. Um, 
so yeah. Probably, probably just to slow the 
pace down at that point” [Trainee A, Post 
Training]. 
Physiotherapy 
session 
Use of a JHS model 
patient 
 
“I think one thing that I would have found 
more useful in going through the assessment 
was actually having a patient here who had 
hypermobility, so that you could have, as they 
were going through the assessment, you would 
actually have seen someone who had 
hypermobility” [Trainee D, Post Training]. 
Patient Handbook Clarify use and content 
of written information 
“I think maybe just a bit more about how they 
would have expected us to go through the 
booklet with patients would be good” [Trainee 
D, Post Training]. 
 
“I think, if it was training for physios that 
hadn’t done any hypermobility before, there’d 
perhaps need to be a bit more about what 
exercise therapy, what way to approach that” 
[Trainee G, Post Training]. 
General Education for Health “A lot of the clinicians won’t recognise what 
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Professionals  
 
they’re seeing. So, it’s getting that information 
over. The Hypermobility Association does do 
their own treatment and training packages. We 
could be using it in conjunction with them a lot 
more as well. People with an interest would 
already be there. Maybe that might be a better 
way forward, I don’t know” [Trainer C, Post 
Training]. 
Provision of background 
information 
“If I was doing more a teaching on 
hypermobility, I'd probably go perhaps a little 
bit more detail into perhaps why people get 
pain – we don't really know why, but what are 
the things that we might look at? – so, in terms 
of objective assessment, might explore that a 
little bit more” [Trainer F, Post Training].  
Interactive training “I think I'd make it very interactive. I think 
what you've got to do is probably have lots of 
examples. You might want either someone, a 
model, coming in or you've got videos […] so 
people are aware of how people might 
compensate on the assessment side of it” 
[Trainer F, Post Training]. 
Distinguish between trial 
training and training 
related to JHS 
“I’d probably almost separate it out a little bit 
from that training from hypermobility 
syndrome. And the trouble is then when you 
come to doing the trial of making sure 
everybody’s clear on what needs to happen 
when and, and how and those sorts of bits of 
stuff , are the bits that, I think, got a bit 
confused. Er, I mean, yeah, I think I’d just try 
and probably be clearer from my point of view. 
And I don’t – I probably don’t think that’s – I 
would, yeah, I think just delivering it clearer. I 
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think we kind of went through the workbook 
and those sorts of things, and, and what was 
supposed to happen. But being clearer with, er, 
exactly what was going to happen” [Trainer B, 
End of Study]. 
 Standardising training “We all do things in a slightly different way. 
But I think in terms of, of really trying to make 
that training as standardised as, as possible is 
quite key because there are a number of things 
within hypermobility that are open to 
interpretation Erm, and I, I think that, again, 
doing a wider study, that has to be probably, 
erm, made quite kind of clear and, and defined 
to, to make it repeatable – and accurate as 
possible – across the sites” [Trainer B, End of 
Study]. 
Ongoing support for 
‘new’ physiotherapists 
“We can probably offer some telephone 
support and things like that, or whether we give 
them another back-up hour, perhaps for a 
session, or something, for case studies, or 
something like that to give them something. I 
think a lot of it is that they don’t know what 
they don’t know” [Trainer C, Post Training]. 
Training materials to be 
available to refer to 
“I said that I’d wanted to take a couple of the 
booklets home and the patient booklet home, 
but I gathered that we haven’t got that many of 
them. We don’t really get time in work to read 
through them and recap and stuff. Obviously, I 
just wanted to take a couple of them home so 
I’d have them to read through the night before.  
Trying to read through them in work doesn’t 
really work for me anyway” [Trainee D, Post 
Training]. 
191 
 
 
Trainees’ ability to carry out the trial post-training 
Three trainee therapists who had not worked with JHS patients before were apprehensive 
about delivering the intervention after the course. However, all realised that their confidence 
would grow as they saw more patients.  One participant who had previously expressed 
anxiety about conducting the trial reported “well, now I’ve seen a patient I feel better” 
[Trainee A, Post Training].   
 
Timing of the training was important; too large a time period between training and recruiting 
a patient with JHS to the trial meant that what was learnt may have been forgotten.  
 
“I would have preferred to have done the training day and then know that I had a patient 
booked in the following week. For me, I felt like I had that training and then didn’t have a 
patient for five weeks … Then I just felt that I didn’t then get that chance to consolidate 
everything you’ve learned and then you were trying to dig it back out of your brain from five 
weeks ago, trying to remember exactly what you were doing and trying to follow all of the 
information sheets I had. I think if I’d done the training and known I had a patient booked in 
the following week, that would have been better for me, I think” [Trainee D, Post Training]. 
 
Conversely, one trainee noted “when I saw that I had that patient a few days afterwards that 
kind of freaked me out a little bit” [Trainee A, Post Training]. 
 
One trainer felt that whilst the course provided basic knowledge and skills, hands on practical 
experience was essential. 
 
“What we’re going to be giving them is the basics; really, they’re not going to have the 
detail. We’re never going to be able to deliver that without having patients to work on. We’ve 
learned through patient mileage, unfortunately, like most things, they will probably learn 
through their own errors” [Trainer C, Post Training].  
 
Although participants were concerned that there was a lot to fit into each treatment and/or 
advice session, one therapist recognised that the intervention did not differ greatly from 
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current standard care. One trainee therapist who routinely worked with in-patient JHS 
patients at Site Two felt confident to treat as per the trial protocol.   
 
Trial training for trainee physiotherapists 
Trainee therapists did not have much prior experience of carrying out trials. Although 
sometimes daunting - this was an area where trainees often felt they learned a lot - it was also 
a valued part of the training. 
 
“So, in terms of the hypermobility part, I was fairly okay with. It, it was then, you know, when 
it moved onto the study part, it was really thinking about what I need to do” [Trainee A, Post 
Training]. 
 
Some felt that providing training about the trial and about delivering the intervention per se 
was problematic. Trainers felt that it was difficult for the trainees to take this information on 
board. 
 
“When we were just delivering the training element, and that should be fine, because we 
would do the assessment and then we could say, ‘Right, now to consent the patient, do this 
and this and this’ whereas, in the normal training, they wouldn’t have asked to do that. I 
think it’s that extra add-on that made them more jumpy about it all” [Trainer C, Post 
Training]. 
 
Physiotherapists providing the training were asked about the practicalities of training 
physiotherapists with little or no prior experience of treating JHS. Most felt that JHS ‘naïve’ 
physiotherapists would require additional training and support. 
 
“The difficulty with it is, it’s a lot to cover – in a very short space of time. I think we probably 
need to maybe be a bit clearer on study protocol and things that, erm, are the actual criteria 
and what happens and, and, from there and there and there. […] I also, I think, erm, having 
that probably ongoing support and back-up.  […] And, as I say, it is the experience of 
treating these sorts of patients because if you’re not used to treating them, any physio would 
find that, I guess, a little bit difficult” [Trainer B, End of Study]. 
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Possible changes to the training were discussed, for example, providing separate training on 
the workbook from training on hypermobility. 
 
“I’d probably almost separate it out a little bit from that training from hypermobility 
syndrome” [Trainer B, Post Training]. 
 
In summary, trainees and trainers felt that there was a lot of information to deliver in order to 
equip physiotherapists to deliver the trial intervention. Trainers felt that only in hindsight did 
it become apparent which aspects of the training course were not clear. 
 
“But being clearer with, er, exactly what was going to happen…And it’s probably easier 
being clearer once you do it and you realise the bits that aren’t quite clear. […] So as we got 
experience of actually running it and, ‘How does this work in?’ and those sorts of things. 
And, erm, so I think that kind of, that could be clearer. But that probably comes from the 
experience of, of running it as well and realising what – doesn’t work so well and what does 
work well” [Trainer B, End of Study]. 
 
Physiotherapists’ experiences of delivering the trial treatment (Advice and 
Advice & Physiotherapy) (Objective 2) 
Four physiotherapists (three trainers and one trainee) were interviewed at the end of the trial 
period, having gained experience of delivering the intervention to at least one patient.  
Participants were asked about their experiences of the trial and about their experiences of 
both of the intervention arms. 
 
Advice intervention   
Evaluation, acceptability and deliverability of the advice intervention 
Physiotherapists described the format of the advice session, of assessing the patient, 
exploring their particular problems, describing the trial to the patient and presenting the 
advice based on the HMSA54 and Arthritis Research UK55 booklets. Most physiotherapists 
felt that the Advice session, although it shared aspects of normal care, was rushed. 
Participants felt that there was a lot of information to provide and administration to undertake 
in the time allocated. 
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“You’ve got to recruit them and then you’ve gotta give them the information quick” [Trainer 
C, End of Study]. 
 
Physiotherapists felt that, although the session was lengthy, by and large, patients did engage 
well with the session. 
 
Interviewer:  “Did you find that the patients were engaged throughout that session?”  
Respondent:  “Yeah. I mean, I think it was a long session. But it’s – for a patient-wise, the 
normal session, that’s fine and the explanation bit, erm, which was the bit they really paid 
attention was - was, was relatively good” [Trainer B, End of Study]. 
 
The standardisation of the Advice session was considered to be potentially problematic in 
terms of its inflexibility. 
 
“Some people might need some information not the other … It makes it very generic then” 
[Trainer F, End of Study]. 
 
However, on the other hand, the standardisation of this session was also potentially valuable. 
 
“… I think probably for someone who perhaps isn’t so used to seeing lots of hypermobility 
maybe it’s a good way of keep making sure that you’re giving consistent information” 
[Trainer F, End of Study]. 
 
Physiotherapists felt that the Advice intervention was acceptable - and potentially valuable - 
for a certain sub-group of patients, who did not have a current issue which needed to be 
addressed, or who had been experiencing manageable symptoms for some time.  For 
example, some participants had been given a prior diagnosis of JHS but had not been 
provided with information about what it was, or how it could be managed.  For these patients, 
physiotherapists highlighted the potential value of the advice intervention.  
 
“… particularly working in rheumatology I have thought, “Actually just, just advice could 
play…quite a big part. […] But for them, for you to actually, kind of, see them early on to 
say, ‘This is what it is. You’re not doing it any harm. But we need just to control what you’re 
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doing a bit better and make you generally fitter’ I think is, is quite a, quite a big factor 
really” [Trainee A, Post Training]. 
 
On the other hand, participants felt that many who were experiencing problems wanted to 
access physiotherapy treatment, or would have benefited from some form of additional 
treatment. 
 
“I mean, I think if you’re picking up a general kind of population of, of hypermobility 
patients that necessarily aren’t struggling that’s an easier. But actually when you’ve got 
people that are struggling, they do kind of want that treatment” [Trainer B, End of Study]. 
 
“It just felt to us that they were getting a sho - a short shrift of a package really” [Trainer C, 
End of Study]. 
 
Physiotherapists felt that for some people, the Advice arm was not an acceptable intervention. 
 
“Would have like to have done something more with those people, or, or, or something else 
with them rather than absolute just one-off treat- information session. ‘Cause they weren’t 
even – we weren’t even allowed to give them exercises and send them away, it was literally, 
‘This is the booklet, this is what hypermobility is now go away and get on with it’ [Trainer C, 
End of Study].  
 What worked well in the Advice intervention? 
As described above, the provision of information about JHS was very valuable for some 
participants. 
 
“It sort of calms them down about the whole situation, I suppose, sort of giving them a 
reason for their pain and things like that, I think, has a massive effect and, um, I think that’s 
one of the main differences, often, working in rheumatology, to normal out-patients, that 
you’re actually giving, the majority of the time, you’re giving people an explanation for their 
pain, which they can understand.… whereas, I think a lot of the things that we do in 
rheumatology, well, for hypermobility and the inflammatory conditions, is there’s a very 
clear explanation as to what’s happening and why it’s happening and the reasons behind it. I 
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think that makes a massive impact on how people manage that mentally” [Trainee E, End of 
Study]. 
 
“It’s just really making sure that their understanding of what hypermobility syndrome is 
really and, and why that – and that reassurance that it isn’t, erm, necessarily anything bad or 
anything disastrous. Or anything like that. And, erm, erm, I think that’s probably the key 
element to get across into, yes, ‘Yes, you have got this. But it’s not a terrible thing. It’s not a 
particularly serious thing. We have to manage it and we have to manage it well.’ But then 
giving them the confidence to go in and, and do a bit more and not necessarily be, be worried 
about their pain all the time [Trainer B, End of Study]. 
 
Physiotherapy intervention 
Evaluation, acceptability and deliverability of the Physiotherapy intervention 
Physiotherapists described the outline of the physiotherapy sessions. Some felt that it was 
necessary to adjust the order or content of the sessions in order to respond to individual 
patients’ specific needs. 
 
“Erm, I was a bit happier to kind of address the bits a bit earlier if they were having things 
with them, and, and, and moved it round to sort – to help me really with their current 
problems.  Rather than kind of stick too rigidly” [Trainer B, End of Study]. 
 
Lack of time was always an issue. 
 
“I think it’s just being aware of timing. And, and getting them in within the four months. I 
tend to not be very good at necessarily thinking about that” [Trainer B, End of Study]. 
 
“Well, I feel it was quite deliverable. You were always running at a pace, you had to keep 
going with the exercises and doing the talking while you’re exercising and reiterating things 
all of the time like that. That was quite hard. I also found that I found, six sessions, in some 
ways we were going at pace to follow what was in the booklet for that week or whatever and 
to give them their exercises, but by about the fifth session we, we were probably there” 
[Trainer C, End of Study]. 
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One physiotherapist identified that patients often experienced improvements from the first 
physiotherapy sessions, but that more difficult-to-treat issues may have required further 
sessions or a longer duration of treatment. 
 
“I think they were surprised how much information they were given.  And I think also a lot of 
them felt very much better very quickly. They would come back with, not major, not massively 
different, but one part of them had felt that much better. That they felt really quite, erm, 
motivated by that I think really. So then, then once you got through some of those initial 
really good progressions then you’re left with the more difficult slower things to recover – 
‘Well, now, these things are going to take longer to improve and this is we’re teaching you 
how to look after you so you sort of stick with the programme and you should continue to 
improve more.’ So in some way they’re having to fit it in in four months, would have been – if 
we could have had a bit longer, we could have maybe got that a bit more, so it was trying to 
squeeze it into that four months’ time as well” [Trainer C, End of Study]. 
 
“…we had a few coming through with multiple other issues going on, which would have 
taken a bit longer, which would have taken, potentially, some of the time away at the end.  
Um, that, but I guess would have had an affect on their education side of things” [Trainee E, 
End of Study]. 
 What worked well:  ‘Active Ingredients’ in the Physiotherapy sessions 
Physiotherapists felt that increasing postural awareness was an important ‘active ingredient’ 
of the physiotherapy sessions. 
 
“It’s that postural awareness.  And that is, is increasing their awareness of their posture 
which is a lot of work that I do with through exercises and, and how they’re moving and how 
they’re doing stuff. Along with keeping that general activity up really” [Trainer B, End of 
Study]. 
 
“She [the patient] said ‘Oh, I’ve really changed how I work now and I don’t get pain from 
wor-working in a bad posture’. Things like that. So one of the big things is probably their 
posture more than anything else that improved” [Trainer C, End of Study]. 
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“It’s the fact that these patients don’t know at times, um, they can’t sort of see the 
compensations they do and the fact that they haven’t got the ability to selectively move […] 
it’s highlighting sort of those aspects in them and they’re so used to moving and behaving in 
that way, that trying to see that and change it is actually really difficult for them.  So, by 
having that sort of regular input, you’re sort of there, sort of showing them whether they’re 
doing it right or correct, you know, and trying to help them find ways to, to get the right 
muscles to facilitate and, and switch on to, sort of, that idea of selective movement and 
control of their movement.  Um, I would say is that is the main thing and that’s really what 
they need.  To help identify and working towards” [Trainee E, End of Study]. 
 
Trained physiotherapists, because of their previous experience of delivering the intervention, 
felt that there were able to deliver the intervention in a way which followed the protocol and 
yet tailor it to the needs of the participant. 
 
“I think having the experience of work and working with it before and not necessarily feeling 
you have to stick to that structure, so much of that book. So I did use the book. But I felt I 
could do probably more of my – I wasn’t just doing the book. I was doing a bit more of my 
normal kind of treatment bit as well. Whereas before when we did it, I got a bit too much of 
doing the book and not enough of looking at the patient” [Trainer B, End of Study]. 
 
The use of the workbook accompanying the physiotherapy sessions for the duration of the 
trial was thought to be valuable for patients (see also Objective 4 below). 
 
“Most of the patients I have, they come back having read the booklet, sort of, actually, they’ll 
know it all completely. It makes sense then.  Um, ‘That completely explains my symptoms’, I 
suppose. So, I think the added benefit of having that longer period of time with them meant 
that you could explain everything in the booklet prior to them reading it.  Which hopefully 
helped with their understanding” [Trainee E, End of Study]. 
 
“The really positive thing I think I would take from it is the booklet itself. And the refection in 
the booklet” [Trainer F, End of Study]. 
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To evaluate the trial booklet (Objective 3)  
Physiotherapists felt the workbook accompanying the physiotherapy sessions was of value 
and rated it positively. 
 
“And it was great to have the booklet, the booklet made quite a bit of difference. They could 
go away, read about it and come back. And the exercises were all in there readymade, so it 
gave us more time to spend with the patients and things as well rather than having to print 
more stuff off” [Trainer C, End of Study]. 
 
The opportunity given by the booklet for reflection, for both the patient and the 
physiotherapist, was considered to be valuable. 
 
“I think the booklet was really good. It’s really -  it’s information that we normally cover. But 
to have it written down in a booklet format was really helpful. ‘Cause often what we do is 
give them bits of paper. It’s not always in one piece.  […] and the feedback from patients was 
that they, it was really nice to, we talked about it, they were able to go back through and 
think, ‘Oh yeah, I remember going through that.’ Er, and the reflection bit was really helpful 
for both therapist and the patient I think. So I, I think on both camps it was really helpful” 
[Trainer F, End of Study]. 
 
Although one physiotherapist felt that the patients would have benefited from engaging in 
more reflection. 
 
“It [the booklet] also gave patients something, a hard copy to take away with them, so in the 
future they would always have something to look back on. And, I think the self-reflections, 
although, [unclear] my patients’ booklets, very few did that. Um, but I think if they had, that 
would have been useful as well” [Trainee E, End of Study]. 
 
The need for the workbook to be used by a trained physiotherapist, who could ensure the 
movements were carried out correctly, was highlighted. 
 
“The positions that you might get someone in isn't actually maybe the position that you would 
teach them, so the picture doesn't always reflect what you might actually show them to do. Or 
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you might not show them any of the exercises in that booklet; we might show them something 
different” [Trainer G, Post Training]. 
 
However, it was felt by some that the workbook may be of limited use if not employed to 
accompany the physiotherapy sessions, and could be potentially restrictive. 
 
“We both agreed that the workbook isn't very useful on its own, because obviously you're 
going to have to give someone an exercise for that individual, and some of the positions in -  
Generally, actually, we don't like physio tools anyway, because it restricts us quite a bit 
[Laughter] [Trainer F, Post Training]. 
 
Although others felt that such restrictions were minimal. 
 
“Most of them [patients] were quite happy just to go through the sections as they were put in 
the book” [Trainee E, End of Study]. 
 
Because of time constraints, one physiotherapist felt that it was not possible to fully utilise 
the exercises at the back of the workbook. 
 
“I don’t think the exercises at the back of the booklet were particularly - I think they were 
good to be there. Erm, but you, you didn’t really have time to go through a lot of exercises. 
So you might have to give them one or two to do” [Trainer F, End of Study]. 
 
To explore physiotherapists’ views regarding the trial design, randomisation, 
equipoise and recruitment (Objective 4) 
Trial inclusion and exclusion criteria, recruitment and randomisation  
Physiotherapists discussed at some length issues surrounding recruitment to the trial, in 
relation to equipoise, randomisation and the acceptability of the treatment arms.  
Physiotherapists generally felt that there were distinct groups of patients; those who required 
treatment for a specific, often acute, problem, and those who had been living with JHS for a 
long period of time and were willing to take part in the research and to potentially accept the 
advice intervention, to find out more about the condition, raise awareness and for altruistic 
purposes – ‘to help others’.  Some of these individuals may have been unable to attend a 
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course of six physiotherapy sessions. One physiotherapist (Trainer C, End of Study) 
described the different groups of patients in some detail. 
 
“…I’ve struggled to recruit because people were in too much pain. […] People were in fear 
of moving and didn’t – a lot of people didn’t want to go on a trial and not get treatment”. 
 
“…there were some that were definitely borderline and they said, ‘No, I definitely want 
treatment.’ And there were a couple that were in really bad pain.  And I sort of said, ‘We 
have got this study going,’ erm, ‘It’s up to you which way you go’ and professionally you 
think they need to be treated. And we wholeheartedly agree together they needed to get on 
with treatment, we didn’t recruit”… 
 
On the other hand. 
 
“… They want a diagnosis and though – and then they can't afford the time to come in - And 
the – that would fit the bill for some of them. And then for others, they need that real looking 
at the quality of how they move and changing it and things like that […]”. 
 
“There was one lot of people that said, ‘I’ve had this for years, I'm gonna cope for another 
seven months and then come back.  […] I just want things changed for the people in the 
future […] and I don’t care what I get and I’ll pick up the pieces in seven months after the 
questionnaires have gone out,’ kind of thing. There was that kind of group[…]”. 
 
“There was another group that was in a lot of pain and they said, erm, and they were very 
fearful of doing things, that they definitely needed someone there to support them through it, 
and they didn’t want to wait for that and they wanted to have treatment immediately.   And so 
we couldn’t recruit them. And then there were another batch that were sort of, ‘Well, erm, 
[unclear] and obviously if I do hit problems there’s a backup system that the service is there 
if we need it.’  […] Some people are very strongly, erm, very much – that they want 
something changed for the future, that they don’t want other people going through what 
they’ve been through”. 
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Physiotherapists felt that patients understood the trial and the implications of participation.  
One physiotherapist reported that patients had sometimes asked their opinion regarding 
whether or not they should enrol on to the trial. 
 
“I tried to stay out – kind of not guide them as much as I can really. But there was kind of bit 
of, ‘Do you think I should do it?’ ‘Do you not think I should do it?’ Erm, as I say, I tried to 
not answer that question as best I could. [Laughter] To not influence it” [Trainer B, End of 
Study].  
 
Physiotherapists felt that patients who did not want or require treatment at that particular time 
were happy to enrol on to the trial, whilst patients who had been referred to physiotherapy 
were less willing to accept the possibility of an Advice only intervention. 
 
“People that have been referred for physio for management of their – in terms of 
hypermobility syndrome, then they, they come in expecting something and wanting 
something. And, and they’ve already kind of selected themselves for that in a way, I guess” 
[Trainer B, End of Study]. 
 
One participant felt that if individuals with JHS without current problems were asked to take 
part in the trial, recruitment rates may have been better. 
 
“If you’re have a just a group of hypermobility patients that you sent out a random and said, 
‘Would you like to come and see if we can manage your hypermobility syndrome better’  then 
you’d get people that probably are a lot more happier doing one or the other.  […]  if they’re 
just diagnosed and they want to learn more about it but don’t have a specific problem, then 
they’re happier to – to, to try, to try both” [Trainer B, End of Study]. 
 
Equipoise 
Although physiotherapists understood the rationale and aim of the trial, and that the lack of 
empirical evidence indicating the efficacy of physiotherapy to treat JHS justified the trial 
design, they anticipated that it may be difficult to ‘persuade’ patients that clinical equipoise 
existed. 
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“I think it’s easy to convince a physiotherapist that the trial is worth doing because we don’t 
know if the treatment is or isn’t beneficial. But to convince a member of the general public, I 
think, would be much harder …the problem that you have is that you tell a patient that 
they’re either going to have treatment or not have treatment. But I think that immediately that 
a puts a barrier for them because they need to get over the option where they’re thinking, 
‘Well, if I don’t accept to join the trial, I will get a treatment. If I do go to the trial, then I 
might potentially not’.  That was the only thing I felt on the day that confused me a little. I 
don’t know if that’s something that would be able to be dealt with at all” [Trainee E, Post 
Training]. 
 
Participants felt strongly that they had a responsibility to their patients to provide optimum 
level of care and considered that the Advice intervention could not provide this for some 
patients. 
 
“That whole of, ‘We’ll just let you get on with it’, as I say, I  found slightly difficult to – 
[erm], well, not ‘sell’, but in terms of – I think that’s a big, big ask of, of patients.  
Particularly when they’re, they’re struggling and not so good.  I mean, I think if you’re 
picking up a general kind of population of, of hypermobility patients that necessarily aren’t 
struggling that’s an easier. But actually when you’ve got people that are struggling, they do 
kind of want that treatment” [Trainer B, End of Study]. 
 
“I think we always didn’t want a no treatment arm - But that was what we ended up having to 
have” [Trainer C, End of Study]. 
 
One participant felt that although the two intervention arms provided a way to help clarify the 
benefits of physiotherapy, the Advice intervention would not be as beneficial to patients as 
Advice & Physiotherapy. 
 
“Obviously, being a physio, I believe in what we’re doing, so it feels a bit harsh for the 
patients who are obviously only getting the advice, I feel that they’re not getting, um, the best 
out of their treatments, I suppose. But, then, you know, like I said, for research purposes, then 
that’s the best way of doing sort of a control group, isn’t it?” [Trainee E, End of Study]. 
 
204 
 
Generally, physiotherapists found the issue of equipoise in this study difficult, and felt that 
this was an issue related to recruitment. One participant alluded to the Advice intervention 
being ‘no treatment’ and felt that it was difficult to ‘sell’ the trial to patients. 
 
Interviewer:  “Okay. Do you think the patients believe there was equipoise?” 
Respondent:  “Erm - very difficult to say. Erm, [Laughter] I would guess probably 
not. Erm, kind of that that they’d been referred. I mean, I would – well I don’t know even if 
they believe that – I think they believed that there was no evidence one way or the other. Erm, 
if it was me coming as a patient – I’d rather try something than nothing. That is, is, I think, is 
generally – how a lot of them viewed it. […]  probably at least 50% of the people I’ve 
assessed, erm, or have responded saying they’re interested in the trial have probably decided 
not to do the trial. For the sake of, of the risk of having – not having treatment essentially.   
So, from – I think that’s the hardest point with it is selling the no-treatment side of the arm. 
And, and, and that there is that 50/50 per cent chance that they might get nothing” [Trainer 
B, End of Study]. 
 
Randomisation 
Physiotherapists felt that patients would prefer to be randomised to the treatment, rather than 
to advice condition. 
 
“Most people were quite positive, in the sense that they were very keen. Anything that they 
could contribute to increase understanding, awareness of their condition. You know, they 
were really happy to participate in a trial of any sort. However, when they, some people who 
found out that they then may not get any input, then felt that actually that wasn’t really what 
they wanted. So they were really keen to participate in a trial. But they didn’t want to then be 
on a trial that meant they might not actually have any input. Or they agreed and then some, 
we had a couple who then said, ‘Actually, I’ve gone off and had some...’  So they might’ve 
been on the advice arm and then they wanted to actually have some physio anyway” [Trainer 
F, End of Study]. 
 
Future recommendations and requirements (Objective 5) 
Physiotherapists’ views were gathered on how the trial intervention arms could be improved 
in future trials or as part of standard care and what improvements could be made and how 
205 
 
physiotherapists can be supported in their role when delivering the physiotherapy 
intervention. Suggestions are summarised in Table 40. 
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Table 40. Suggested improvements to the trial.  
Suggested improvement Illustrative quote 
Advice intervention  
arm 
 
Reduce the ‘information load’ for the 
patient and improve delivery of 
information in the advice session, for 
example by delivering the advice in two 
sessions. 
“When we were doing that advice session, we weren’t necessarily sure 
which arm they, that they’ll go down. So we tried to give them any - 
everything. I personally would prefer people to come back. I would 
prefer, but, I mean, again, it’s logistics of asking people to come back 
just for an advice session […] all the logistics behind getting here, 
difficulties of getting here, getting time off work, parking here, etc. But, 
I would have personally found it better to almost, um, have done the 
assessment, introduced the idea of the trial to people, let people go 
away, think about that. And then booked them in for their first 
treatment after that” [Trainee E, End of Study]. 
 
“Um, I just think it’s a lot of information for people to take on board, 
you’re coming in, you’re assessing them, you’re telling them, ‘You’re 
hypermobile,’ you’re then explaining a trial to them, which, probably 
most of them aren’t very familiar with how things like that work. And 
then on top of that, you’re then asking them to listen to you while you 
explain what hypermobility is” [Trainee E, End of Study]. 
Provide additional ‘treatments’ to 
augment advice session 
“The other thing I wanted to include but I don’t think costing would 
allow it and wasn’t available for equipoise around the country would 
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be some, like, hydrotherapy as well. As another arm, or maybe they just 
get given a one-off set of home exercises. Rather than nothing at all. If 
they were just told to go and do Tai Chi, go and do Pilates and see how 
you get on. But maybe we could have given them, ‘This is a generic 
exercise programme, carry on with it and see’” [Trainer C, End of 
Study]. 
Allow more time for the advice session “No time was the main one, more than anything else. […] time was 
really the only thing that you were fighting against” [Trainer C, End of 
Study]. 
Suggest to patients that they come 
accompanied to the Advice/Assessment 
session 
“Erm, I suppose things like you could always say to them they could 
have brought a carer with them and things like that” [Trainer C, End 
of Study]. 
Physiotherapy arm Group sessions “I think they missed out on the group session. We have a lot more time 
to describe things and the peer support and things, and they can look at 
other people and see what they’re doing better than we – ‘cause I can't 
show them the things that they’re doing, I think they find that much 
better” [Trainer C, End of Study]. 
Longer/flexible trial duration  “So in some way they’re having to fit it in in four months, would have 
been – if we could have had a bit longer- We could have maybe got that 
a bit more, so it was trying to squeeze it into that four months’ time as 
well” [Trainer C, End of Study]. 
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Trial Workbook Reorganisation/modification of exercises “For example, all the hand ones might be better to all be on one place 
and all the hip ones were a little bit, sort of, er, intermittent” [Trainer 
F, End of Study]. 
Diagnosis 
 
Standardising or addressing limitations of 
diagnosis 
“And while the Brighton criteria does help, erm, a lot of those, those 
sorts of thing is – that, again, is open to a degree of interpretation” 
[Trainer B, End of Study]. 
Inclusion/exclusion 
criteria 
Reconsider/clarify  
inclusion/exclusion criteria 
“Think we need to make sure that we exclude, and, and be a little bit 
clearer on people with other inflammatory arthropathies. Erm, because 
there was a little bit of confusion with some people” [Trainer B, End of 
Study]. 
 
“And actually some people that are, are quite active and, and, and 
quite keen can actually go through it in less sessions than they do. … 
and I think so catching them early is, is, is quite, quite important in, in 
terms of prompt treatment, er, and those sorts of things and before 
they’ve had too much other surgery. So that’s too many other problems 
that will limit their exercise” [Trainer B, End of Study]. 
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5.4.5 Discussion and recommendations 
A particular strength of this part of the research lay in strong recruitment to the interviews. 
All therapists who were trained and/or were directly involved with the trial were also 
interviewed. The strong recruitment generated extensive data. The decision not to interview 
physiotherapists who were not involved with the study (see justification in Section 5.4.2) 
might be seen as a limitation as we have limited data on potential issues with rolling out the 
intervention. However the data generated was based on direct experience of training and/or 
delivering the intervention rather than hypothetical projections on the behalf of therapists. 
 
Trainees and trainers were generally satisfied with both the one day training sessions and the 
training which took place at Study Site 2 over two non-consecutive days. Combining training 
on the advice and physiotherapy interventions for JHS with training specific to the trial in one 
session meant that there was a lot for new physiotherapists to take on board. Some therapists 
felt that the training day was “too long”, but generally it was felt that this was preferable to 
splitting the course into more sessions. However, one training session for the trial and one 
session for the intervention may be preferable. Flexibility in training delivery and content is a 
‘double edged sword’. Whilst this flexibility was necessary to respond to the needs of the 
trainees, it also may reduce standardisation. ‘Take home’ training literature for the trainee 
physios was required; to support their confidence and allow them to refer back. Hands on 
experience and contact with JHS patients are necessary soon after training. A JHS model 
patient would help trainees new to treating JHS to understand the nature of the syndrome and 
its manifestations. 
 
Trainers and trainees felt that the volume of information in the Advice session may be 
overwhelming. There was some agreement that the Advice session, whilst acceptable to 
some, left some patients requiring more input. 
 
The patient handbook was helpful in many ways but physiotherapists’ attitudes to the 
exercises included at the end of the booklet were more ambivalent. The workbook was rated 
positively as an adjunct to the physiotherapy sessions. It was felt, however, that 
physiotherapy input was also required. The physiotherapy sessions were regarded positively.  
Time and duration were raised as issues which may have impacted upon effectiveness of the 
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intervention. Being treated for JHS and simply having the condition recognised was 
considered by physiotherapists to be a very important component of the intervention. 
 
Inclusion and exclusion criteria were discussed at length in relation to clinical equipoise and 
recruitment issues. It was felt that there may be distinct groups of patients who may 
differentially benefit from each of the intervention arms. 
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CHAPTER 6 – CONCLUSIONS & RECOMMENDATIONS 
6.1 MAIN FINDINGS 
The focus group data demonstrated that JHS is a complex and unpredictable condition with a 
wide impact on physical and psychological wellbeing. Diagnosis is often delayed and this 
may make the condition more difficult to manage. Patients and health professionals with 
experience of managing JHS shared many key notions of what a good physiotherapy 
intervention should look like. Essentially JHS needs to be treated holistically as a long term 
multi-joint condition, rather than treating individual acutely painful joints in isolation. 
 
A comprehensive user-informed Physiotherapy intervention and associated training package 
was developed which was generally evaluated positively by patients and physiotherapists. 
Training could be improved to incorporate patient models and more practical hands-on 
teaching, including early clinical experience of treating JHS patients following training. The 
Advice intervention and the patient handbook and general structure and content of the 
Physiotherapy intervention were generally commented upon favourably.  
 
The pilot RCT provided evidence of promise that the Physiotherapy intervention may 
produce moderate clinical effects on outcome measures which are specific to rheumatological 
conditions (RAPID3) and JHS (BIoH questionnaire) over and above Advice alone. The 
qualitative interviews with patients and physiotherapists supported the potential effectiveness 
of both the Advice intervention and the Physiotherapy intervention and generated clear 
recommendations concerning the design and conduct of any future RCT. There were no clear 
trends in terms of cost-effectiveness, although the Value of Information estimates were 
supportive of the likely benefit of conducting a future definitive RCT. Taken as a whole, the 
data generated in the current project suggest that a future definitive RCT is warranted. 
 
There were some specific challenges in conducting the pilot RCT and these would need to be 
addressed in any future RCT. Further consultation with people with JHS and with health 
professionals with regards to these issues would be crucial in refining the final design of a 
future definitive trial. Specific lessons are discussed in the following section. 
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6.2 SPECIFIC LESSONS FROM THE PHyT STUDY 
6.2.1 Clinical equipoise 
Conducting the pilot RCT was challenging due to the perceived lack of equipoise between the 
advice intervention and the physiotherapy intervention. Qualitative data suggested that this 
was an issue both for patients and physiotherapists involved with the study and is likely to 
have negatively impacted upon recruitment and retention. The lack of adequate control 
groups has been highlighted in the literature as a major issue in convincingly demonstrating 
the effectiveness of physiotherapy for JHS.31 Only one previous RCT included a no-treatment 
control group22 but unfortunately those authors failed to report a direct statistical comparison 
of trial arms following treatment. The only other controlled studies were conducted with 
children and employed different types of exercise as comparator groups.35-36 So, there is an 
argument that the existing research evidence (or lack thereof) supports a notion of clinical 
equipoise in terms of whether physiotherapy is better than advice or indeed doing nothing. 
The qualitative data seems to support the notion that this was largely understood by patients 
and physiotherapists in the present study. It is clear, however, that this collective 
understanding of clinical equipoise did not translate to personal equipoise on behalf of 
patients and physiotherapists, with many believing that the advice intervention was inferior. 
This conflict between clinical and personal equipoise has been recognised in other areas of 
physiotherapy research such as manual therapy.96 
 
Any future RCT in this area will need to ensure robust training and monitoring of trial 
personnel to ensure notions of equipoise are delivered and reinforced consistently. This might 
include openly eliciting and discussing treatment preferences with patients as part of the 
informed consent process.97 Revision of the wording of participant information sheets should 
also be undertaken with the assistance of patient research partners to reinforce messages 
related to equipoise.  
 
6.2.2 Design of the comparator trial arm 
An issue closely related to equipoise was the design of the advice control intervention in this 
pilot RCT. Some patients clearly benefitted from the one-off advice intervention and 
booklets, reporting that the information helped them to understand their condition better and 
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that it acted as a catalyst for change. Other patients and physiotherapists however were 
clearly not convinced that it represented a credible alternative to the physiotherapy 
intervention. Patients had been referred for physiotherapy and therefore many felt that advice 
was ‘less’ of an intervention. Another important consideration in this was that the advice 
session deviated from ‘usual care’ at the two study centres involved in the research, both of 
which have particular expertise in the management of JHS. Patients and physiotherapists 
provided some useful suggestions for how the comparator intervention might be redesigned 
for any future study. In considering these suggestions, the research team was mindful of 
striking a balance between creating a credible comparator trial arm and diluting the potential 
difference in effectiveness between trial arms, should one exist.  
 
It was felt that the principles of the advice intervention used in the present pilot RCT were 
probably sound – aiming to respond to questions and issues generated by individual patients, 
supported by advice literature. The data suggested that there was insufficient time in the one-
off advice session to do this effectively, however. The strategies of using telephone support 
and additional face-to face sessions suggested by study participants would seem to allow the 
opportunity to maintain the existing principles of the advice intervention but allow additional 
time to listen to and respond to individuals’ issues. It is therefore recommended that a future 
RCT employs additional telephone and face-to face contact to support participants 
randomised to the advice control arm. The participant information sheet should again be 
revised with the assistance of patient research partners to ensure that the advice arm is 
portrayed positively.  
 
6.2.3 Recruitment rates  
A further inter-related issue was the lower than expected rate of recruitment to the pilot RCT. 
An initial target was set of n=60 participants over 12 months (equivalent to 5 per month). 
Due to delays in NHS approvals, a shorter 8 month recruitment period was available, over 
which n=29 participants consented to the study (equivalent to 3.6 per month). The 
recruitment period also coincided with a move of one of the physiotherapy services into a 
new hospital building which caused a hiatus of recruitment activity at that site. A range of 
strategies were implemented to boost referrals and enhance consent rates but recruitment 
remained disappointing.  
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Issues related to perceived equipoise between study arms and the design of the control 
intervention have already been discussed and attention to those factors is likely to improve 
recruitment rates to a future RCT. It is also worth noting, however, that some 28% 
(n=34/121) of referrals either failed to respond or did not attend (DNA) for assessment during 
the recruitment period. A DNA has been defined as “a wasted appointment slot, caused by a 
patient who does not attend an appointment (whether they cancel or do not turn up on the 
day) and the appointment slot is unused”.93 The average DNA rate for musculoskeletal 
physiotherapy outpatient services has been reported to be 9.45% across the UK.93 Whilst 
many of the 28% of referrals in the present study simply did not respond and would not 
officially be classified as DNAs, this still represents a sizeable group of potential participants 
who were not available for assessment of eligibility. A future RCT should ensure that 
resources are in place to follow up all potential participants to maximise recruitment.  
 
Another potential strategy would be to try to identify participants earlier in the referral 
pathway, for example in primary care. Given the difficulties in recognising and diagnosing 
JHS reported by participants throughout this research, however, this is likely to be extremely 
difficult and would require concerted education and awareness-raising in primary care. It 
would likely be more productive to concentrate on adequately identifying those with JHS 
from referrals to musculoskeletal outpatient physiotherapy services. Connelly et al14 found 
that 30% of all referrals to a musculoskeletal triage service met the diagnostic criteria for 
JHS. Whilst not all of those patients would have been referred for symptoms directly 
attributed to JHS, it does suggest that there is a large population of potential JHS patients 
being referred to physiotherapy services. Clark et al98 reported that JHS is accompanied by a 
wide range of concomitant diagnoses such as chronic widespread pain (86%), chronic fatigue 
syndrome (31%) and fibromyalgia (19%), each of which might form the basis for a referral 
for physiotherapy. It might therefore be possible to screen all referrals to physiotherapy 
services to help identify participants with JHS. A simple five-item screening questionnaire 
for identifying those with JHS was developed by Hakim and Grahame99 and has been shown 
to have 84% sensitivity. Such a tool could help to identify patients with other concomitant 
diagnoses who are hypermobile and who might be likely to receive benefit from the advice 
and/or physiotherapy intervention package. A diagnosis of JHS could then be confirmed 
clinically before recruitment to the trial. As a minimum a future RCT should aim to train all 
musculoskeletal physiotherapists within participating organisations to recognise those 
patients likely to have JHS so that they could help to identify potential trial participants.  
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Recruitment of men was roughly proportionate to expected rates. It has been reported that 
symptomatic joint hypermobility affects 5% of women and 0.6% of men (Simpson 2006),10 
equating to an approximate ratio of 88% women to 12% men (if the populations are roughly 
equal). Men comprised 12% (3/25) of those recruited to Stage 1 and 10.3% (3/29) of those 
recruited to Stage 3 of the current research. Stratification by sex should be employed as part 
of the randomised allocation to trial arms in any future RCT as, by chance, all 3 men were 
allocated to the Advice intervention in Stage 3 of the current project.      
 
It is clear that a future RCT should be multi-centre to maximise recruitment. Sample size 
calculations for a future RCT have been conducted on the basis of a similar recruitment and 
attrition rate as was experienced in the pilot RCT, although there are clear opportunities to 
improve on these. Recruiting six centres of a similar size to those participating in the pilot 
RCT seems realistic and it is estimated that recruitment would take 20 months (based on the 
RAPID3 as the primary outcome measure) or 25 months (based on the BIoH). Again, this 
seems feasible.   
 
6.2.4 Questionnaire return 
In the pilot RCT questionnaire completion was 83%, 65% and 73% at baseline, 4 months and 
7 months respectively.  The rate of completion was consistently lower in the Advice arm than 
the Advice & Physiotherapy arm, which may indicate an element of disengagement from the 
study on behalf of those randomised to receive the Advice intervention in isolation. 
Administration of questionnaires was by mail and, despite mail and telephone reminders, it 
was very difficult to secure completion and return of questionnaires. A future RCT should 
schedule face-to-face review to ensure completion and return (or complete over the 
telephone). If the advice intervention was redesigned it might be possible to schedule face-to-
face advice sessions with outcome assessment. 
 
6.2.5 Adverse events 
The rate of adverse events was higher in the Advice arm than in the Advice & Physiotherapy 
arm. It was extremely difficult to attribute events directly to treatment (or the lack thereof), 
particularly when a baseline of adverse events had not been established. It is known that this 
patient group is prone to events such as trips and falls, joint subluxation and dislocation, and 
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a range of soft tissue conditions2 and one interpretation may be that the Physiotherapy 
intervention reduced the incidence relative to the Advice intervention. However, because the 
Advice intervention deviated from ‘usual care’ at the two NHS Trusts involved with the trial, 
the DMEC asserted that all participants in the Advice arm should be offered physiotherapy at 
the end of the trial and this was enacted. It is recommended that a future RCT should record 
adverse event rates at baseline to better inform judgements about changes in rates over time 
and between trial arms. 
 
6.3 RECOMMENDATIONS FOR FUTURE RESEARCH  
Based on a wide range of quantitative and qualitative data generated as part of this research, 
it is recommended that a future definitive RCT is warranted. Some specific lessons to inform 
a future RCT have been identified in the previous section (Section 6.2) and are summarised 
as follows:  
 
• Train and monitor trial personnel to ensure notions of equipoise are delivered and 
reinforced consistently. 
• Offer additional telephone and face-to face contact to support participants randomised to 
the Advice control arm. 
• Screen all referrals to physiotherapy services to identify those with JHS 
• Stratify randomisation to trial arms by sex.  
• Employ multi-centre recruitment. 
• Schedule face-to-face review to complete study outcome measures. 
• Record adverse event rates at baseline.   
 
The lack of high quality epidemiological evidence on the incidence and prevalence of JHS 
remains a barrier to development of research in this area. Future epidemiological research 
should also aim to identify prognostic indicators which might form the focus for refinement 
of management interventions. 
 
Future research is required to understand the extent to which any changes are maintained in 
the longer term. A minimum of 12 month follow-up would be useful to determine long term 
benefits of treatment.  
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Participants and physiotherapists talked of the potential benefit of ongoing review and 
support and it might be useful to explore whether the addition of such review enhances long 
term management. This might be difficult within the constraints of an RCT but it is worth 
investigating in the future whether ongoing access to treatment and advice is effective in the 
long term. 
 
It would be helpful to determine if there are sub-groups of patients who might have different 
requirements, for example those recently diagnosed and those who have lived with the 
condition for a number of years. De Wandele et al100 found evidence for three distinct sub-
types of patients with EDS-HT, with non-musculoskeletal symptoms acting as an important 
distinction between sub-groups. If sub-groups of patients are verified, then future research 
could determine what their specific needs might be and whether more tailored physiotherapy 
interventions might enhance effectiveness. Future research should also endeavour to recruit 
wider ethnic and gender diversity than was reflected in the current research.   
 
Barriers to physiotherapy treatment effectiveness also need to be explored in more depth. 
This could include future research exploring factors affecting treatment adherence and the 
extent to which participants did adhere to the advice given by the physiotherapists. As 
numbers in the Advice & Physiotherapy arm were small, it was difficult to assess the extent 
to which the intervention was adhered to. 
 
Both therapists and patients in this study reported that difficulties in diagnoses often stem 
from primary care so recognition and diagnosis needs to be improved. There are obvious 
implications for the education and training of General Practitioners and other health 
professionals. Research should be conducted to identify the educational needs of primary care 
health professionals with regards to JHS diagnosis. 
 
6.4 CONCLUSION 
The present research has developed and evaluated a comprehensive user-informed 
physiotherapy intervention. The findings demonstrate that a future definitive RCT of 
physiotherapy for JHS is feasible in the UK.   
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